data_1xv3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xv3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -70.37 -25.99 63.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.691 -0.887 . . . . 0.0 110.36 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -76.89 3.75 11.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 111.2 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 t -142.76 69.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 m -50.65 -25.82 4.7 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.635 -0.666 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -107.61 124.87 50.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.855 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.05 -29.28 7.81 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.477 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 41.2 pt -77.4 163.2 65.73 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.245 -1.15 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.46 154.38 50.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.023 1.539 . . . . 0.0 111.165 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -57.44 -41.35 80.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.89 -0.506 . . . . 0.0 110.969 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -60.58 -45.55 93.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 80.1 m -67.8 -40.4 83.89 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.54 91.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 110.012 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -43.48 98.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.355 -0.841 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.7 -40.45 95.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.763 -0.586 . . . . 0.0 109.811 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -64.27 -30.12 71.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.456 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.6 t -85.93 -36.95 19.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.843 . . . . 0.0 109.741 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -70.07 -38.8 75.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.68 -0.638 . . . . 0.0 111.034 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -58.74 1.95 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 111.757 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 87.0 m-85 -79.88 -36.91 35.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 111.257 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.44 13.51 38.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -106.73 160.07 15.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.074 -1.251 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.379 0.609 . . . . 0.0 109.694 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -66.66 -30.29 70.52 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.676 -0.896 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -83.53 10.92 7.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 0.0 110.78 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.29 61.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 108.719 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.2 m -47.37 -27.55 1.69 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.935 -0.478 . . . . 0.0 111.37 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.73 125.77 51.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 0.0 109.819 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.97 -29.28 7.84 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.502 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.2 pt -79.37 164.0 56.42 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.234 -1.157 . . . . 0.0 110.463 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.25 155.76 51.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.046 1.55 . . . . 0.0 111.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 t -57.74 -41.04 81.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.898 -0.501 . . . . 0.0 111.219 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -62.46 -43.48 98.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.854 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 47.6 m -64.86 -41.36 95.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.396 -0.815 . . . . 0.0 109.299 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.11 -41.76 88.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.723 -0.611 . . . . 0.0 110.48 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -63.62 -43.11 97.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.478 -0.764 . . . . 0.0 109.826 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -37.09 80.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -66.9 -30.14 70.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.61 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 t -86.28 -36.28 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.913 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.436 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 17.1 t80 -70.41 -38.77 74.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.635 -0.665 . . . . 0.0 111.047 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -98.18 -60.21 1.6 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 111.696 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 77.7 m-85 -75.58 -39.22 58.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.232 -0.918 . . . . 0.0 111.068 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.99 38.78 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.668 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.59 160.52 15.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.917 -179.406 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.22 -29.35 68.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.669 -0.901 . . . . 0.0 110.674 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 16.76 4.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -0.816 . . . . 0.0 110.556 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.58 61.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.031 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.2 m -48.64 -26.24 2.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.811 -0.556 . . . . 0.0 111.241 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -105.34 128.32 53.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.84 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.82 -30.84 7.46 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.8 pt -84.0 162.18 52.93 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.336 -1.097 . . . . 0.0 110.426 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.1 Cg_endo -74.21 153.09 45.77 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.166 1.614 . . . . 0.0 111.001 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -58.73 -36.67 74.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.861 -0.524 . . . . 0.0 111.288 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -64.14 -45.04 90.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.8 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 m -68.41 -41.86 79.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.94 89.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.815 -0.553 . . . . 0.0 110.213 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -64.01 -42.78 97.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -0.768 . . . . 0.0 109.428 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.18 -38.8 91.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.606 -0.684 . . . . 0.0 109.618 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -61.04 -33.82 73.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.783 -0.573 . . . . 0.0 110.329 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.4 t -78.67 -37.74 41.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 109.907 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -66.81 -38.97 87.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.38 -56.23 2.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 111.856 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.1 m-85 -80.18 -37.33 33.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.202 -0.936 . . . . 0.0 111.072 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 11.41 45.91 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.42 157.86 18.04 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.999 -1.295 . . . . 0.0 110.273 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 121.38 0.61 . . . . 0.0 109.987 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.82 -28.57 61.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.631 -0.923 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.84 8.8 6.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.302 -0.874 . . . . 0.0 111.02 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.41 65.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.021 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.4 m -50.51 -24.17 2.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.664 -0.647 . . . . 0.0 111.288 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -106.78 126.03 51.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.39 -27.2 10.23 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.457 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.5 pt -81.84 162.17 58.46 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.123 -1.222 . . . . 0.0 110.754 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.77 155.53 48.95 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.16 1.611 . . . . 0.0 111.099 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -58.58 -39.15 79.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.79 -0.569 . . . . 0.0 111.111 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 t -61.8 -45.52 93.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.372 -0.83 . . . . 0.0 109.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -69.43 -40.13 77.42 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.08 93.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.701 -0.624 . . . . 0.0 110.282 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -65.7 -42.32 91.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.428 -0.795 . . . . 0.0 109.517 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.88 -38.25 85.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.709 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -61.93 -30.89 71.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.62 -0.675 . . . . 0.0 110.202 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -83.93 -37.68 22.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.358 -0.838 . . . . 0.0 109.548 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -71.2 -35.46 71.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 111.015 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -55.72 2.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -86.31 -36.22 19.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.308 -0.87 . . . . 0.0 111.129 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.32 37.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.64 159.97 15.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.089 -1.242 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.794 -0.566 . . . . 0.0 109.913 -179.693 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.32 -28.15 66.91 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.669 -0.901 . . . . 0.0 110.979 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.9 11.86 5.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.8 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -139.76 63.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.28 -0.887 . . . . 0.0 109.024 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.5 m -49.54 -25.94 3.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.729 -0.607 . . . . 0.0 111.069 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -105.87 126.06 51.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -29.77 7.46 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.473 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.6 pt -81.27 162.89 57.37 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.34 155.26 51.21 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.096 1.577 . . . . 0.0 111.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 t -56.94 -41.66 78.64 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.012 -0.43 . . . . 0.0 111.132 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -62.25 -45.75 91.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.9 m -66.37 -40.57 89.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.21 96.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.731 -0.605 . . . . 0.0 110.15 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -42.85 99.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.765 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.1 -38.9 89.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.526 -0.734 . . . . 0.0 109.703 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -62.83 -29.15 70.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.629 . . . . 0.0 110.396 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -85.98 -37.02 19.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.378 -0.826 . . . . 0.0 109.622 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -70.79 -36.66 73.11 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.701 -0.624 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -57.58 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.9 m-85 -81.76 -37.19 27.6 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.093 -1.004 . . . . 0.0 111.175 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.61 12.24 38.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.69 159.59 15.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.121 -1.223 . . . . 0.0 109.778 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 121.385 0.612 . . . . 0.0 109.77 -179.436 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.7 m -66.42 -30.54 70.92 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.831 -0.805 . . . . 0.0 110.594 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.0 12.27 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.785 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 t -139.57 63.04 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.322 -0.861 . . . . 0.0 108.862 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.6 m -49.83 -25.09 2.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.839 -0.538 . . . . 0.0 111.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -105.34 126.78 52.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.139 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.89 -28.29 8.98 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.9 pt -84.61 162.08 51.67 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.155 -1.203 . . . . 0.0 110.611 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -74.16 155.11 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.139 1.599 . . . . 0.0 111.011 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -58.36 -40.78 83.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.822 -0.549 . . . . 0.0 111.022 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -60.48 -45.98 91.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.45 -0.781 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.0 m -66.16 -41.83 89.79 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.24 92.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.758 -0.589 . . . . 0.0 109.904 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.8 -44.2 97.17 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.463 -0.773 . . . . 0.0 109.908 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.593 -0.692 . . . . 0.0 109.824 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.64 -35.15 78.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.635 . . . . 0.0 110.555 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -78.98 -38.62 36.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.83 -38.73 83.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.608 -0.683 . . . . 0.0 111.175 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -57.94 2.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.428 -0.795 . . . . 0.0 111.731 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 83.3 m-85 -84.02 -34.59 24.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.154 -0.966 . . . . 0.0 111.421 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.97 12.17 47.28 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -104.78 157.13 17.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.898 -1.354 . . . . 0.0 109.971 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.126 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -67.24 -29.41 69.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.726 -0.867 . . . . 0.0 110.212 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.76 16.19 4.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.537 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 t -141.71 63.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.224 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.7 m -48.14 -25.87 1.65 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.761 -0.587 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.5 126.29 52.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.39 -31.76 6.26 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.8 pt -80.76 162.8 58.91 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.307 -1.113 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.7 Cg_endo -73.33 153.4 50.63 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.08 1.568 . . . . 0.0 111.134 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -37.67 73.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.878 -0.514 . . . . 0.0 111.309 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -65.13 -44.67 87.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.39 -0.819 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 54.2 m -64.81 -41.33 95.87 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 109.21 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.44 78.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.634 . . . . 0.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.06 -41.19 91.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 109.09 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -40.47 95.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.78 -40.46 95.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.633 . . . . 0.0 109.769 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.52 -38.52 68.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 109.983 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -67.5 -38.14 83.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.7 -0.625 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -58.74 1.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 111.811 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -77.7 -39.67 43.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.261 -0.899 . . . . 0.0 111.169 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.03 14.0 32.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 6.1 m-20 -112.02 159.11 18.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.061 -1.258 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 32.3 m . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.364 0.602 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -67.78 -31.14 70.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.796 -0.826 . . . . 0.0 109.83 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -72.22 -0.49 12.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.66 -0.65 . . . . 0.0 111.48 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.1 t -143.03 74.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.14 -0.975 . . . . 0.0 108.989 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.1 m -50.43 -23.1 2.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.765 -0.585 . . . . 0.0 111.339 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -104.96 128.13 53.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.227 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -25.11 15.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.458 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.4 pt -79.55 162.09 64.57 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.153 -1.204 . . . . 0.0 110.908 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.53 156.65 49.6 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.206 1.635 . . . . 0.0 111.333 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -56.89 -40.97 77.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.958 -0.464 . . . . 0.0 111.31 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -63.35 -43.61 97.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.449 -0.782 . . . . 0.0 110.243 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 30.8 m -64.51 -41.15 96.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.42 -0.8 . . . . 0.0 109.111 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.75 79.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.712 -0.617 . . . . 0.0 110.294 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -64.71 -42.08 95.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.04 -37.22 78.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.635 -0.665 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -67.64 -31.53 71.6 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.557 -0.714 . . . . 0.0 110.269 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.9 t -86.85 -35.15 19.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -70.21 -40.58 74.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.602 -0.686 . . . . 0.0 111.363 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -53.42 3.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 111.844 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 94.5 m-85 -82.85 -36.03 25.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.89 . . . . 0.0 111.304 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 12.17 48.58 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.98 158.86 16.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.76 -0.588 . . . . 0.0 109.936 -179.719 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.407 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 m -66.55 -28.98 68.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.788 -0.83 . . . . 0.0 109.813 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.24 3.09 9.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.6 -0.688 . . . . 0.0 111.346 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.63 71.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.014 . . . . 0.0 109.216 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.8 m -51.34 -22.68 3.03 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.706 -0.621 . . . . 0.0 111.472 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.97 128.71 53.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 0.0 110.313 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.41 -27.46 9.98 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.0 pt -84.41 161.93 52.68 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.142 -1.211 . . . . 0.0 110.769 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.0 156.36 47.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.103 1.58 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.0 t -58.82 -40.54 84.44 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.804 -0.56 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -60.14 -46.01 91.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.806 . . . . 0.0 109.871 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 98.4 m -68.96 -40.36 78.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.89 92.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.777 -0.577 . . . . 0.0 110.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -64.47 -42.03 96.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.405 -0.809 . . . . 0.0 109.374 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.93 -39.5 93.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.682 -0.637 . . . . 0.0 109.619 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -63.44 -29.94 71.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.785 -0.572 . . . . 0.0 110.263 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.0 t -86.18 -37.7 18.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 0.0 109.562 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -67.17 -38.69 85.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.816 -0.553 . . . . 0.0 111.191 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -100.2 -55.07 2.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -0.851 . . . . 0.0 112.036 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 91.2 m-85 -82.64 -36.18 26.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.102 -0.998 . . . . 0.0 111.13 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.96 11.18 43.91 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.21 158.31 16.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.012 -1.287 . . . . 0.0 109.959 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 -179.686 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 7.7 m -65.84 -30.58 71.22 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.702 -0.881 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.47 13.55 4.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.687 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.67 63.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 108.879 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.99 -25.14 3.06 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.795 -0.566 . . . . 0.0 111.269 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -105.78 129.35 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.73 -30.42 7.49 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.3 pt -84.97 162.38 49.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.22 -1.165 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.92 154.3 48.01 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.109 1.584 . . . . 0.0 110.887 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 t -58.3 -39.29 78.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.827 -0.545 . . . . 0.0 111.084 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.39 -46.62 89.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.84 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 86.0 m -66.85 -40.59 87.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 108.974 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.99 96.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.788 -0.57 . . . . 0.0 110.073 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -62.42 -42.73 99.66 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -39.79 95.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -34.73 76.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.801 -0.562 . . . . 0.0 110.265 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.8 t -76.24 -38.35 56.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.495 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 13.8 t80 -67.11 -38.18 85.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 111.361 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.495 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 6.1 mmm180 -98.95 -57.06 2.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.228 -0.92 . . . . 0.0 111.75 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CD1' ' SG ' ' A' ' 23' ' ' CYS . 83.0 m-85 -81.5 -36.86 28.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.933 . . . . 0.0 111.208 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.01 12.11 47.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.11 155.78 18.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -1.207 . . . . 0.0 109.892 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 121.345 0.593 . . . . 0.0 109.773 -179.715 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 1.6 m -71.21 -28.93 64.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.765 -0.844 . . . . 0.0 110.465 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 14.28 4.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.303 -0.873 . . . . 0.0 110.55 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -139.33 65.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 108.702 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 90.2 m -47.95 -24.17 0.98 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.903 -0.498 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.82 127.08 50.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.91 -26.1 13.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.45 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.9 pt -87.63 162.68 41.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.193 -1.181 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.8 Cg_endo -74.55 154.66 44.97 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.152 1.606 . . . . 0.0 111.182 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 t -59.28 -39.37 82.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.813 -0.555 . . . . 0.0 110.914 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -59.3 -46.5 88.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.744 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 90.6 m -68.38 -41.15 80.99 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.45 88.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.732 -0.605 . . . . 0.0 110.176 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -65.75 -43.87 87.61 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.341 -0.849 . . . . 0.0 109.392 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -36.45 80.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.554 -0.716 . . . . 0.0 109.373 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -60.84 -31.08 70.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.82 -0.55 . . . . 0.0 110.465 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.5 t -84.35 -37.33 21.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.14 -0.975 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -68.91 -38.97 79.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 0.0 111.234 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -56.91 2.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.309 -0.869 . . . . 0.0 111.836 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 63.5 m-85 -80.19 -37.8 32.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.219 -0.926 . . . . 0.0 111.234 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.36 12.29 42.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.2 157.44 17.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -1.21 . . . . 0.0 109.585 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.504 2.236 0 O-C-N 121.713 -0.617 . . . . 0.0 109.676 -179.202 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.7 m -66.51 -29.17 69.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.689 -0.889 . . . . 0.0 110.684 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.38 15.16 4.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.225 -0.922 . . . . 0.0 110.497 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -138.46 62.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.71 -24.72 1.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.851 -0.531 . . . . 0.0 111.357 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -105.65 126.93 52.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.822 . . . . 0.0 109.955 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.84 8.89 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.424 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.0 pt -83.31 161.63 56.5 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.198 -1.177 . . . . 0.0 110.532 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.8 Cg_endo -74.02 153.66 47.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.186 1.624 . . . . 0.0 111.315 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 t -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.952 -0.467 . . . . 0.0 111.112 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.96 -45.7 92.49 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.523 -0.736 . . . . 0.0 110.246 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.7 m -67.52 -41.38 84.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 0.0 108.731 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.6 91.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.732 -0.605 . . . . 0.0 110.037 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.461 -0.774 . . . . 0.0 109.473 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -37.54 87.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.763 -0.585 . . . . 0.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -64.01 -32.55 74.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.771 -0.58 . . . . 0.0 110.558 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.5 t -81.9 -37.83 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.77 -37.77 85.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.695 -0.628 . . . . 0.0 111.325 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -101.78 -58.41 1.89 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -0.916 . . . . 0.0 111.638 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.4 m-85 -77.01 -38.45 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.157 -0.964 . . . . 0.0 111.16 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.51 42.95 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.15 157.15 18.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.009 -1.289 . . . . 0.0 109.934 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.443 0.639 . . . . 0.0 109.705 -179.402 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 m -66.02 -29.2 69.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.752 -0.852 . . . . 0.0 110.8 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 11.6 6.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.02 63.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 108.745 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -49.8 -23.06 1.66 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.0 111.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -105.81 126.48 52.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.306 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.95 -24.75 14.06 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.853 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.2 pt -86.17 160.07 52.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.031 -1.276 . . . . 0.0 110.924 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.3 Cg_endo -74.34 157.82 45.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.214 1.639 . . . . 0.0 111.24 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -59.43 -40.28 86.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.734 -0.604 . . . . 0.0 110.94 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -59.65 -44.86 93.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.399 -0.813 . . . . 0.0 109.697 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 82.1 m -68.43 -41.04 80.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.34 90.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.713 -0.617 . . . . 0.0 109.793 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.54 -45.5 93.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.503 -0.748 . . . . 0.0 109.305 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -36.25 82.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 109.833 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -68.06 -37.39 81.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.6 t -80.33 -33.85 37.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 0.0 110.049 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 35' ' ' ARG . 28.1 t80 -70.85 -41.43 71.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 111.528 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.355 -0.841 . . . . 0.0 111.821 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 90.6 m-85 -82.37 -37.1 26.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.175 -0.953 . . . . 0.0 111.14 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.04 42.82 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.87 156.24 18.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.246 . . . . 0.0 109.845 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 121.426 0.632 . . . . 0.0 109.821 -179.71 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.87 -16.37 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.747 -0.855 . . . . 0.0 110.293 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.94 -4.28 43.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.669 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -143.71 74.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.312 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 m -48.47 -26.91 2.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.921 -0.487 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.57 129.26 55.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.925 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.81 -28.97 8.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 45.0 pt -80.06 163.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.214 -1.168 . . . . 0.0 110.498 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.45 155.64 50.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.118 1.589 . . . . 0.0 111.144 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 t -58.54 -39.29 79.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 111.033 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 t -61.18 -46.42 90.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.6 m -67.19 -41.39 85.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 29' ' ' ILE . . . -62.6 -37.69 87.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.706 -0.621 . . . . 0.0 110.129 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -64.23 -44.07 92.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.542 -0.723 . . . . 0.0 109.579 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -37.25 83.54 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 0.0 109.888 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -65.9 -30.22 70.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.48 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -87.98 -36.44 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 109.982 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.81 -38.01 70.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 111.329 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -100.21 -55.36 2.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.279 -0.888 . . . . 0.0 111.601 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.3 m-85 -79.16 -37.76 37.66 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.183 -0.948 . . . . 0.0 110.932 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.52 12.11 42.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -109.07 160.0 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.064 -1.257 . . . . 0.0 110.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.503 2.189 0 O-C-N 121.722 -0.611 . . . . 0.0 109.761 -179.29 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -68.11 -30.12 69.21 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.834 -0.803 . . . . 0.0 110.244 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.57 13.3 4.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.36 -0.838 . . . . 0.0 110.573 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 t -139.81 64.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 109.174 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.7 m -49.34 -24.24 1.8 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.769 -0.582 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -105.36 126.78 52.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.18 8.44 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 38.3 pt -83.52 162.56 53.0 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -73.57 154.59 49.96 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.123 1.591 . . . . 0.0 111.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -57.95 -38.73 76.52 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.924 -0.485 . . . . 0.0 111.264 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 t -63.9 -44.99 91.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.389 -0.82 . . . . 0.0 110.011 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 70.0 m -65.89 -41.63 91.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.31 -0.869 . . . . 0.0 109.056 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.83 84.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -46.19 86.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.45 -0.781 . . . . 0.0 109.584 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.56 -31.5 72.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.672 -0.643 . . . . 0.0 110.409 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -83.36 -36.63 24.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -69.38 -37.59 77.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.653 . . . . 0.0 111.144 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -99.77 -59.75 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.355 -0.84 . . . . 0.0 111.605 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 63.8 m-85 -76.74 -39.21 52.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.901 . . . . 0.0 111.112 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.2 35.95 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.24 159.03 16.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.064 -1.256 . . . . 0.0 110.128 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 121.471 0.653 . . . . 0.0 109.543 -179.131 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.563 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.3 m -79.2 -13.44 59.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.815 -0.814 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.26 -0.82 38.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.438 -0.789 . . . . 0.0 111.515 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -143.69 72.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.104 -0.998 . . . . 0.0 109.463 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.9 m -50.04 -24.91 2.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.869 -0.52 . . . . 0.0 111.112 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -107.53 126.7 52.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 110.033 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.76 -27.77 9.5 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 42.2 pt -80.27 162.7 60.46 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.197 -1.178 . . . . 0.0 110.445 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.61 155.19 49.91 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.053 1.554 . . . . 0.0 111.201 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -57.94 -39.99 79.41 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.787 -0.571 . . . . 0.0 110.863 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -47.41 86.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 109.876 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.7 m -67.86 -40.43 83.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.042 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' HD11 ' A' ' 29' ' ' ILE . . . -62.81 -38.04 89.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 110.095 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.16 -42.95 93.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.4 -0.813 . . . . 0.0 109.412 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.1 -39.29 86.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.651 . . . . 0.0 109.817 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -64.19 -28.83 70.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 110.069 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.9 t -88.18 -37.07 16.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.77 -39.26 70.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.663 . . . . 0.0 111.276 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -52.27 3.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 111.749 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.1 m-85 -82.96 -38.22 23.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 11.7 39.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.97 160.74 15.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.024 -1.28 . . . . 0.0 110.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.503 2.195 0 CA-C-O 121.387 0.613 . . . . 0.0 109.704 -179.219 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.3 -29.94 70.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.774 -0.839 . . . . 0.0 111.049 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.32 13.24 6.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.311 -0.868 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.26 61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.195 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.7 m -48.8 -25.5 1.89 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.764 -0.585 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -105.03 124.94 50.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.883 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.1 -29.44 7.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.1 pt -84.26 161.96 52.97 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.205 -1.174 . . . . 0.0 110.514 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.82 154.78 48.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.157 1.609 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -58.78 -38.51 78.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.901 -0.499 . . . . 0.0 111.169 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -62.78 -45.62 91.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.863 . . . . 0.0 109.846 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.5 m -67.55 -41.23 84.6 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.2 -40.85 97.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.574 . . . . 0.0 109.905 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -61.78 -43.42 98.89 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.475 -0.765 . . . . 0.0 109.683 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.32 -39.39 93.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.676 -0.64 . . . . 0.0 109.78 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.99 -31.12 72.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.741 -0.599 . . . . 0.0 110.597 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.2 t -82.52 -38.6 23.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.423 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 9.8 t80 -68.67 -35.83 77.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.673 -0.642 . . . . 0.0 111.219 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -100.92 -58.01 1.98 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.177 -0.952 . . . . 0.0 111.597 -178.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.2 m-85 -79.46 -38.36 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.217 -0.927 . . . . 0.0 111.074 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.43 39.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.65 158.14 17.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.112 -1.229 . . . . 0.0 110.074 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.464 0.649 . . . . 0.0 109.596 -179.169 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.6 m -67.72 -30.23 69.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.659 -0.906 . . . . 0.0 111.114 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.43 14.05 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.521 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -138.9 63.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.853 . . . . 0.0 109.02 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.07 -24.16 1.49 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.76 -0.588 . . . . 0.0 111.3 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -104.38 128.86 52.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.22 -28.54 9.6 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 34.6 pt -87.18 162.09 44.42 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.197 -1.178 . . . . 0.0 110.511 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.2 Cg_endo -74.35 154.64 46.0 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -58.71 -39.74 81.65 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.775 -0.578 . . . . 0.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -60.61 -44.76 95.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.349 -0.844 . . . . 0.0 109.778 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 79.6 m -67.89 -41.52 82.62 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.73 87.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.826 -0.546 . . . . 0.0 110.168 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -44.94 92.0 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.377 -0.827 . . . . 0.0 109.399 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -38.27 90.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.59 -0.694 . . . . 0.0 109.732 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.612 . . . . 0.0 110.428 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.7 t -80.79 -37.91 29.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -68.27 -37.8 81.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 111.167 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -60.17 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -0.877 . . . . 0.0 111.673 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 70.8 m-85 -77.3 -39.72 46.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.134 -0.979 . . . . 0.0 111.075 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.74 11.94 36.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.52 158.34 17.29 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.043 -1.269 . . . . 0.0 110.074 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.386 0.612 . . . . 0.0 109.645 -179.281 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.653 -0.91 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.43 12.69 6.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 110.782 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 t -139.69 63.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.0 m -48.2 -26.21 1.83 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.714 -0.616 . . . . 0.0 111.134 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.72 128.62 46.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.164 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.68 -26.17 15.15 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.6 pt -88.14 161.34 43.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.173 -1.192 . . . . 0.0 110.677 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.33 154.25 45.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.203 1.633 . . . . 0.0 111.258 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -56.82 -41.42 77.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.955 -0.466 . . . . 0.0 111.104 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 t -61.56 -46.17 91.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.764 . . . . 0.0 110.378 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.407 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 83.7 m -67.32 -41.25 85.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 108.934 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.37 -38.14 89.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.722 -0.611 . . . . 0.0 110.03 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.94 -45.47 93.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.537 -0.727 . . . . 0.0 109.535 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.2 -38.15 90.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.743 -0.598 . . . . 0.0 109.783 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -60.99 -34.61 75.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 0.0 110.349 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -80.38 -36.62 33.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -0.915 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.58 -39.68 88.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.775 -0.578 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.17 -54.29 2.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.265 -0.897 . . . . 0.0 111.829 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 89.6 m-85 -81.9 -36.57 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.209 -0.932 . . . . 0.0 111.114 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 10.6 47.42 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.978 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.64 156.4 19.09 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.988 -1.301 . . . . 0.0 110.248 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 121.425 0.631 . . . . 0.0 109.743 -179.219 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 5.3 m -69.6 -28.02 65.59 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.746 -0.855 . . . . 0.0 110.668 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.36 9.28 6.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.428 -0.795 . . . . 0.0 110.918 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.46 64.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.871 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.7 m -49.44 -24.6 2.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -104.38 126.27 51.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.361 -0.837 . . . . 0.0 110.119 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -27.12 10.87 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.448 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.4 pt -82.79 161.82 57.24 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.159 -1.2 . . . . 0.0 110.658 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.0 Cg_endo -73.79 155.63 48.83 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.167 1.614 . . . . 0.0 111.227 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t -58.76 -38.34 78.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.816 -0.552 . . . . 0.0 111.084 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -62.65 -45.08 94.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 0.0 109.876 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 99.0 m -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.09 95.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.814 -0.554 . . . . 0.0 110.199 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -64.47 -43.16 95.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.2 -37.42 83.6 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 109.629 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.8 -29.93 71.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.204 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.1 t -88.36 -36.82 16.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -68.5 -39.01 81.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.729 -0.607 . . . . 0.0 110.947 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -99.15 -61.75 1.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -73.42 -42.2 62.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.291 -0.881 . . . . 0.0 111.178 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.62 10.39 31.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.6 160.78 14.27 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.049 -1.265 . . . . 0.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.503 2.219 0 CA-C-O 121.335 0.588 . . . . 0.0 109.704 -179.478 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 t60 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 120.89 0.376 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t 52.37 65.77 1.41 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.531 0.681 . . . . 0.0 110.56 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -84.69 163.15 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -0.787 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.35 -91.97 0.75 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -160.65 134.4 6.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.508 -0.995 . . . . 0.0 110.548 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.0 m -147.67 133.98 19.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.548 -0.72 . . . . 0.0 110.06 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.6 72.66 7.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 110.548 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.8 162.08 35.54 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 124.04 1.548 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.75 145.2 50.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.683 -0.636 . . . . 0.0 110.277 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -138.94 138.04 36.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.351 -0.843 . . . . 0.0 110.875 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.24 163.36 68.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.718 . . . . 0.0 110.311 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.22 -166.78 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 124.024 1.539 . . . . 0.0 110.742 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 m -58.91 129.01 40.06 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.503 -0.748 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 153.83 73.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.533 -0.73 . . . . 0.0 110.348 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.85 159.22 48.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 124.075 1.566 . . . . 0.0 110.533 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.89 165.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.645 -0.659 . . . . 0.0 110.608 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -164.79 164.22 21.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.727 . . . . 0.0 110.196 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.3 pt -68.6 168.5 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.389 -0.82 . . . . 0.0 110.005 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.434 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -88.91 164.22 32.06 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 110.309 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 19' ' ' ARG . 39.8 Cg_endo -70.9 169.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 124.15 1.605 . . . . 0.0 111.17 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.2 mm -72.2 165.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.683 0.754 . . . . 0.0 110.684 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 108.36 -62.26 0.3 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -70.37 -25.99 63.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.691 -0.887 . . . . 0.0 110.36 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -76.89 3.75 11.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 111.2 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 t -142.76 69.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 m -50.65 -25.82 4.7 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.635 -0.666 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -107.61 124.87 50.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.855 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.05 -29.28 7.81 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.477 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 41.2 pt -77.4 163.2 65.73 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.245 -1.15 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.46 154.38 50.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.023 1.539 . . . . 0.0 111.165 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -57.44 -41.35 80.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.89 -0.506 . . . . 0.0 110.969 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -60.58 -45.55 93.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 80.1 m -67.8 -40.4 83.89 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.54 91.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 110.012 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -43.48 98.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.355 -0.841 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.7 -40.45 95.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.763 -0.586 . . . . 0.0 109.811 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -64.27 -30.12 71.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.456 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.6 t -85.93 -36.95 19.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.843 . . . . 0.0 109.741 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -70.07 -38.8 75.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.68 -0.638 . . . . 0.0 111.034 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -58.74 1.95 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 111.757 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 87.0 m-85 -79.88 -36.91 35.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 111.257 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.44 13.51 38.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -106.73 160.07 15.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.074 -1.251 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m 61.14 41.18 13.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.379 0.609 . . . . 0.0 109.694 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -90.31 -60.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 110.199 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -101.13 83.43 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.579 -0.7 . . . . 0.0 110.129 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.396 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 34.8 p80 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.043 0.449 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 56.86 79.0 0.2 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.384 0.612 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.71 162.83 40.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.408 -0.808 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.44 -116.44 4.51 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 68.13 156.28 0.12 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.955 -0.732 . . . . 0.0 111.04 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.0 m -116.6 135.04 54.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.487 -0.758 . . . . 0.0 110.379 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 152.79 92.47 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.632 -0.668 . . . . 0.0 110.253 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.31 149.29 56.85 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.896 1.472 . . . . 0.0 110.902 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.07 175.71 9.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.26 148.55 51.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.53 -0.731 . . . . 0.0 110.504 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.79 107.33 10.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.745 . . . . 0.0 110.241 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.29 -170.32 0.98 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.875 1.46 . . . . 0.0 110.654 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -105.54 63.4 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.44 136.99 19.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.241 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.74 171.67 17.36 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 124.053 1.554 . . . . 0.0 110.835 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.5 pt -59.38 168.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.705 -0.622 . . . . 0.0 110.588 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -154.47 165.02 37.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.651 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.0 pt -73.09 174.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.636 -0.665 . . . . 0.0 110.517 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 154.14 91.16 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 110.31 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -70.38 165.14 32.65 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.983 1.517 . . . . 0.0 111.372 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.74 165.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.497 0.665 . . . . 0.0 110.933 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.42 -60.44 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -66.66 -30.29 70.52 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.676 -0.896 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -83.53 10.92 7.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 0.0 110.78 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.29 61.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 108.719 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.2 m -47.37 -27.55 1.69 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.935 -0.478 . . . . 0.0 111.37 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.73 125.77 51.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 0.0 109.819 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.97 -29.28 7.84 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.502 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.2 pt -79.37 164.0 56.42 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.234 -1.157 . . . . 0.0 110.463 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.25 155.76 51.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.046 1.55 . . . . 0.0 111.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 t -57.74 -41.04 81.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.898 -0.501 . . . . 0.0 111.219 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -62.46 -43.48 98.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.854 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 47.6 m -64.86 -41.36 95.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.396 -0.815 . . . . 0.0 109.299 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.11 -41.76 88.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.723 -0.611 . . . . 0.0 110.48 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -63.62 -43.11 97.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.478 -0.764 . . . . 0.0 109.826 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -37.09 80.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -66.9 -30.14 70.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.61 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 t -86.28 -36.28 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.913 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.436 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 17.1 t80 -70.41 -38.77 74.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.635 -0.665 . . . . 0.0 111.047 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -98.18 -60.21 1.6 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 111.696 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 77.7 m-85 -75.58 -39.22 58.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.232 -0.918 . . . . 0.0 111.068 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.99 38.78 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.668 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.59 160.52 15.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.3 m 63.59 36.44 11.0 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.917 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.5 m -88.01 -61.42 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.52 -0.737 . . . . 0.0 109.54 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -89.66 88.36 7.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.686 -0.634 . . . . 0.0 109.55 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.501 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.036 0.446 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -146.07 150.98 36.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.351 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 t -94.32 118.77 32.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.437 -0.789 . . . . 0.0 110.32 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.19 125.1 7.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 134.1 41.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.409 -1.054 . . . . 0.0 110.622 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.0 m -96.6 103.59 15.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.539 -0.726 . . . . 0.0 109.59 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tpp180 -158.65 135.65 6.8 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.796 . . . . 0.0 110.7 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 7' ' ' ARG . 46.9 Cg_endo -73.67 152.17 47.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.977 1.514 . . . . 0.0 110.504 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.48 155.84 11.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.587 -0.695 . . . . 0.0 110.969 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.64 128.74 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.925 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -77.68 146.95 73.86 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 110.553 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.27 -156.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.221 1.643 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.5 m -58.09 171.93 0.49 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -44.8 127.98 5.2 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.636 -0.665 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.53 -179.08 3.78 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 124.08 1.569 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.38 162.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.295 0.569 . . . . 0.0 110.739 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.43 -179.2 0.23 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.532 -0.73 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.64 -177.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 121.584 0.707 . . . . 0.0 111.287 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 123.2 41.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.79 175.84 8.39 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.119 1.589 . . . . 0.0 111.385 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.49 166.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.61 -0.681 . . . . 0.0 110.675 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.1 -61.69 0.31 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.22 -29.35 68.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.669 -0.901 . . . . 0.0 110.674 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 16.76 4.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -0.816 . . . . 0.0 110.556 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.2 t -141.58 61.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.031 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.2 m -48.64 -26.24 2.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.811 -0.556 . . . . 0.0 111.241 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -105.34 128.32 53.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.84 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.82 -30.84 7.46 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.414 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.8 pt -84.0 162.18 52.93 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.336 -1.097 . . . . 0.0 110.426 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.1 Cg_endo -74.21 153.09 45.77 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.166 1.614 . . . . 0.0 111.001 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -58.73 -36.67 74.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.861 -0.524 . . . . 0.0 111.288 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -64.14 -45.04 90.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.8 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 m -68.41 -41.86 79.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.94 89.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.815 -0.553 . . . . 0.0 110.213 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -64.01 -42.78 97.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -0.768 . . . . 0.0 109.428 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.18 -38.8 91.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.606 -0.684 . . . . 0.0 109.618 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -61.04 -33.82 73.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.783 -0.573 . . . . 0.0 110.329 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.4 t -78.67 -37.74 41.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 109.907 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -66.81 -38.97 87.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.38 -56.23 2.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 111.856 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.1 m-85 -80.18 -37.33 33.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.202 -0.936 . . . . 0.0 111.072 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 11.41 45.91 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.42 157.86 18.04 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.999 -1.295 . . . . 0.0 110.273 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 m 63.09 39.99 9.46 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.38 0.61 . . . . 0.0 109.987 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.3 m -82.38 -58.51 2.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.416 -0.802 . . . . 0.0 109.68 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -92.49 88.34 6.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 0.0 109.845 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 117.9 -1.047 . . . . 0.0 110.484 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.0 t60 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.097 0.475 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.8 p -77.69 145.0 36.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.731 . . . . 0.0 110.167 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 2' ' ' SER . 44.5 m 64.42 116.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.379 0.609 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 85.8 1.08 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.8 142.01 46.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.548 -0.972 . . . . 0.0 110.442 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -79.42 92.7 5.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.168 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 147.14 17.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.88 . . . . 0.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.6 128.95 13.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.877 1.462 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -83.89 131.68 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.54 -0.725 . . . . 0.0 110.443 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -74.75 91.48 2.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.448 -0.782 . . . . 0.0 110.454 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -151.45 107.78 2.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.52 -0.737 . . . . 0.0 110.186 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.98 -165.88 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.866 1.456 . . . . 0.0 110.348 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.8 p -87.67 161.22 17.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.336 -0.852 . . . . 0.0 110.33 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.581 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 ttt180 66.78 134.72 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 122.019 -0.426 . . . . 0.0 111.143 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD2' ' HG2' ' A' ' 14' ' ' ARG . 45.0 Cg_endo -70.56 161.38 46.24 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.609 1.32 . . . . 0.0 110.636 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.03 176.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.594 -0.691 . . . . 0.0 110.924 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.53 170.11 3.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.632 -0.667 . . . . 0.0 110.737 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 pt -71.14 178.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.57 -0.706 . . . . 0.0 110.622 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 138.05 88.62 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.723 . . . . 0.0 110.706 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.62 175.86 7.43 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 124.187 1.625 . . . . 0.0 111.855 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -74.52 165.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.692 0.758 . . . . 0.0 110.806 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.51 -59.12 0.41 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.82 -28.57 61.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.631 -0.923 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.84 8.8 6.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.302 -0.874 . . . . 0.0 111.02 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.41 65.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.021 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.4 m -50.51 -24.17 2.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.664 -0.647 . . . . 0.0 111.288 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -106.78 126.03 51.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.39 -27.2 10.23 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.457 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.5 pt -81.84 162.17 58.46 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.123 -1.222 . . . . 0.0 110.754 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.77 155.53 48.95 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.16 1.611 . . . . 0.0 111.099 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -58.58 -39.15 79.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.79 -0.569 . . . . 0.0 111.111 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 t -61.8 -45.52 93.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.372 -0.83 . . . . 0.0 109.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -69.43 -40.13 77.42 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.08 93.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.701 -0.624 . . . . 0.0 110.282 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -65.7 -42.32 91.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.428 -0.795 . . . . 0.0 109.517 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.88 -38.25 85.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.709 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -61.93 -30.89 71.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.62 -0.675 . . . . 0.0 110.202 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -83.93 -37.68 22.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.358 -0.838 . . . . 0.0 109.548 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -71.2 -35.46 71.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 111.015 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -55.72 2.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -86.31 -36.22 19.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.308 -0.87 . . . . 0.0 111.129 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.32 37.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.64 159.97 15.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.089 -1.242 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m 60.63 38.26 18.75 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.794 -0.566 . . . . 0.0 109.913 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -83.7 -59.22 2.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -93.44 86.6 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.684 -0.635 . . . . 0.0 109.78 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.226 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.036 0.446 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.34 114.62 2.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.481 -0.762 . . . . 0.0 110.123 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.9 m -73.08 144.33 47.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.58 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.16 113.49 4.23 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -131.89 140.7 49.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.4 -1.059 . . . . 0.0 110.546 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.5 m -144.76 121.48 11.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 109.915 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.54 127.19 36.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.06 155.9 38.2 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.937 1.493 . . . . 0.0 110.792 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tp -82.85 60.9 5.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.016 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.53 135.15 0.89 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.758 -0.588 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -133.32 88.59 34.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 110.385 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.21 -164.35 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.964 1.507 . . . . 0.0 110.661 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -87.39 -160.75 0.63 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.303 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -55.23 124.71 55.23 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.588 -0.695 . . . . 0.0 110.329 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.46 164.36 35.97 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.974 1.513 . . . . 0.0 111.109 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mt -75.37 166.48 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.798 -0.564 . . . . 0.0 110.238 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -56.89 152.56 12.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.536 -0.727 . . . . 0.0 110.778 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 pt -68.85 169.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.554 -0.716 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.54 153.32 37.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.637 -0.664 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.89 177.38 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.044 1.549 . . . . 0.0 111.808 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.4 mm -86.91 167.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.501 0.667 . . . . 0.0 110.876 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.94 -60.76 0.45 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.32 -28.15 66.91 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.669 -0.901 . . . . 0.0 110.979 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.9 11.86 5.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.8 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -139.76 63.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.28 -0.887 . . . . 0.0 109.024 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.5 m -49.54 -25.94 3.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.729 -0.607 . . . . 0.0 111.069 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -105.87 126.06 51.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -29.77 7.46 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.473 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.6 pt -81.27 162.89 57.37 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.34 155.26 51.21 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.096 1.577 . . . . 0.0 111.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 t -56.94 -41.66 78.64 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.012 -0.43 . . . . 0.0 111.132 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -62.25 -45.75 91.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.9 m -66.37 -40.57 89.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.21 96.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.731 -0.605 . . . . 0.0 110.15 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -42.85 99.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.765 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.1 -38.9 89.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.526 -0.734 . . . . 0.0 109.703 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -62.83 -29.15 70.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.629 . . . . 0.0 110.396 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -85.98 -37.02 19.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.378 -0.826 . . . . 0.0 109.622 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -70.79 -36.66 73.11 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.701 -0.624 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -57.58 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.9 m-85 -81.76 -37.19 27.6 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.093 -1.004 . . . . 0.0 111.175 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.61 12.24 38.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.69 159.59 15.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.121 -1.223 . . . . 0.0 109.778 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 m 61.66 40.04 13.72 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.385 0.612 . . . . 0.0 109.77 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -90.88 -60.37 1.93 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.502 -0.748 . . . . 0.0 109.882 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -92.43 84.8 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.645 -0.66 . . . . 0.0 109.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.31 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 121.145 0.498 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t -88.54 116.23 26.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.505 -0.747 . . . . 0.0 110.031 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -83.77 99.12 10.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.348 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.37 -140.27 6.73 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -71.6 131.58 43.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.391 -1.064 . . . . 0.0 109.917 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -144.63 128.11 16.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 54.95 81.44 0.26 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HA ' HG23 ' A' ' 16' ' ' ILE . 42.4 Cg_endo -70.71 151.33 63.56 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.924 1.486 . . . . 0.0 110.867 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.85 133.43 26.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 110.097 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -70.99 91.94 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.745 . . . . 0.0 109.934 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -144.94 109.86 4.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 176.83 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.813 1.428 . . . . 0.0 110.77 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.07 31.75 5.21 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.09 0.472 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.48 148.44 0.39 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.443 -0.785 . . . . 0.0 110.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.88 158.6 46.2 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.808 1.425 . . . . 0.0 110.858 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 66.9 mt -60.43 149.97 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.72 -0.612 . . . . 0.0 109.846 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 81.6 t80 61.47 163.94 0.08 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.444 0.64 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.5 pt -70.86 -172.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.144 -0.973 . . . . 0.0 110.57 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.86 153.92 61.84 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.274 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.46 171.85 12.3 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.962 1.506 . . . . 0.0 111.842 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -74.33 167.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.644 0.735 . . . . 0.0 110.945 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.2 -61.33 0.47 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.7 m -66.42 -30.54 70.92 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.831 -0.805 . . . . 0.0 110.594 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.0 12.27 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.785 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 t -139.57 63.04 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.322 -0.861 . . . . 0.0 108.862 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.6 m -49.83 -25.09 2.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.839 -0.538 . . . . 0.0 111.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -105.34 126.78 52.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.139 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.89 -28.29 8.98 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.9 pt -84.61 162.08 51.67 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.155 -1.203 . . . . 0.0 110.611 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -74.16 155.11 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.139 1.599 . . . . 0.0 111.011 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -58.36 -40.78 83.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.822 -0.549 . . . . 0.0 111.022 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -60.48 -45.98 91.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.45 -0.781 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.0 m -66.16 -41.83 89.79 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.24 92.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.758 -0.589 . . . . 0.0 109.904 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.8 -44.2 97.17 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.463 -0.773 . . . . 0.0 109.908 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.593 -0.692 . . . . 0.0 109.824 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.64 -35.15 78.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.635 . . . . 0.0 110.555 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -78.98 -38.62 36.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.83 -38.73 83.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.608 -0.683 . . . . 0.0 111.175 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -57.94 2.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.428 -0.795 . . . . 0.0 111.731 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 83.3 m-85 -84.02 -34.59 24.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.154 -0.966 . . . . 0.0 111.421 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.97 12.17 47.28 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -104.78 157.13 17.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.898 -1.354 . . . . 0.0 109.971 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.6 m 62.47 37.73 13.2 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.126 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.0 m -80.86 -58.97 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.985 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -91.75 67.72 5.4 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.561 -0.712 . . . . 0.0 110.019 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.446 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 120.993 0.425 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -152.34 76.37 1.16 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.542 -0.723 . . . . 0.0 110.201 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -139.35 147.22 41.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.41 66.56 0.28 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.9 t80 52.78 85.05 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.85 -0.794 . . . . 0.0 111.271 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 29.6 m -133.09 83.55 2.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 6' ' ' THR . 0.4 OUTLIER 67.29 131.18 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 122.069 -0.394 . . . . 0.0 110.899 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.34 146.42 50.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -94.27 133.57 37.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.914 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -147.41 109.41 4.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HG2' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -80.89 144.55 55.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD2' ' HG2' ' A' ' 11' ' ' LYS . 48.7 Cg_endo -75.68 -160.11 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 124.183 1.623 . . . . 0.0 110.424 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 m -54.18 146.93 14.0 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.0 110.61 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.77 124.85 84.87 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.501 -0.75 . . . . 0.0 110.274 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.38 173.69 13.89 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.024 1.539 . . . . 0.0 110.596 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 pt -61.1 161.0 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.692 -0.63 . . . . 0.0 110.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -141.66 164.44 30.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.706 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.5 pt -69.92 174.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.44 128.16 65.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 110.305 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.33 161.3 44.78 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.2 1.631 . . . . 0.0 110.915 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -78.28 166.71 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.681 0.753 . . . . 0.0 111.047 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 107.57 -62.34 0.3 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -67.24 -29.41 69.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.726 -0.867 . . . . 0.0 110.212 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.76 16.19 4.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.537 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 t -141.71 63.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.224 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.7 m -48.14 -25.87 1.65 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.761 -0.587 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -106.5 126.29 52.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.39 -31.76 6.26 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.8 pt -80.76 162.8 58.91 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.307 -1.113 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.7 Cg_endo -73.33 153.4 50.63 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.08 1.568 . . . . 0.0 111.134 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -37.67 73.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.878 -0.514 . . . . 0.0 111.309 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -65.13 -44.67 87.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.39 -0.819 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 54.2 m -64.81 -41.33 95.87 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 109.21 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.44 78.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.634 . . . . 0.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.06 -41.19 91.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 109.09 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -40.47 95.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.78 -40.46 95.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.633 . . . . 0.0 109.769 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.52 -38.52 68.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 109.983 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -67.5 -38.14 83.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.7 -0.625 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -58.74 1.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 111.811 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -77.7 -39.67 43.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.261 -0.899 . . . . 0.0 111.169 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.03 14.0 32.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 44' ' ' CYS . 6.1 m-20 -112.02 159.11 18.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.061 -1.258 . . . . 0.0 110.205 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' ASP . 32.3 m 62.44 39.73 11.62 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.364 0.602 . . . . 0.0 109.944 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.4 m -82.84 -59.42 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.831 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.67 84.35 7.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.731 . . . . 0.0 109.622 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.8 t60 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t 62.65 174.6 0.14 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.491 0.662 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -141.66 131.86 24.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.471 -0.768 . . . . 0.0 110.264 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.5 146.87 36.38 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 t80 67.86 142.34 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.925 -0.75 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 m -74.39 114.24 12.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.345 -0.847 . . . . 0.0 109.798 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.95 67.35 3.28 Favored Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.832 -0.542 . . . . 0.0 110.258 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.38 148.24 38.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 124.062 1.559 . . . . 0.0 110.701 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.47 154.51 41.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.15 106.95 16.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 130.88 2.1 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.585 -0.697 . . . . 0.0 110.36 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.54 -160.95 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.97 1.511 . . . . 0.0 110.148 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -59.86 128.17 35.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -109.84 127.06 27.77 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.417 -0.802 . . . . 0.0 110.638 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.6 -178.03 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.915 1.481 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 pt -62.91 174.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 121.342 0.591 . . . . 0.0 110.728 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -52.05 153.67 2.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.639 -0.663 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 mt -60.5 139.06 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.629 -0.669 . . . . 0.0 110.677 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 136.27 19.64 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.681 -0.637 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.18 174.94 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.015 1.534 . . . . 0.0 111.321 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -78.25 167.77 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.475 0.655 . . . . 0.0 110.26 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.99 -61.23 0.32 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -67.78 -31.14 70.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.796 -0.826 . . . . 0.0 109.83 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -72.22 -0.49 12.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.66 -0.65 . . . . 0.0 111.48 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.1 t -143.03 74.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.14 -0.975 . . . . 0.0 108.989 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.1 m -50.43 -23.1 2.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.765 -0.585 . . . . 0.0 111.339 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -104.96 128.13 53.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.227 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -25.11 15.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.458 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.4 pt -79.55 162.09 64.57 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.153 -1.204 . . . . 0.0 110.908 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.53 156.65 49.6 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.206 1.635 . . . . 0.0 111.333 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -56.89 -40.97 77.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.958 -0.464 . . . . 0.0 111.31 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -63.35 -43.61 97.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.449 -0.782 . . . . 0.0 110.243 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 30.8 m -64.51 -41.15 96.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.42 -0.8 . . . . 0.0 109.111 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.75 79.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.712 -0.617 . . . . 0.0 110.294 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -64.71 -42.08 95.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.04 -37.22 78.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.635 -0.665 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -67.64 -31.53 71.6 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.557 -0.714 . . . . 0.0 110.269 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.9 t -86.85 -35.15 19.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -70.21 -40.58 74.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.602 -0.686 . . . . 0.0 111.363 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -53.42 3.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 111.844 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 94.5 m-85 -82.85 -36.03 25.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.89 . . . . 0.0 111.304 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 12.17 48.58 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.98 158.86 16.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 m 61.99 39.1 13.71 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.76 -0.588 . . . . 0.0 109.936 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.5 m -88.86 -59.91 2.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.429 -0.794 . . . . 0.0 109.949 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -99.07 66.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.586 -0.696 . . . . 0.0 109.88 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.429 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.981 0.42 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -104.61 107.22 18.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.412 -0.805 . . . . 0.0 109.986 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -127.94 74.65 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.459 -0.776 . . . . 0.0 110.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.11 169.22 39.09 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -132.24 135.41 46.27 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.44 -1.035 . . . . 0.0 109.987 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 11.4 t -106.49 54.23 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.42 -0.8 . . . . 0.0 110.647 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 6' ' ' THR . 4.7 ttp180 62.97 121.52 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.992 -0.442 . . . . 0.0 111.147 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 47.8 Cg_endo -76.84 163.49 31.22 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.457 1.241 . . . . 0.0 110.803 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.45 109.01 7.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.593 -0.692 . . . . 0.0 109.922 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.415 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 4.5 tpt180 60.19 92.33 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.366 0.603 . . . . 0.0 110.333 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HG3' ' HG2' ' A' ' 8' ' ' PRO . 15.6 mtpp -64.47 111.6 5.98 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.667 -0.645 . . . . 0.0 110.957 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 53.7 Cg_endo -79.06 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 124.024 1.539 . . . . 0.0 110.224 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -68.73 175.24 3.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.289 -0.882 . . . . 0.0 110.034 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -48.16 108.69 0.96 Allowed Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.549 -0.719 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.7 157.23 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.683 1.359 . . . . 0.0 110.866 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 pt -69.8 158.57 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.627 -0.671 . . . . 0.0 109.677 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -126.57 140.15 52.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.9 . . . . 0.0 110.996 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.5 pt -97.01 -177.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.868 -0.52 . . . . 0.0 109.743 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.32 139.55 46.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 110.048 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.8 172.71 12.17 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.995 1.523 . . . . 0.0 111.256 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -77.16 167.84 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.435 0.636 . . . . 0.0 110.123 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.38 -62.11 0.3 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 m -66.55 -28.98 68.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.788 -0.83 . . . . 0.0 109.813 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.24 3.09 9.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.6 -0.688 . . . . 0.0 111.346 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.8 t -142.63 71.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.014 . . . . 0.0 109.216 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.8 m -51.34 -22.68 3.03 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.706 -0.621 . . . . 0.0 111.472 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.97 128.71 53.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 0.0 110.313 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.41 -27.46 9.98 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.0 pt -84.41 161.93 52.68 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.142 -1.211 . . . . 0.0 110.769 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.0 156.36 47.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.103 1.58 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.0 t -58.82 -40.54 84.44 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.804 -0.56 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -60.14 -46.01 91.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.806 . . . . 0.0 109.871 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 98.4 m -68.96 -40.36 78.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.89 92.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.777 -0.577 . . . . 0.0 110.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -64.47 -42.03 96.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.405 -0.809 . . . . 0.0 109.374 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.93 -39.5 93.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.682 -0.637 . . . . 0.0 109.619 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -63.44 -29.94 71.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.785 -0.572 . . . . 0.0 110.263 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.0 t -86.18 -37.7 18.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 0.0 109.562 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -67.17 -38.69 85.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.816 -0.553 . . . . 0.0 111.191 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -100.2 -55.07 2.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -0.851 . . . . 0.0 112.036 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 91.2 m-85 -82.64 -36.18 26.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.102 -0.998 . . . . 0.0 111.13 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.96 11.18 43.91 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.21 158.31 16.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.012 -1.287 . . . . 0.0 109.959 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 m 61.95 39.18 13.75 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.4 m -84.58 -59.49 2.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.44 -0.787 . . . . 0.0 109.927 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -94.58 87.4 5.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.677 -0.64 . . . . 0.0 109.885 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.25 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 120.81 0.338 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 m 57.42 76.9 0.3 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.385 0.612 . . . . 0.0 110.479 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 p -66.58 142.53 57.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 0.0 110.268 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.3 -67.18 1.01 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 66.89 114.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.005 -0.703 . . . . 0.0 111.049 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.3 m -90.42 132.39 35.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 144.21 68.13 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.538 -0.726 . . . . 0.0 110.076 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.19 145.13 30.45 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.909 1.478 . . . . 0.0 110.688 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mp -75.71 170.49 16.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.606 -0.683 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 114.87 2.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 110.501 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.24 120.97 63.24 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.583 -0.698 . . . . 0.0 110.566 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.73 -162.21 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 124.04 1.548 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -97.58 61.5 1.63 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.379 -0.826 . . . . 0.0 110.281 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' HG3' ' HD2' ' A' ' 15' ' ' PRO . 9.4 tpt180 67.44 136.33 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.925 -0.485 . . . . 0.0 111.321 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HG3' ' A' ' 14' ' ' ARG . 49.1 Cg_endo -74.54 171.35 18.32 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.64 1.337 . . . . 0.0 110.886 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.94 159.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.784 -0.572 . . . . 0.0 110.352 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -61.78 179.07 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.626 -0.671 . . . . 0.0 111.056 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 mt -46.82 137.09 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.381 0.61 . . . . 0.0 111.059 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 120.38 78.2 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.764 -0.585 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.94 161.76 43.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.202 1.632 . . . . 0.0 110.704 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.5 mt -75.0 163.16 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -61.94 0.3 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 7.7 m -65.84 -30.58 71.22 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.702 -0.881 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.47 13.55 4.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.687 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 t -141.67 63.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 108.879 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.99 -25.14 3.06 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.795 -0.566 . . . . 0.0 111.269 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -105.78 129.35 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.73 -30.42 7.49 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.3 pt -84.97 162.38 49.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.22 -1.165 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.92 154.3 48.01 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.109 1.584 . . . . 0.0 110.887 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 t -58.3 -39.29 78.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.827 -0.545 . . . . 0.0 111.084 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.39 -46.62 89.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.84 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 86.0 m -66.85 -40.59 87.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 108.974 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.99 96.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.788 -0.57 . . . . 0.0 110.073 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -62.42 -42.73 99.66 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -39.79 95.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -34.73 76.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.801 -0.562 . . . . 0.0 110.265 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.8 t -76.24 -38.35 56.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.495 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 13.8 t80 -67.11 -38.18 85.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 111.361 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.495 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 6.1 mmm180 -98.95 -57.06 2.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.228 -0.92 . . . . 0.0 111.75 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CD1' ' SG ' ' A' ' 23' ' ' CYS . 83.0 m-85 -81.5 -36.86 28.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.933 . . . . 0.0 111.208 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.01 12.11 47.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.11 155.78 18.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -1.207 . . . . 0.0 109.892 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.4 m 62.17 42.0 10.08 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.345 0.593 . . . . 0.0 109.773 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.4 m -84.86 -56.51 3.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 110.431 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -96.43 54.81 1.41 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.717 -0.614 . . . . 0.0 110.791 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tp . . . . . 0 N--CA 1.499 1.975 0 O-C-N 121.262 -0.899 . . . . 0.0 110.534 179.679 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.075 0.464 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.74 112.48 25.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.427 -0.795 . . . . 0.0 110.265 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -133.33 111.87 11.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.94 -47.85 81.82 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.25 138.02 31.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.43 -1.041 . . . . 0.0 110.115 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -98.36 161.16 13.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.716 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.87 76.0 54.05 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.437 -0.789 . . . . 0.0 110.546 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.65 137.95 25.82 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.793 1.417 . . . . 0.0 110.37 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp 56.01 64.94 1.57 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.565 0.698 . . . . 0.0 110.136 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.4 118.75 9.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.643 -0.66 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 tptm 57.89 80.19 0.29 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.849 -0.532 . . . . 0.0 110.65 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.9 -161.99 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.837 1.44 . . . . 0.0 110.623 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -97.77 36.22 1.56 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.173 -0.954 . . . . 0.0 111.036 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.4 ttm180 64.13 142.81 0.07 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 121.909 -0.495 . . . . 0.0 111.661 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 14' ' ' ARG . 46.8 Cg_endo -74.11 175.68 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.716 1.377 . . . . 0.0 110.22 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 pt -52.35 135.55 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 121.347 0.594 . . . . 0.0 110.458 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -156.11 165.13 37.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.768 . . . . 0.0 110.556 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.43 -171.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.647 -0.658 . . . . 0.0 110.239 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 122.8 7.41 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.741 -0.6 . . . . 0.0 110.596 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.86 169.88 19.24 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.296 1.682 . . . . 0.0 111.289 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.9 mm -78.53 166.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.676 0.751 . . . . 0.0 111.095 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.44 -63.61 0.29 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 1.6 m -71.21 -28.93 64.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.765 -0.844 . . . . 0.0 110.465 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 14.28 4.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.303 -0.873 . . . . 0.0 110.55 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -139.33 65.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 108.702 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 90.2 m -47.95 -24.17 0.98 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.903 -0.498 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -102.82 127.08 50.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.91 -26.1 13.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.45 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.9 pt -87.63 162.68 41.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.193 -1.181 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.8 Cg_endo -74.55 154.66 44.97 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.152 1.606 . . . . 0.0 111.182 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 t -59.28 -39.37 82.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.813 -0.555 . . . . 0.0 110.914 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -59.3 -46.5 88.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.744 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 90.6 m -68.38 -41.15 80.99 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.45 88.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.732 -0.605 . . . . 0.0 110.176 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -65.75 -43.87 87.61 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.341 -0.849 . . . . 0.0 109.392 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -36.45 80.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.554 -0.716 . . . . 0.0 109.373 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -60.84 -31.08 70.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.82 -0.55 . . . . 0.0 110.465 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.5 t -84.35 -37.33 21.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.14 -0.975 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -68.91 -38.97 79.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 0.0 111.234 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -56.91 2.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.309 -0.869 . . . . 0.0 111.836 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 63.5 m-85 -80.19 -37.8 32.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.219 -0.926 . . . . 0.0 111.234 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.36 12.29 42.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.2 157.44 17.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -1.21 . . . . 0.0 109.585 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 m 62.05 40.21 12.33 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.713 -0.617 . . . . 0.0 109.676 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 m -90.29 -59.34 2.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.538 -0.726 . . . . 0.0 110.426 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -86.19 51.73 2.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.578 -0.701 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 tt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.306 179.781 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.039 0.447 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.45 164.53 32.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.485 -0.759 . . . . 0.0 110.473 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t 56.44 77.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.275 0.56 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.08 51.69 4.58 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -171.61 153.54 3.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.652 -0.91 . . . . 0.0 110.028 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.24 164.32 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.517 0.675 . . . . 0.0 110.986 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -82.8 137.42 43.95 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 48.1 Cg_endo -74.61 152.02 42.34 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 124.021 1.537 . . . . 0.0 110.755 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mp -76.99 175.4 9.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.647 -0.658 . . . . 0.0 110.571 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -68.31 92.53 0.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.627 -0.671 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.99 86.46 3.43 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.567 -0.708 . . . . 0.0 109.969 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.17 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.893 1.47 . . . . 0.0 110.74 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -77.53 166.37 23.15 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.521 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.83 60.34 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.493 -0.754 . . . . 0.0 110.456 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.4 153.55 65.88 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.084 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pt -90.98 172.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.763 -0.585 . . . . 0.0 110.507 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -124.53 140.16 53.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.55 -0.719 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -133.58 -179.47 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.502 -0.749 . . . . 0.0 110.53 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' HD3' ' HD2' ' A' ' 20' ' ' PRO . 1.1 tpp85 -61.08 126.39 85.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.632 -0.668 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' HD3' ' A' ' 19' ' ' ARG . 40.7 Cg_endo -70.92 166.22 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 124.161 1.611 . . . . 0.0 111.026 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.485 HG23 HD13 ' A' ' 21' ' ' ILE . 4.5 mm -80.53 167.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.71 0.767 . . . . 0.0 111.2 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.06 -61.53 0.34 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.7 m -66.51 -29.17 69.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.689 -0.889 . . . . 0.0 110.684 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.38 15.16 4.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.225 -0.922 . . . . 0.0 110.497 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -138.46 62.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.71 -24.72 1.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.851 -0.531 . . . . 0.0 111.357 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -105.65 126.93 52.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.822 . . . . 0.0 109.955 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.84 8.89 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.424 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.0 pt -83.31 161.63 56.5 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.198 -1.177 . . . . 0.0 110.532 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.8 Cg_endo -74.02 153.66 47.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.186 1.624 . . . . 0.0 111.315 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 t -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.952 -0.467 . . . . 0.0 111.112 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.96 -45.7 92.49 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.523 -0.736 . . . . 0.0 110.246 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.7 m -67.52 -41.38 84.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 0.0 108.731 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.6 91.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.732 -0.605 . . . . 0.0 110.037 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.461 -0.774 . . . . 0.0 109.473 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -37.54 87.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.763 -0.585 . . . . 0.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -64.01 -32.55 74.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.771 -0.58 . . . . 0.0 110.558 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.5 t -81.9 -37.83 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.77 -37.77 85.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.695 -0.628 . . . . 0.0 111.325 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -101.78 -58.41 1.89 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -0.916 . . . . 0.0 111.638 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.4 m-85 -77.01 -38.45 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.157 -0.964 . . . . 0.0 111.16 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.51 42.95 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.15 157.15 18.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.009 -1.289 . . . . 0.0 109.934 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.482 ' HA ' HD22 ' A' ' 47' ' ' LEU . 10.7 m 62.1 42.81 9.38 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.443 0.639 . . . . 0.0 109.705 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.6 m -86.45 -58.5 2.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.544 -0.722 . . . . 0.0 110.128 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -95.73 64.27 2.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.627 -0.671 . . . . 0.0 110.292 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.178 0.514 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -65.95 153.91 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.65 135.17 51.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 110.485 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.11 94.0 0.89 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.18 152.08 46.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.534 -0.98 . . . . 0.0 110.762 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -79.66 128.32 33.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.675 -0.641 . . . . 0.0 110.135 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.48 115.47 10.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.71 -0.618 . . . . 0.0 110.638 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.0 149.27 41.46 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.724 1.381 . . . . 0.0 110.711 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.36 168.39 19.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.558 -0.714 . . . . 0.0 110.405 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 65.8 160.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.502 0.668 . . . . 0.0 110.807 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.58 148.32 56.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.64 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.37 -160.23 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.993 1.522 . . . . 0.0 110.642 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -67.2 166.42 14.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.354 -0.841 . . . . 0.0 110.835 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 153.86 52.07 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.603 -0.686 . . . . 0.0 110.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.15 152.28 61.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.81 1.426 . . . . 0.0 111.023 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.3 pt -137.47 178.64 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.637 . . . . 0.0 110.427 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -65.07 173.54 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.29 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.8 pt -67.04 169.88 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.553 -0.717 . . . . 0.0 110.635 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.57 151.95 69.14 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 0.0 110.245 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.19 167.83 22.56 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.056 1.556 . . . . 0.0 111.372 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.3 mt -81.63 166.24 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.526 0.679 . . . . 0.0 110.93 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.63 -61.07 0.37 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 m -66.02 -29.2 69.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.752 -0.852 . . . . 0.0 110.8 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 11.6 6.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.02 63.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 108.745 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' HB3' HD11 ' A' ' 47' ' ' LEU . 57.7 m -49.8 -23.06 1.66 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.0 111.796 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -105.81 126.48 52.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.306 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.95 -24.75 14.06 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.853 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.2 pt -86.17 160.07 52.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.031 -1.276 . . . . 0.0 110.924 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.3 Cg_endo -74.34 157.82 45.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.214 1.639 . . . . 0.0 111.24 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -59.43 -40.28 86.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.734 -0.604 . . . . 0.0 110.94 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -59.65 -44.86 93.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.399 -0.813 . . . . 0.0 109.697 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 82.1 m -68.43 -41.04 80.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.34 90.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.713 -0.617 . . . . 0.0 109.793 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.54 -45.5 93.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.503 -0.748 . . . . 0.0 109.305 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -36.25 82.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 109.833 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -68.06 -37.39 81.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.6 t -80.33 -33.85 37.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 0.0 110.049 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 35' ' ' ARG . 28.1 t80 -70.85 -41.43 71.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 111.528 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.355 -0.841 . . . . 0.0 111.821 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 90.6 m-85 -82.37 -37.1 26.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.175 -0.953 . . . . 0.0 111.14 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.04 42.82 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.87 156.24 18.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.246 . . . . 0.0 109.845 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 m 63.09 41.5 8.1 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.426 0.632 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -89.5 -61.91 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.521 -0.737 . . . . 0.0 109.74 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -92.62 76.27 5.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.705 -0.622 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.9 p80 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.106 0.479 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -78.73 139.73 38.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.465 -0.772 . . . . 0.0 109.919 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 124.77 49.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.46 -0.775 . . . . 0.0 110.278 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.3 -100.61 0.15 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.6 t80 63.93 101.88 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.909 -0.759 . . . . 0.0 111.029 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -68.56 103.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 110.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -79.68 140.71 55.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 110.42 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.44 143.88 35.44 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.881 1.464 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.28 123.37 22.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.331 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -131.89 139.92 48.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.743 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -73.27 142.53 82.02 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.508 -0.745 . . . . 0.0 110.655 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.45 -163.47 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 124.016 1.535 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.05 46.1 2.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -76.72 159.55 78.84 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.449 -0.782 . . . . 0.0 110.539 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.33 168.87 23.79 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 124.09 1.574 . . . . 0.0 110.939 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mt -57.79 146.09 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.792 -0.568 . . . . 0.0 110.461 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.33 162.05 30.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.508 -0.745 . . . . 0.0 110.513 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 pt -77.15 -173.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.699 -0.626 . . . . 0.0 110.535 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 117.15 9.33 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.746 -0.597 . . . . 0.0 110.196 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.79 169.41 22.09 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 124.314 1.692 . . . . 0.0 111.412 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -78.41 166.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.516 0.674 . . . . 0.0 110.81 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 108.27 -59.4 0.37 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.87 -16.37 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.747 -0.855 . . . . 0.0 110.293 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.94 -4.28 43.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.669 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 t -143.71 74.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.312 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.503 ' HB3' HD12 ' A' ' 47' ' ' LEU . 16.5 m -48.47 -26.91 2.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.921 -0.487 . . . . 0.0 111.281 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -107.57 129.26 55.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.925 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.81 -28.97 8.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 45.0 pt -80.06 163.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.214 -1.168 . . . . 0.0 110.498 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.45 155.64 50.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.118 1.589 . . . . 0.0 111.144 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 t -58.54 -39.29 79.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 111.033 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 t -61.18 -46.42 90.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.6 m -67.19 -41.39 85.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HA ' HD11 ' A' ' 29' ' ' ILE . . . -62.6 -37.69 87.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.706 -0.621 . . . . 0.0 110.129 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -64.23 -44.07 92.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.542 -0.723 . . . . 0.0 109.579 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -37.25 83.54 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 0.0 109.888 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -65.9 -30.22 70.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.48 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -87.98 -36.44 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 109.982 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.81 -38.01 70.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 111.329 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -100.21 -55.36 2.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.279 -0.888 . . . . 0.0 111.601 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.3 m-85 -79.16 -37.76 37.66 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.183 -0.948 . . . . 0.0 110.932 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.52 12.11 42.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -109.07 160.0 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.064 -1.257 . . . . 0.0 110.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.6 m 62.96 40.88 8.96 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.722 -0.611 . . . . 0.0 109.761 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.66 -60.81 1.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.906 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -90.3 71.26 7.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 26' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.499 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.029 0.442 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.51 148.09 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.503 -0.748 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.33 92.73 3.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 109.957 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.49 -156.59 27.04 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.38 151.5 21.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.438 -1.036 . . . . 0.0 110.593 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.3 m -119.73 135.95 54.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.173 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 148.29 66.15 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.536 -0.727 . . . . 0.0 110.24 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.42 160.12 49.51 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.917 1.483 . . . . 0.0 110.797 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 148.23 52.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.684 -0.635 . . . . 0.0 110.291 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.4 107.6 1.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.424 -0.797 . . . . 0.0 110.272 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.85 139.71 36.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 110.303 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.81 -161.85 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.978 1.515 . . . . 0.0 110.337 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t 51.77 52.82 13.77 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.53 -0.731 . . . . 0.0 110.445 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -89.12 164.65 29.94 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.576 -0.702 . . . . 0.0 110.762 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.65 -179.12 4.22 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 124.08 1.568 . . . . 0.0 111.09 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 pt -62.25 176.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.401 0.62 . . . . 0.0 110.901 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -57.37 152.69 13.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.595 -0.691 . . . . 0.0 110.809 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 pt -90.61 -172.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.662 -0.649 . . . . 0.0 110.61 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.74 145.4 16.34 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.33 173.1 11.07 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 124.086 1.572 . . . . 0.0 112.194 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -77.54 169.26 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.627 0.727 . . . . 0.0 111.045 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 102.3 -62.1 0.5 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -68.11 -30.12 69.21 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.834 -0.803 . . . . 0.0 110.244 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.57 13.3 4.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.36 -0.838 . . . . 0.0 110.573 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 t -139.81 64.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 109.174 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.7 m -49.34 -24.24 1.8 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.769 -0.582 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -105.36 126.78 52.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.18 8.44 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 38.3 pt -83.52 162.56 53.0 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -73.57 154.59 49.96 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.123 1.591 . . . . 0.0 111.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -57.95 -38.73 76.52 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.924 -0.485 . . . . 0.0 111.264 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 t -63.9 -44.99 91.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.389 -0.82 . . . . 0.0 110.011 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 70.0 m -65.89 -41.63 91.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.31 -0.869 . . . . 0.0 109.056 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.83 84.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -46.19 86.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.45 -0.781 . . . . 0.0 109.584 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.56 -31.5 72.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.672 -0.643 . . . . 0.0 110.409 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -83.36 -36.63 24.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -69.38 -37.59 77.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.653 . . . . 0.0 111.144 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -99.77 -59.75 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.355 -0.84 . . . . 0.0 111.605 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 63.8 m-85 -76.74 -39.21 52.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.901 . . . . 0.0 111.112 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.2 35.95 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.24 159.03 16.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.064 -1.256 . . . . 0.0 110.128 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m 62.55 42.03 9.01 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.471 0.653 . . . . 0.0 109.543 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -89.42 -61.21 1.75 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.056 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -90.14 76.38 6.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.645 -0.659 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.343 -179.909 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.028 0.442 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -115.46 133.85 55.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.478 -0.764 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.65 75.17 0.37 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 74.67 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.23 149.61 38.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.464 -1.021 . . . . 0.0 110.437 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -92.53 89.12 6.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.563 -0.711 . . . . 0.0 110.366 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -158.18 130.36 4.18 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 110.406 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.53 135.14 17.76 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.893 1.47 . . . . 0.0 110.565 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.8 mt -86.47 153.63 21.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.414 -0.804 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -59.35 139.8 56.69 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 110.647 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 50.53 69.2 2.75 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.767 -0.583 . . . . 0.0 110.696 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.78 -168.53 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.741 1.39 . . . . 0.0 110.667 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 m -118.68 57.39 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 110.199 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -89.79 119.69 69.44 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 110.123 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.13 173.72 13.65 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 124.007 1.53 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.9 pt -50.38 133.87 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-O 121.364 0.602 . . . . 0.0 110.529 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -148.1 176.42 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 110.634 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.3 pt -69.27 174.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.664 -0.648 . . . . 0.0 110.301 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.63 114.13 5.31 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.722 -0.611 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.21 171.29 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 124.308 1.688 . . . . 0.0 111.171 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.4 mm -81.19 167.78 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.49 0.662 . . . . 0.0 110.797 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.62 -56.45 0.5 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.3 m -79.2 -13.44 59.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.815 -0.814 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.26 -0.82 38.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.438 -0.789 . . . . 0.0 111.515 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -143.69 72.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.104 -0.998 . . . . 0.0 109.463 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.9 m -50.04 -24.91 2.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.869 -0.52 . . . . 0.0 111.112 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -107.53 126.7 52.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 110.033 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.76 -27.77 9.5 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 42.2 pt -80.27 162.7 60.46 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.197 -1.178 . . . . 0.0 110.445 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.61 155.19 49.91 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.053 1.554 . . . . 0.0 111.201 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -57.94 -39.99 79.41 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.787 -0.571 . . . . 0.0 110.863 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -47.41 86.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 109.876 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.7 m -67.86 -40.43 83.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.042 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' HA ' HD11 ' A' ' 29' ' ' ILE . . . -62.81 -38.04 89.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 110.095 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.16 -42.95 93.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.4 -0.813 . . . . 0.0 109.412 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.1 -39.29 86.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.651 . . . . 0.0 109.817 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -64.19 -28.83 70.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 110.069 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.9 t -88.18 -37.07 16.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.77 -39.26 70.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.663 . . . . 0.0 111.276 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -52.27 3.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 111.749 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.1 m-85 -82.96 -38.22 23.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 11.7 39.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.97 160.74 15.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.024 -1.28 . . . . 0.0 110.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m 62.41 39.74 11.73 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.387 0.613 . . . . 0.0 109.704 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.41 -62.12 1.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.799 . . . . 0.0 110.141 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -92.78 65.49 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.712 . . . . 0.0 109.944 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.616 -179.844 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 2' ' ' SER . 77.1 m-70 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.841 0.353 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 1' ' ' HIS . 44.6 m 61.42 172.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 121.511 0.672 . . . . 0.0 111.136 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 p -154.9 153.27 30.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.345 -0.847 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.54 -136.18 3.76 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 t80 54.61 78.35 0.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.759 -0.847 . . . . 0.0 110.706 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 m -85.43 77.89 9.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 71.4 7.83 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.811 . . . . 0.0 110.297 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.83 131.68 14.78 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.984 1.518 . . . . 0.0 110.633 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 94.87 4.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 110.475 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.8 111.4 7.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.381 -0.824 . . . . 0.0 110.137 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.22 125.99 8.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 110.398 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.4 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.893 1.47 . . . . 0.0 110.276 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t 52.06 52.18 14.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.513 0.673 . . . . 0.0 110.246 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -73.39 154.58 89.99 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.541 -0.725 . . . . 0.0 110.746 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.63 -176.2 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 124.036 1.546 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -56.13 167.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.312 0.577 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -56.38 156.06 6.34 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.536 -0.727 . . . . 0.0 111.218 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 18' ' ' ILE . 23.3 pt -88.19 62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.791 0.805 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.62 151.81 38.77 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 110.587 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.26 165.13 31.46 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 124.02 1.537 . . . . 0.0 111.382 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.468 HD11 HG21 ' A' ' 21' ' ' ILE . 2.5 mm -78.96 168.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.661 0.743 . . . . 0.0 111.193 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.29 -60.66 0.48 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.3 -29.94 70.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.774 -0.839 . . . . 0.0 111.049 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.32 13.24 6.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.311 -0.868 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.26 61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.195 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.7 m -48.8 -25.5 1.89 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.764 -0.585 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -105.03 124.94 50.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.883 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.1 -29.44 7.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.1 pt -84.26 161.96 52.97 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.205 -1.174 . . . . 0.0 110.514 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.82 154.78 48.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.157 1.609 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -58.78 -38.51 78.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.901 -0.499 . . . . 0.0 111.169 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -62.78 -45.62 91.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.863 . . . . 0.0 109.846 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.5 m -67.55 -41.23 84.6 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.2 -40.85 97.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.574 . . . . 0.0 109.905 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -61.78 -43.42 98.89 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.475 -0.765 . . . . 0.0 109.683 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.32 -39.39 93.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.676 -0.64 . . . . 0.0 109.78 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.99 -31.12 72.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.741 -0.599 . . . . 0.0 110.597 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.2 t -82.52 -38.6 23.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.423 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 9.8 t80 -68.67 -35.83 77.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.673 -0.642 . . . . 0.0 111.219 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -100.92 -58.01 1.98 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.177 -0.952 . . . . 0.0 111.597 -178.587 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.2 m-85 -79.46 -38.36 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.217 -0.927 . . . . 0.0 111.074 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.43 39.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.65 158.14 17.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.112 -1.229 . . . . 0.0 110.074 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.21 42.93 8.98 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.464 0.649 . . . . 0.0 109.596 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.0 m -87.22 -58.34 2.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.747 . . . . 0.0 110.159 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -123.46 109.06 13.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.646 -0.658 . . . . 0.0 110.198 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.331 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.958 0.409 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.94 177.4 0.15 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.425 0.631 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.28 130.12 8.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.497 -0.752 . . . . 0.0 110.241 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.71 178.21 15.22 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -140.93 129.25 22.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.462 -1.022 . . . . 0.0 110.279 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.6 m -145.77 149.13 33.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -143.26 152.56 57.92 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.314 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.52 148.32 42.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.875 1.461 . . . . 0.0 110.656 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.72 91.78 6.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.588 -0.695 . . . . 0.0 110.093 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.86 165.66 31.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.399 -0.813 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.89 115.0 9.65 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.72 -0.612 . . . . 0.0 110.271 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.1 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 124.021 1.537 . . . . 0.0 110.749 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -65.09 173.52 2.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.827 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -56.11 163.95 2.06 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.531 -0.731 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.88 158.41 56.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.962 1.506 . . . . 0.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.3 -170.3 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.448 0.642 . . . . 0.0 110.992 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -65.33 -175.41 0.24 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.465 0.65 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 19' ' ' ARG . 4.3 mm -54.4 165.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.587 0.708 . . . . 0.0 111.286 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 1.6 tmm_? -46.38 124.5 7.32 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 122.0 -0.437 . . . . 0.0 111.299 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.51 166.16 30.63 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.244 1.655 . . . . 0.0 110.565 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -83.24 165.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.535 0.683 . . . . 0.0 111.231 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.3 -62.08 0.33 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.6 m -67.72 -30.23 69.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.659 -0.906 . . . . 0.0 111.114 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.43 14.05 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.521 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.9 t -138.9 63.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.853 . . . . 0.0 109.02 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.07 -24.16 1.49 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.76 -0.588 . . . . 0.0 111.3 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -104.38 128.86 52.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.22 -28.54 9.6 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 34.6 pt -87.18 162.09 44.42 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.197 -1.178 . . . . 0.0 110.511 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.2 Cg_endo -74.35 154.64 46.0 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -58.71 -39.74 81.65 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.775 -0.578 . . . . 0.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -60.61 -44.76 95.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.349 -0.844 . . . . 0.0 109.778 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 79.6 m -67.89 -41.52 82.62 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.73 87.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.826 -0.546 . . . . 0.0 110.168 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -44.94 92.0 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.377 -0.827 . . . . 0.0 109.399 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -38.27 90.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.59 -0.694 . . . . 0.0 109.732 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.612 . . . . 0.0 110.428 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.7 t -80.79 -37.91 29.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -68.27 -37.8 81.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 111.167 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -60.17 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -0.877 . . . . 0.0 111.673 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 70.8 m-85 -77.3 -39.72 46.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.134 -0.979 . . . . 0.0 111.075 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.74 11.94 36.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.52 158.34 17.29 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.043 -1.269 . . . . 0.0 110.074 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.4 m 62.32 40.42 11.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.386 0.612 . . . . 0.0 109.645 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -85.28 -59.19 2.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.472 -0.767 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -83.55 88.7 7.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.023 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.545 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.016 0.436 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p -82.45 68.93 9.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.448 -0.782 . . . . 0.0 109.856 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -75.75 130.15 38.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.556 -0.715 . . . . 0.0 110.21 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.4 -48.83 0.96 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -157.08 135.04 10.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.983 . . . . 0.0 110.402 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 m -96.8 106.73 19.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.525 -0.735 . . . . 0.0 109.752 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 116.2 21.02 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 110.286 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.45 169.83 21.13 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.752 1.396 . . . . 0.0 111.174 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 66.67 113.72 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.331 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 105.88 1.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 109.526 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.0 85.7 0.15 Allowed Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.867 -0.521 . . . . 0.0 109.805 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.01 -164.65 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.85 1.447 . . . . 0.0 110.603 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -51.55 135.26 28.42 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.459 -0.776 . . . . 0.0 111.326 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.5 mtt85 -101.54 164.11 16.57 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.737 -0.602 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 14' ' ' ARG . 46.8 Cg_endo -74.63 173.79 13.75 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 124.0 1.526 . . . . 0.0 110.556 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.65 150.75 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.639 -0.663 . . . . 0.0 110.492 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -162.71 158.55 23.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.436 -0.79 . . . . 0.0 110.803 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 18' ' ' ILE . 15.8 pt -78.83 68.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.695 0.759 . . . . 0.0 110.141 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.53 150.79 0.85 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.589 -0.694 . . . . 0.0 111.552 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.64 170.57 17.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.09 1.574 . . . . 0.0 111.578 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.49 HG23 HD13 ' A' ' 21' ' ' ILE . 1.8 mm -78.25 168.13 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.588 0.708 . . . . 0.0 110.664 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 105.31 -60.57 0.39 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.653 -0.91 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.43 12.69 6.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 110.782 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 t -139.69 63.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.0 m -48.2 -26.21 1.83 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.714 -0.616 . . . . 0.0 111.134 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -100.72 128.62 46.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.164 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.68 -26.17 15.15 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.6 pt -88.14 161.34 43.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.173 -1.192 . . . . 0.0 110.677 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.33 154.25 45.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.203 1.633 . . . . 0.0 111.258 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -56.82 -41.42 77.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.955 -0.466 . . . . 0.0 111.104 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 t -61.56 -46.17 91.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.764 . . . . 0.0 110.378 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.407 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 83.7 m -67.32 -41.25 85.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 108.934 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.37 -38.14 89.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.722 -0.611 . . . . 0.0 110.03 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.94 -45.47 93.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.537 -0.727 . . . . 0.0 109.535 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.2 -38.15 90.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.743 -0.598 . . . . 0.0 109.783 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -60.99 -34.61 75.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 0.0 110.349 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -80.38 -36.62 33.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -0.915 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.58 -39.68 88.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.775 -0.578 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.17 -54.29 2.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.265 -0.897 . . . . 0.0 111.829 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 89.6 m-85 -81.9 -36.57 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.209 -0.932 . . . . 0.0 111.114 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 10.6 47.42 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.978 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.64 156.4 19.09 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.988 -1.301 . . . . 0.0 110.248 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 m 62.35 42.69 8.87 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.425 0.631 . . . . 0.0 109.743 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 m -81.53 -54.13 5.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.49 -0.756 . . . . 0.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.496 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 30.7 p-80 -77.56 -158.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.631 -0.668 . . . . 0.0 109.669 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 46' ' ' HIS . 1.6 tt . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.652 -0.655 . . . . 0.0 110.603 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.856 0.36 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m 48.64 68.2 0.74 Allowed 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.359 0.6 . . . . 0.0 110.839 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 p -85.45 81.42 8.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 110.081 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.42 -88.76 1.56 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 t80 67.27 153.96 0.09 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.98 -0.718 . . . . 0.0 111.009 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.4 m -80.14 131.46 35.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -73.39 150.11 89.23 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.627 -0.67 . . . . 0.0 110.148 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.66 135.25 25.68 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.927 1.488 . . . . 0.0 110.872 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 tp 66.67 141.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.485 0.659 . . . . 0.0 111.221 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -60.8 134.92 57.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.379 -0.826 . . . . 0.0 109.591 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttt 61.89 95.11 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.975 -0.453 . . . . 0.0 110.299 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.38 -159.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.876 1.461 . . . . 0.0 110.691 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t 65.54 -173.75 0.18 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.663 -0.648 . . . . 0.0 110.921 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -77.45 135.37 65.28 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.16 166.03 29.86 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.974 1.513 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.1 pt -72.63 172.33 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 121.329 0.585 . . . . 0.0 110.868 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.98 152.52 45.41 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.624 -0.672 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 pt -107.68 -177.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.572 -0.705 . . . . 0.0 110.698 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.15 150.07 0.12 Allowed Pre-proline 0 N--CA 1.501 2.11 0 CA-C-O 121.035 0.445 . . . . 0.0 111.404 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.55 176.67 7.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.799 1.421 . . . . 0.0 111.909 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.7 mm -76.0 167.29 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.682 0.753 . . . . 0.0 110.823 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 105.73 -62.79 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 5.3 m -69.6 -28.02 65.59 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.746 -0.855 . . . . 0.0 110.668 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.36 9.28 6.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.428 -0.795 . . . . 0.0 110.918 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.46 64.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.871 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.7 m -49.44 -24.6 2.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -104.38 126.27 51.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.361 -0.837 . . . . 0.0 110.119 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -27.12 10.87 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.448 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.4 pt -82.79 161.82 57.24 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.159 -1.2 . . . . 0.0 110.658 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.0 Cg_endo -73.79 155.63 48.83 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.167 1.614 . . . . 0.0 111.227 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t -58.76 -38.34 78.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.816 -0.552 . . . . 0.0 111.084 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -62.65 -45.08 94.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 0.0 109.876 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 99.0 m -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.09 95.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.814 -0.554 . . . . 0.0 110.199 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -64.47 -43.16 95.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.2 -37.42 83.6 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 109.629 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.8 -29.93 71.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.204 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.1 t -88.36 -36.82 16.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -68.5 -39.01 81.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.729 -0.607 . . . . 0.0 110.947 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -99.15 -61.75 1.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -73.42 -42.2 62.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.291 -0.881 . . . . 0.0 111.178 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.62 10.39 31.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.6 160.78 14.27 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.049 -1.265 . . . . 0.0 109.911 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 m 60.85 40.31 15.94 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.335 0.588 . . . . 0.0 109.704 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.7 m -91.69 -59.65 2.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 110.213 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -87.94 87.07 7.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.879 -1.058 . . . . 0.0 110.41 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -70.37 -25.99 63.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.691 -0.887 . . . . 0.0 110.36 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -76.89 3.75 11.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 111.2 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' TYR . 6.5 t -142.76 69.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 m -50.65 -25.82 4.7 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.635 -0.666 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 25' ' ' VAL . 9.9 m-85 -107.61 124.87 50.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.855 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.05 -29.28 7.81 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 41.2 pt -77.4 163.2 65.73 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.245 -1.15 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.46 154.38 50.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.023 1.539 . . . . 0.0 111.165 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -57.44 -41.35 80.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.89 -0.506 . . . . 0.0 110.969 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -60.58 -45.55 93.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 80.1 m -67.8 -40.4 83.89 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.54 91.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 110.012 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -43.48 98.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.355 -0.841 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.7 -40.45 95.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.763 -0.586 . . . . 0.0 109.811 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -64.27 -30.12 71.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.456 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.6 t -85.93 -36.95 19.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.843 . . . . 0.0 109.741 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -70.07 -38.8 75.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.68 -0.638 . . . . 0.0 111.034 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -58.74 1.95 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 111.757 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 87.0 m-85 -79.88 -36.91 35.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 111.257 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.44 13.51 38.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -106.73 160.07 15.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.074 -1.251 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.379 0.609 . . . . 0.0 109.694 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -66.66 -30.29 70.52 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.676 -0.896 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -83.53 10.92 7.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 0.0 110.78 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.29 61.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 108.719 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.2 m -47.37 -27.55 1.69 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.935 -0.478 . . . . 0.0 111.37 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.73 125.77 51.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 0.0 109.819 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.97 -29.28 7.84 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.2 pt -79.37 164.0 56.42 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.234 -1.157 . . . . 0.0 110.463 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.25 155.76 51.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.046 1.55 . . . . 0.0 111.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 t -57.74 -41.04 81.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.898 -0.501 . . . . 0.0 111.219 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -62.46 -43.48 98.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.854 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 47.6 m -64.86 -41.36 95.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.396 -0.815 . . . . 0.0 109.299 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.11 -41.76 88.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.723 -0.611 . . . . 0.0 110.48 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -63.62 -43.11 97.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.478 -0.764 . . . . 0.0 109.826 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -37.09 80.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -66.9 -30.14 70.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.61 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 t -86.28 -36.28 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.913 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 17.1 t80 -70.41 -38.77 74.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.635 -0.665 . . . . 0.0 111.047 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -98.18 -60.21 1.6 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 111.696 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 77.7 m-85 -75.58 -39.22 58.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.232 -0.918 . . . . 0.0 111.068 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.99 38.78 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.668 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.59 160.52 15.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.917 -179.406 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.22 -29.35 68.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.669 -0.901 . . . . 0.0 110.674 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 16.76 4.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -0.816 . . . . 0.0 110.556 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 27' ' ' TYR . 12.2 t -141.58 61.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.031 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.2 m -48.64 -26.24 2.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.811 -0.556 . . . . 0.0 111.241 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 25' ' ' VAL . 70.1 m-85 -105.34 128.32 53.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.84 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.82 -30.84 7.46 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.433 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.8 pt -84.0 162.18 52.93 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.336 -1.097 . . . . 0.0 110.426 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.1 Cg_endo -74.21 153.09 45.77 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.166 1.614 . . . . 0.0 111.001 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -58.73 -36.67 74.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.861 -0.524 . . . . 0.0 111.288 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -64.14 -45.04 90.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.8 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 81.7 m -68.41 -41.86 79.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.94 89.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.815 -0.553 . . . . 0.0 110.213 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -64.01 -42.78 97.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -0.768 . . . . 0.0 109.428 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.18 -38.8 91.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.606 -0.684 . . . . 0.0 109.618 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -61.04 -33.82 73.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.783 -0.573 . . . . 0.0 110.329 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.4 t -78.67 -37.74 41.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 109.907 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -66.81 -38.97 87.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.38 -56.23 2.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 111.856 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.1 m-85 -80.18 -37.33 33.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.202 -0.936 . . . . 0.0 111.072 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 11.41 45.91 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.42 157.86 18.04 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.999 -1.295 . . . . 0.0 110.273 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 121.38 0.61 . . . . 0.0 109.987 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.82 -28.57 61.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.631 -0.923 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.84 8.8 6.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.302 -0.874 . . . . 0.0 111.02 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.41 65.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.021 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.4 m -50.51 -24.17 2.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.664 -0.647 . . . . 0.0 111.288 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -106.78 126.03 51.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.39 -27.2 10.23 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.5 pt -81.84 162.17 58.46 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.123 -1.222 . . . . 0.0 110.754 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.77 155.53 48.95 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.16 1.611 . . . . 0.0 111.099 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -58.58 -39.15 79.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.79 -0.569 . . . . 0.0 111.111 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 t -61.8 -45.52 93.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.372 -0.83 . . . . 0.0 109.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.6 m -69.43 -40.13 77.42 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.08 93.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.701 -0.624 . . . . 0.0 110.282 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -65.7 -42.32 91.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.428 -0.795 . . . . 0.0 109.517 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.88 -38.25 85.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.709 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -61.93 -30.89 71.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.62 -0.675 . . . . 0.0 110.202 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -83.93 -37.68 22.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.358 -0.838 . . . . 0.0 109.548 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -71.2 -35.46 71.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 111.015 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -55.72 2.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -86.31 -36.22 19.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.308 -0.87 . . . . 0.0 111.129 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.32 37.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.64 159.97 15.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.089 -1.242 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.794 -0.566 . . . . 0.0 109.913 -179.693 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.32 -28.15 66.91 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.669 -0.901 . . . . 0.0 110.979 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.9 11.86 5.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.8 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 27' ' ' TYR . 8.6 t -139.76 63.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.28 -0.887 . . . . 0.0 109.024 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.5 m -49.54 -25.94 3.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.729 -0.607 . . . . 0.0 111.069 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 25' ' ' VAL . 33.2 m-85 -105.87 126.06 51.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -29.77 7.46 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.485 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.6 pt -81.27 162.89 57.37 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.34 155.26 51.21 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.096 1.577 . . . . 0.0 111.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 t -56.94 -41.66 78.64 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.012 -0.43 . . . . 0.0 111.132 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -62.25 -45.75 91.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.9 m -66.37 -40.57 89.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.21 96.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.731 -0.605 . . . . 0.0 110.15 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -42.85 99.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.765 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.1 -38.9 89.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.526 -0.734 . . . . 0.0 109.703 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -62.83 -29.15 70.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.629 . . . . 0.0 110.396 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -85.98 -37.02 19.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.378 -0.826 . . . . 0.0 109.622 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -70.79 -36.66 73.11 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.701 -0.624 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -57.58 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.9 m-85 -81.76 -37.19 27.6 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.093 -1.004 . . . . 0.0 111.175 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.61 12.24 38.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.69 159.59 15.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.121 -1.223 . . . . 0.0 109.778 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 121.385 0.612 . . . . 0.0 109.77 -179.436 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.7 m -66.42 -30.54 70.92 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.831 -0.805 . . . . 0.0 110.594 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.0 12.27 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.785 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 t -139.57 63.04 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.322 -0.861 . . . . 0.0 108.862 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.6 m -49.83 -25.09 2.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.839 -0.538 . . . . 0.0 111.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -105.34 126.78 52.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.139 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.89 -28.29 8.98 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.9 pt -84.61 162.08 51.67 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.155 -1.203 . . . . 0.0 110.611 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -74.16 155.11 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.139 1.599 . . . . 0.0 111.011 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -58.36 -40.78 83.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.822 -0.549 . . . . 0.0 111.022 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -60.48 -45.98 91.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.45 -0.781 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.0 m -66.16 -41.83 89.79 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.24 92.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.758 -0.589 . . . . 0.0 109.904 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.8 -44.2 97.17 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.463 -0.773 . . . . 0.0 109.908 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.593 -0.692 . . . . 0.0 109.824 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.64 -35.15 78.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.635 . . . . 0.0 110.555 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -78.98 -38.62 36.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.83 -38.73 83.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.608 -0.683 . . . . 0.0 111.175 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -57.94 2.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.428 -0.795 . . . . 0.0 111.731 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.446 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 83.3 m-85 -84.02 -34.59 24.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.154 -0.966 . . . . 0.0 111.421 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.97 12.17 47.28 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -104.78 157.13 17.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.898 -1.354 . . . . 0.0 109.971 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.126 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -67.24 -29.41 69.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.726 -0.867 . . . . 0.0 110.212 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.76 16.19 4.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.537 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 27' ' ' TYR . 16.3 t -141.71 63.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.224 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.7 m -48.14 -25.87 1.65 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.761 -0.587 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.464 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.4 m-85 -106.5 126.29 52.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.39 -31.76 6.26 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.459 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.8 pt -80.76 162.8 58.91 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.307 -1.113 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.7 Cg_endo -73.33 153.4 50.63 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.08 1.568 . . . . 0.0 111.134 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -37.67 73.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.878 -0.514 . . . . 0.0 111.309 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -65.13 -44.67 87.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.39 -0.819 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 54.2 m -64.81 -41.33 95.87 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 109.21 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.44 78.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.634 . . . . 0.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.06 -41.19 91.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 109.09 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -40.47 95.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.78 -40.46 95.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.633 . . . . 0.0 109.769 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.52 -38.52 68.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 109.983 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -67.5 -38.14 83.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.7 -0.625 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -58.74 1.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 111.811 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -77.7 -39.67 43.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.261 -0.899 . . . . 0.0 111.169 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.03 14.0 32.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.02 159.11 18.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.061 -1.258 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.364 0.602 . . . . 0.0 109.944 -179.599 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -67.78 -31.14 70.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.796 -0.826 . . . . 0.0 109.83 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -72.22 -0.49 12.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.66 -0.65 . . . . 0.0 111.48 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 27' ' ' TYR . 19.1 t -143.03 74.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.14 -0.975 . . . . 0.0 108.989 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.1 m -50.43 -23.1 2.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.765 -0.585 . . . . 0.0 111.339 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.549 ' O ' HG12 ' A' ' 25' ' ' VAL . 22.3 m-85 -104.96 128.13 53.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.227 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -25.11 15.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.468 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.4 pt -79.55 162.09 64.57 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.153 -1.204 . . . . 0.0 110.908 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.53 156.65 49.6 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.206 1.635 . . . . 0.0 111.333 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -56.89 -40.97 77.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.958 -0.464 . . . . 0.0 111.31 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -63.35 -43.61 97.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.449 -0.782 . . . . 0.0 110.243 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 30.8 m -64.51 -41.15 96.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.42 -0.8 . . . . 0.0 109.111 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.75 79.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.712 -0.617 . . . . 0.0 110.294 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -64.71 -42.08 95.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.04 -37.22 78.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.635 -0.665 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -67.64 -31.53 71.6 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.557 -0.714 . . . . 0.0 110.269 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.9 t -86.85 -35.15 19.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -70.21 -40.58 74.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.602 -0.686 . . . . 0.0 111.363 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -53.42 3.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 111.844 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 94.5 m-85 -82.85 -36.03 25.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.89 . . . . 0.0 111.304 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 12.17 48.58 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -104.98 158.86 16.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.76 -0.588 . . . . 0.0 109.936 -179.719 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.407 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 m -66.55 -28.98 68.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.788 -0.83 . . . . 0.0 109.813 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.24 3.09 9.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.6 -0.688 . . . . 0.0 111.346 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 27' ' ' TYR . 7.8 t -142.63 71.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.014 . . . . 0.0 109.216 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.8 m -51.34 -22.68 3.03 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.706 -0.621 . . . . 0.0 111.472 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.4 m-85 -105.97 128.71 53.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 0.0 110.313 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.41 -27.46 9.98 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.0 pt -84.41 161.93 52.68 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.142 -1.211 . . . . 0.0 110.769 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.0 156.36 47.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.103 1.58 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.0 t -58.82 -40.54 84.44 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.804 -0.56 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -60.14 -46.01 91.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.806 . . . . 0.0 109.871 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 98.4 m -68.96 -40.36 78.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.89 92.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.777 -0.577 . . . . 0.0 110.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -64.47 -42.03 96.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.405 -0.809 . . . . 0.0 109.374 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.93 -39.5 93.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.682 -0.637 . . . . 0.0 109.619 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -63.44 -29.94 71.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.785 -0.572 . . . . 0.0 110.263 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.0 t -86.18 -37.7 18.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 0.0 109.562 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -67.17 -38.69 85.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.816 -0.553 . . . . 0.0 111.191 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -100.2 -55.07 2.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -0.851 . . . . 0.0 112.036 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 91.2 m-85 -82.64 -36.18 26.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.102 -0.998 . . . . 0.0 111.13 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.96 11.18 43.91 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -105.21 158.31 16.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.012 -1.287 . . . . 0.0 109.959 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 -179.686 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 7.7 m -65.84 -30.58 71.22 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.702 -0.881 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.47 13.55 4.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.687 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 27' ' ' TYR . 14.0 t -141.67 63.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 108.879 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.99 -25.14 3.06 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.795 -0.566 . . . . 0.0 111.269 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' VAL . 64.0 m-85 -105.78 129.35 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.73 -30.42 7.49 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.3 pt -84.97 162.38 49.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.22 -1.165 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.92 154.3 48.01 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.109 1.584 . . . . 0.0 110.887 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 t -58.3 -39.29 78.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.827 -0.545 . . . . 0.0 111.084 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.39 -46.62 89.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.84 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 86.0 m -66.85 -40.59 87.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 108.974 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.99 96.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.788 -0.57 . . . . 0.0 110.073 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -62.42 -42.73 99.66 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.13 -39.79 95.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -34.73 76.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.801 -0.562 . . . . 0.0 110.265 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.8 t -76.24 -38.35 56.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 13.8 t80 -67.11 -38.18 85.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 111.361 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 6.1 mmm180 -98.95 -57.06 2.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.228 -0.92 . . . . 0.0 111.75 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CD1' ' SG ' ' A' ' 23' ' ' CYS . 83.0 m-85 -81.5 -36.86 28.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.933 . . . . 0.0 111.208 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.01 12.11 47.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.11 155.78 18.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -1.207 . . . . 0.0 109.892 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 121.345 0.593 . . . . 0.0 109.773 -179.715 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 1.6 m -71.21 -28.93 64.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.765 -0.844 . . . . 0.0 110.465 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 14.28 4.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.303 -0.873 . . . . 0.0 110.55 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 27' ' ' TYR . 23.3 t -139.33 65.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 108.702 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 90.2 m -47.95 -24.17 0.98 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.903 -0.498 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 25' ' ' VAL . 25.6 m-85 -102.82 127.08 50.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.91 -26.1 13.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.46 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.9 pt -87.63 162.68 41.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.193 -1.181 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.8 Cg_endo -74.55 154.66 44.97 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.152 1.606 . . . . 0.0 111.182 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 t -59.28 -39.37 82.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.813 -0.555 . . . . 0.0 110.914 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -59.3 -46.5 88.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.744 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 90.6 m -68.38 -41.15 80.99 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.45 88.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.732 -0.605 . . . . 0.0 110.176 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -65.75 -43.87 87.61 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.341 -0.849 . . . . 0.0 109.392 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -36.45 80.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.554 -0.716 . . . . 0.0 109.373 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -60.84 -31.08 70.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.82 -0.55 . . . . 0.0 110.465 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.5 t -84.35 -37.33 21.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.14 -0.975 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -68.91 -38.97 79.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 0.0 111.234 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -56.91 2.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.309 -0.869 . . . . 0.0 111.836 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 63.5 m-85 -80.19 -37.8 32.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.219 -0.926 . . . . 0.0 111.234 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.36 12.29 42.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.2 157.44 17.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -1.21 . . . . 0.0 109.585 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.504 2.236 0 O-C-N 121.713 -0.617 . . . . 0.0 109.676 -179.202 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.7 m -66.51 -29.17 69.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.689 -0.889 . . . . 0.0 110.684 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.38 15.16 4.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.225 -0.922 . . . . 0.0 110.497 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -138.46 62.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.71 -24.72 1.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.851 -0.531 . . . . 0.0 111.357 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -105.65 126.93 52.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.822 . . . . 0.0 109.955 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.84 8.89 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.0 pt -83.31 161.63 56.5 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.198 -1.177 . . . . 0.0 110.532 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.442 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.8 Cg_endo -74.02 153.66 47.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.186 1.624 . . . . 0.0 111.315 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 t -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.952 -0.467 . . . . 0.0 111.112 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.96 -45.7 92.49 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.523 -0.736 . . . . 0.0 110.246 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.7 m -67.52 -41.38 84.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 0.0 108.731 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.6 91.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.732 -0.605 . . . . 0.0 110.037 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.461 -0.774 . . . . 0.0 109.473 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -37.54 87.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.763 -0.585 . . . . 0.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -64.01 -32.55 74.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.771 -0.58 . . . . 0.0 110.558 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.5 t -81.9 -37.83 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.77 -37.77 85.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.695 -0.628 . . . . 0.0 111.325 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -101.78 -58.41 1.89 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -0.916 . . . . 0.0 111.638 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.4 m-85 -77.01 -38.45 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.157 -0.964 . . . . 0.0 111.16 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.51 42.95 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.15 157.15 18.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.009 -1.289 . . . . 0.0 109.934 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.443 0.639 . . . . 0.0 109.705 -179.402 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 m -66.02 -29.2 69.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.752 -0.852 . . . . 0.0 110.8 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 11.6 6.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.02 63.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 108.745 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -49.8 -23.06 1.66 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.0 111.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -105.81 126.48 52.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.306 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.95 -24.75 14.06 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.853 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.2 pt -86.17 160.07 52.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.031 -1.276 . . . . 0.0 110.924 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.3 Cg_endo -74.34 157.82 45.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.214 1.639 . . . . 0.0 111.24 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -59.43 -40.28 86.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.734 -0.604 . . . . 0.0 110.94 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -59.65 -44.86 93.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.399 -0.813 . . . . 0.0 109.697 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.433 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 82.1 m -68.43 -41.04 80.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.34 90.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.713 -0.617 . . . . 0.0 109.793 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.54 -45.5 93.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.503 -0.748 . . . . 0.0 109.305 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -36.25 82.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 109.833 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -68.06 -37.39 81.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.6 t -80.33 -33.85 37.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 0.0 110.049 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 35' ' ' ARG . 28.1 t80 -70.85 -41.43 71.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 111.528 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.355 -0.841 . . . . 0.0 111.821 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 90.6 m-85 -82.37 -37.1 26.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.175 -0.953 . . . . 0.0 111.14 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.04 42.82 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -106.87 156.24 18.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.246 . . . . 0.0 109.845 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 121.426 0.632 . . . . 0.0 109.821 -179.71 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.87 -16.37 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.747 -0.855 . . . . 0.0 110.293 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.94 -4.28 43.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.669 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.7 t -143.71 74.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.312 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 m -48.47 -26.91 2.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.921 -0.487 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.613 ' O ' HG12 ' A' ' 25' ' ' VAL . 98.2 m-85 -107.57 129.26 55.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.925 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.81 -28.97 8.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 45.0 pt -80.06 163.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.214 -1.168 . . . . 0.0 110.498 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.45 155.64 50.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.118 1.589 . . . . 0.0 111.144 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 t -58.54 -39.29 79.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 111.033 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 t -61.18 -46.42 90.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.6 m -67.19 -41.39 85.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.69 87.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.706 -0.621 . . . . 0.0 110.129 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -64.23 -44.07 92.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.542 -0.723 . . . . 0.0 109.579 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -67.12 -37.25 83.54 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 0.0 109.888 179.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -65.9 -30.22 70.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.48 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -87.98 -36.44 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 109.982 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.81 -38.01 70.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 111.329 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -100.21 -55.36 2.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.279 -0.888 . . . . 0.0 111.601 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.3 m-85 -79.16 -37.76 37.66 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.183 -0.948 . . . . 0.0 110.932 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.52 12.11 42.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -109.07 160.0 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.064 -1.257 . . . . 0.0 110.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.503 2.189 0 O-C-N 121.722 -0.611 . . . . 0.0 109.761 -179.29 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -68.11 -30.12 69.21 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.834 -0.803 . . . . 0.0 110.244 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.57 13.3 4.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.36 -0.838 . . . . 0.0 110.573 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.0 t -139.81 64.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 109.174 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.7 m -49.34 -24.24 1.8 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.769 -0.582 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.2 m-85 -105.36 126.78 52.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.18 8.44 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 38.3 pt -83.52 162.56 53.0 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -73.57 154.59 49.96 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.123 1.591 . . . . 0.0 111.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -57.95 -38.73 76.52 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.924 -0.485 . . . . 0.0 111.264 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 t -63.9 -44.99 91.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.389 -0.82 . . . . 0.0 110.011 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 70.0 m -65.89 -41.63 91.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.31 -0.869 . . . . 0.0 109.056 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.83 84.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -46.19 86.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.45 -0.781 . . . . 0.0 109.584 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.56 -31.5 72.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.672 -0.643 . . . . 0.0 110.409 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -83.36 -36.63 24.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -69.38 -37.59 77.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.653 . . . . 0.0 111.144 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -99.77 -59.75 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.355 -0.84 . . . . 0.0 111.605 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 63.8 m-85 -76.74 -39.21 52.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.901 . . . . 0.0 111.112 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.2 35.95 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 9.1 m-20 -108.24 159.03 16.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.064 -1.256 . . . . 0.0 110.128 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 121.471 0.653 . . . . 0.0 109.543 -179.131 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.563 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.3 m -79.2 -13.44 59.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.815 -0.814 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.26 -0.82 38.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.438 -0.789 . . . . 0.0 111.515 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.2 t -143.69 72.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.104 -0.998 . . . . 0.0 109.463 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.9 m -50.04 -24.91 2.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.869 -0.52 . . . . 0.0 111.112 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 25' ' ' VAL . 10.4 m-85 -107.53 126.7 52.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 110.033 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.76 -27.77 9.5 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 42.2 pt -80.27 162.7 60.46 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.197 -1.178 . . . . 0.0 110.445 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.61 155.19 49.91 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.053 1.554 . . . . 0.0 111.201 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -57.94 -39.99 79.41 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.787 -0.571 . . . . 0.0 110.863 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -47.41 86.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 109.876 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.7 m -67.86 -40.43 83.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.042 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 110.095 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.16 -42.95 93.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.4 -0.813 . . . . 0.0 109.412 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.1 -39.29 86.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.651 . . . . 0.0 109.817 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -64.19 -28.83 70.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 110.069 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.9 t -88.18 -37.07 16.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.77 -39.26 70.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.663 . . . . 0.0 111.276 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -52.27 3.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 111.749 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.1 m-85 -82.96 -38.22 23.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 11.7 39.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.97 160.74 15.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.024 -1.28 . . . . 0.0 110.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.503 2.195 0 CA-C-O 121.387 0.613 . . . . 0.0 109.704 -179.219 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.3 -29.94 70.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.774 -0.839 . . . . 0.0 111.049 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.32 13.24 6.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.311 -0.868 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.26 61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.195 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.7 m -48.8 -25.5 1.89 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.764 -0.585 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -105.03 124.94 50.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.883 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.1 -29.44 7.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.456 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.1 pt -84.26 161.96 52.97 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.205 -1.174 . . . . 0.0 110.514 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.82 154.78 48.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.157 1.609 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -58.78 -38.51 78.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.901 -0.499 . . . . 0.0 111.169 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -62.78 -45.62 91.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.863 . . . . 0.0 109.846 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.5 m -67.55 -41.23 84.6 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.2 -40.85 97.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.574 . . . . 0.0 109.905 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -61.78 -43.42 98.89 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.475 -0.765 . . . . 0.0 109.683 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.32 -39.39 93.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.676 -0.64 . . . . 0.0 109.78 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.99 -31.12 72.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.741 -0.599 . . . . 0.0 110.597 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.2 t -82.52 -38.6 23.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 9.8 t80 -68.67 -35.83 77.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.673 -0.642 . . . . 0.0 111.219 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -100.92 -58.01 1.98 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.177 -0.952 . . . . 0.0 111.597 -178.587 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.2 m-85 -79.46 -38.36 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.217 -0.927 . . . . 0.0 111.074 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.43 39.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.65 158.14 17.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.112 -1.229 . . . . 0.0 110.074 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.464 0.649 . . . . 0.0 109.596 -179.169 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.6 m -67.72 -30.23 69.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.659 -0.906 . . . . 0.0 111.114 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.43 14.05 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.521 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.9 t -138.9 63.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.853 . . . . 0.0 109.02 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.07 -24.16 1.49 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.76 -0.588 . . . . 0.0 111.3 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 25' ' ' VAL . 38.6 m-85 -104.38 128.86 52.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.22 -28.54 9.6 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 34.6 pt -87.18 162.09 44.42 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.197 -1.178 . . . . 0.0 110.511 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.2 Cg_endo -74.35 154.64 46.0 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -58.71 -39.74 81.65 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.775 -0.578 . . . . 0.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -60.61 -44.76 95.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.349 -0.844 . . . . 0.0 109.778 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 79.6 m -67.89 -41.52 82.62 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.73 87.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.826 -0.546 . . . . 0.0 110.168 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -44.94 92.0 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.377 -0.827 . . . . 0.0 109.399 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.43 -38.27 90.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.59 -0.694 . . . . 0.0 109.732 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.612 . . . . 0.0 110.428 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.7 t -80.79 -37.91 29.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -68.27 -37.8 81.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 111.167 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -60.17 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -0.877 . . . . 0.0 111.673 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 70.8 m-85 -77.3 -39.72 46.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.134 -0.979 . . . . 0.0 111.075 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.74 11.94 36.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.52 158.34 17.29 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.043 -1.269 . . . . 0.0 110.074 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.386 0.612 . . . . 0.0 109.645 -179.281 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.653 -0.91 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.43 12.69 6.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 110.782 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 27' ' ' TYR . 11.3 t -139.69 63.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.0 m -48.2 -26.21 1.83 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.714 -0.616 . . . . 0.0 111.134 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 25' ' ' VAL . 94.4 m-85 -100.72 128.62 46.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.68 -26.17 15.15 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.6 pt -88.14 161.34 43.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.173 -1.192 . . . . 0.0 110.677 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.33 154.25 45.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.203 1.633 . . . . 0.0 111.258 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -56.82 -41.42 77.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.955 -0.466 . . . . 0.0 111.104 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 t -61.56 -46.17 91.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.764 . . . . 0.0 110.378 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 83.7 m -67.32 -41.25 85.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 108.934 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.37 -38.14 89.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.722 -0.611 . . . . 0.0 110.03 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.94 -45.47 93.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.537 -0.727 . . . . 0.0 109.535 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.2 -38.15 90.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.743 -0.598 . . . . 0.0 109.783 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -60.99 -34.61 75.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 0.0 110.349 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -80.38 -36.62 33.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -0.915 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.58 -39.68 88.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.775 -0.578 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.17 -54.29 2.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.265 -0.897 . . . . 0.0 111.829 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 89.6 m-85 -81.9 -36.57 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.209 -0.932 . . . . 0.0 111.114 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 10.6 47.42 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.978 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.64 156.4 19.09 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.988 -1.301 . . . . 0.0 110.248 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 121.425 0.631 . . . . 0.0 109.743 -179.219 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 5.3 m -69.6 -28.02 65.59 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.746 -0.855 . . . . 0.0 110.668 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.36 9.28 6.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.428 -0.795 . . . . 0.0 110.918 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.46 64.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.871 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.7 m -49.44 -24.6 2.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -104.38 126.27 51.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.361 -0.837 . . . . 0.0 110.119 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -27.12 10.87 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.464 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.4 pt -82.79 161.82 57.24 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.159 -1.2 . . . . 0.0 110.658 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.0 Cg_endo -73.79 155.63 48.83 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.167 1.614 . . . . 0.0 111.227 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t -58.76 -38.34 78.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.816 -0.552 . . . . 0.0 111.084 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -62.65 -45.08 94.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 0.0 109.876 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 99.0 m -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.09 95.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.814 -0.554 . . . . 0.0 110.199 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -64.47 -43.16 95.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.2 -37.42 83.6 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 109.629 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.8 -29.93 71.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.204 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.1 t -88.36 -36.82 16.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -68.5 -39.01 81.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.729 -0.607 . . . . 0.0 110.947 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -99.15 -61.75 1.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -73.42 -42.2 62.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.291 -0.881 . . . . 0.0 111.178 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.62 10.39 31.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 2.1 m-20 -102.6 160.78 14.27 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.049 -1.265 . . . . 0.0 109.911 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.503 2.219 0 CA-C-O 121.335 0.588 . . . . 0.0 109.704 -179.478 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 t60 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 120.89 0.376 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t 52.37 65.77 1.41 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.531 0.681 . . . . 0.0 110.56 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -84.69 163.15 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -0.787 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.35 -91.97 0.75 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -160.65 134.4 6.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.508 -0.995 . . . . 0.0 110.548 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.617 HG22 ' HD3' ' A' ' 8' ' ' PRO . 17.0 m -147.67 133.98 19.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.548 -0.72 . . . . 0.0 110.06 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.6 72.66 7.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 110.548 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.617 ' HD3' HG22 ' A' ' 6' ' ' THR . 47.9 Cg_endo -75.8 162.08 35.54 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 124.04 1.548 . . . . 0.0 110.632 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.75 145.2 50.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.683 -0.636 . . . . 0.0 110.277 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -138.94 138.04 36.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.351 -0.843 . . . . 0.0 110.875 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.24 163.36 68.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.718 . . . . 0.0 110.311 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.22 -166.78 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 124.024 1.539 . . . . 0.0 110.742 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 m -58.91 129.01 40.06 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.503 -0.748 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 153.83 73.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.533 -0.73 . . . . 0.0 110.348 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.85 159.22 48.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 124.075 1.566 . . . . 0.0 110.533 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.89 165.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.645 -0.659 . . . . 0.0 110.608 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -164.79 164.22 21.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.727 . . . . 0.0 110.196 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.3 pt -68.6 168.5 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.389 -0.82 . . . . 0.0 110.005 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -88.91 164.22 32.06 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 110.309 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 19' ' ' ARG . 39.8 Cg_endo -70.9 169.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 124.15 1.605 . . . . 0.0 111.17 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.2 mm -72.2 165.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.683 0.754 . . . . 0.0 110.684 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 108.36 -62.26 0.3 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -70.37 -25.99 63.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.691 -0.887 . . . . 0.0 110.36 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -76.89 3.75 11.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 111.2 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' TYR . 6.5 t -142.76 69.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 m -50.65 -25.82 4.7 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.635 -0.666 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 25' ' ' VAL . 9.9 m-85 -107.61 124.87 50.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.855 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.05 -29.28 7.81 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 41.2 pt -77.4 163.2 65.73 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.245 -1.15 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.46 154.38 50.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.023 1.539 . . . . 0.0 111.165 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -57.44 -41.35 80.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.89 -0.506 . . . . 0.0 110.969 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -60.58 -45.55 93.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 80.1 m -67.8 -40.4 83.89 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.54 91.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 110.012 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -43.48 98.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.355 -0.841 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.7 -40.45 95.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.763 -0.586 . . . . 0.0 109.811 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -64.27 -30.12 71.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.456 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.6 t -85.93 -36.95 19.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.843 . . . . 0.0 109.741 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -70.07 -38.8 75.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.68 -0.638 . . . . 0.0 111.034 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -58.74 1.95 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 111.757 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 87.0 m-85 -79.88 -36.91 35.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 111.257 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.44 13.51 38.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -106.73 160.07 15.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.074 -1.251 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m 61.14 41.18 13.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.379 0.609 . . . . 0.0 109.694 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -90.31 -60.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 110.199 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -101.13 83.43 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.579 -0.7 . . . . 0.0 110.129 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.396 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 34.8 p80 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.043 0.449 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 56.86 79.0 0.2 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.384 0.612 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.71 162.83 40.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.408 -0.808 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.44 -116.44 4.51 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 68.13 156.28 0.12 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.955 -0.732 . . . . 0.0 111.04 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.0 m -116.6 135.04 54.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.487 -0.758 . . . . 0.0 110.379 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 152.79 92.47 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.632 -0.668 . . . . 0.0 110.253 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.31 149.29 56.85 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.896 1.472 . . . . 0.0 110.902 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.07 175.71 9.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.26 148.55 51.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.53 -0.731 . . . . 0.0 110.504 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.79 107.33 10.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.745 . . . . 0.0 110.241 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.29 -170.32 0.98 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.875 1.46 . . . . 0.0 110.654 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -105.54 63.4 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.44 136.99 19.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.241 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.74 171.67 17.36 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 124.053 1.554 . . . . 0.0 110.835 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.5 pt -59.38 168.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.705 -0.622 . . . . 0.0 110.588 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -154.47 165.02 37.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.651 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.0 pt -73.09 174.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.636 -0.665 . . . . 0.0 110.517 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 154.14 91.16 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 110.31 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -70.38 165.14 32.65 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.983 1.517 . . . . 0.0 111.372 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.3 mt -79.74 165.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.497 0.665 . . . . 0.0 110.933 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 106.42 -60.44 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -66.66 -30.29 70.52 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.676 -0.896 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -83.53 10.92 7.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 0.0 110.78 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.29 61.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 108.719 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 47' ' ' LEU . 68.2 m -47.37 -27.55 1.69 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.935 -0.478 . . . . 0.0 111.37 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.73 125.77 51.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 0.0 109.819 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.97 -29.28 7.84 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.2 pt -79.37 164.0 56.42 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.234 -1.157 . . . . 0.0 110.463 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.25 155.76 51.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.046 1.55 . . . . 0.0 111.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 t -57.74 -41.04 81.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.898 -0.501 . . . . 0.0 111.219 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -62.46 -43.48 98.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.854 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 47.6 m -64.86 -41.36 95.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.396 -0.815 . . . . 0.0 109.299 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.11 -41.76 88.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.723 -0.611 . . . . 0.0 110.48 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -63.62 -43.11 97.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.478 -0.764 . . . . 0.0 109.826 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -37.09 80.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -66.9 -30.14 70.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.61 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 t -86.28 -36.28 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.913 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 17.1 t80 -70.41 -38.77 74.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.635 -0.665 . . . . 0.0 111.047 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -98.18 -60.21 1.6 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 111.696 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 77.7 m-85 -75.58 -39.22 58.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.232 -0.918 . . . . 0.0 111.068 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.99 38.78 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.668 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.59 160.52 15.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HA ' HD13 ' A' ' 47' ' ' LEU . 20.3 m 63.59 36.44 11.0 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.917 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.5 m -88.01 -61.42 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.52 -0.737 . . . . 0.0 109.54 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -89.66 88.36 7.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.686 -0.634 . . . . 0.0 109.55 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.501 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.036 0.446 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -146.07 150.98 36.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.351 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 t -94.32 118.77 32.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.437 -0.789 . . . . 0.0 110.32 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.19 125.1 7.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 134.1 41.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.409 -1.054 . . . . 0.0 110.622 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.0 m -96.6 103.59 15.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.539 -0.726 . . . . 0.0 109.59 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tpp180 -158.65 135.65 6.8 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.796 . . . . 0.0 110.7 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 7' ' ' ARG . 46.9 Cg_endo -73.67 152.17 47.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.977 1.514 . . . . 0.0 110.504 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.48 155.84 11.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.587 -0.695 . . . . 0.0 110.969 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.64 128.74 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.925 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -77.68 146.95 73.86 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 110.553 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.27 -156.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.221 1.643 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.5 m -58.09 171.93 0.49 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -44.8 127.98 5.2 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.636 -0.665 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.53 -179.08 3.78 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 124.08 1.569 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.38 162.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.295 0.569 . . . . 0.0 110.739 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.43 -179.2 0.23 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.532 -0.73 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.64 -177.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 121.584 0.707 . . . . 0.0 111.287 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 123.2 41.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.79 175.84 8.39 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.119 1.589 . . . . 0.0 111.385 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.3 mt -83.49 166.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.61 -0.681 . . . . 0.0 110.675 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 107.1 -61.69 0.31 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.22 -29.35 68.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.669 -0.901 . . . . 0.0 110.674 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 16.76 4.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -0.816 . . . . 0.0 110.556 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 27' ' ' TYR . 12.2 t -141.58 61.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.031 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.2 m -48.64 -26.24 2.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.811 -0.556 . . . . 0.0 111.241 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 25' ' ' VAL . 70.1 m-85 -105.34 128.32 53.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.84 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.82 -30.84 7.46 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.433 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.8 pt -84.0 162.18 52.93 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.336 -1.097 . . . . 0.0 110.426 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.1 Cg_endo -74.21 153.09 45.77 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.166 1.614 . . . . 0.0 111.001 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -58.73 -36.67 74.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.861 -0.524 . . . . 0.0 111.288 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -64.14 -45.04 90.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.8 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 81.7 m -68.41 -41.86 79.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.94 89.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.815 -0.553 . . . . 0.0 110.213 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -64.01 -42.78 97.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -0.768 . . . . 0.0 109.428 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.18 -38.8 91.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.606 -0.684 . . . . 0.0 109.618 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -61.04 -33.82 73.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.783 -0.573 . . . . 0.0 110.329 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.4 t -78.67 -37.74 41.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 109.907 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -66.81 -38.97 87.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.38 -56.23 2.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 111.856 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.1 m-85 -80.18 -37.33 33.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.202 -0.936 . . . . 0.0 111.072 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 11.41 45.91 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.42 157.86 18.04 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.999 -1.295 . . . . 0.0 110.273 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 m 63.09 39.99 9.46 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.38 0.61 . . . . 0.0 109.987 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.3 m -82.38 -58.51 2.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.416 -0.802 . . . . 0.0 109.68 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -92.49 88.34 6.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 0.0 109.845 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 117.9 -1.047 . . . . 0.0 110.484 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.0 t60 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.097 0.475 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.8 p -77.69 145.0 36.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.731 . . . . 0.0 110.167 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 2' ' ' SER . 44.5 m 64.42 116.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.379 0.609 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 85.8 1.08 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.8 142.01 46.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.548 -0.972 . . . . 0.0 110.442 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 6' ' ' THR . 8.4 t -79.42 92.7 5.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.168 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 147.14 17.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.88 . . . . 0.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.6 128.95 13.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.877 1.462 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -83.89 131.68 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.54 -0.725 . . . . 0.0 110.443 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -74.75 91.48 2.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.448 -0.782 . . . . 0.0 110.454 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -151.45 107.78 2.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.52 -0.737 . . . . 0.0 110.186 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.98 -165.88 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.866 1.456 . . . . 0.0 110.348 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.8 p -87.67 161.22 17.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.336 -0.852 . . . . 0.0 110.33 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.589 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 ttt180 66.78 134.72 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 122.019 -0.426 . . . . 0.0 111.143 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HG2' ' A' ' 14' ' ' ARG . 45.0 Cg_endo -70.56 161.38 46.24 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.609 1.32 . . . . 0.0 110.636 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.03 176.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.594 -0.691 . . . . 0.0 110.924 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.53 170.11 3.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.632 -0.667 . . . . 0.0 110.737 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 pt -71.14 178.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.57 -0.706 . . . . 0.0 110.622 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 138.05 88.62 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.723 . . . . 0.0 110.706 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.62 175.86 7.43 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 124.187 1.625 . . . . 0.0 111.855 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -74.52 165.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.692 0.758 . . . . 0.0 110.806 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.51 -59.12 0.41 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.82 -28.57 61.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.631 -0.923 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.84 8.8 6.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.302 -0.874 . . . . 0.0 111.02 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.41 65.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.021 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.495 ' HB3' HD11 ' A' ' 47' ' ' LEU . 42.4 m -50.51 -24.17 2.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.664 -0.647 . . . . 0.0 111.288 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -106.78 126.03 51.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.39 -27.2 10.23 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.5 pt -81.84 162.17 58.46 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.123 -1.222 . . . . 0.0 110.754 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.77 155.53 48.95 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.16 1.611 . . . . 0.0 111.099 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -58.58 -39.15 79.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.79 -0.569 . . . . 0.0 111.111 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 t -61.8 -45.52 93.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.372 -0.83 . . . . 0.0 109.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.6 m -69.43 -40.13 77.42 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.08 93.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.701 -0.624 . . . . 0.0 110.282 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -65.7 -42.32 91.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.428 -0.795 . . . . 0.0 109.517 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.88 -38.25 85.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.709 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -61.93 -30.89 71.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.62 -0.675 . . . . 0.0 110.202 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -83.93 -37.68 22.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.358 -0.838 . . . . 0.0 109.548 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -71.2 -35.46 71.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 111.015 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -55.72 2.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -86.31 -36.22 19.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.308 -0.87 . . . . 0.0 111.129 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.32 37.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.64 159.97 15.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.089 -1.242 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m 60.63 38.26 18.75 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.794 -0.566 . . . . 0.0 109.913 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -83.7 -59.22 2.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -93.44 86.6 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.684 -0.635 . . . . 0.0 109.78 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.226 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.036 0.446 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.34 114.62 2.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.481 -0.762 . . . . 0.0 110.123 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.9 m -73.08 144.33 47.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.58 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.16 113.49 4.23 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -131.89 140.7 49.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.4 -1.059 . . . . 0.0 110.546 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.5 m -144.76 121.48 11.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 109.915 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.54 127.19 36.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.06 155.9 38.2 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.937 1.493 . . . . 0.0 110.792 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tp -82.85 60.9 5.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.016 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.53 135.15 0.89 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.758 -0.588 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -133.32 88.59 34.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 110.385 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.21 -164.35 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.964 1.507 . . . . 0.0 110.661 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -87.39 -160.75 0.63 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.303 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -55.23 124.71 55.23 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.588 -0.695 . . . . 0.0 110.329 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.46 164.36 35.97 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.974 1.513 . . . . 0.0 111.109 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 17' ' ' PHE . 4.3 mt -75.37 166.48 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.798 -0.564 . . . . 0.0 110.238 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.432 ' N ' HG22 ' A' ' 16' ' ' ILE . 64.0 m-85 -56.89 152.56 12.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.536 -0.727 . . . . 0.0 110.778 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 pt -68.85 169.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.554 -0.716 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.54 153.32 37.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.637 -0.664 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.89 177.38 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.044 1.549 . . . . 0.0 111.808 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.4 mm -86.91 167.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.501 0.667 . . . . 0.0 110.876 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.94 -60.76 0.45 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.32 -28.15 66.91 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.669 -0.901 . . . . 0.0 110.979 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.9 11.86 5.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.8 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 27' ' ' TYR . 8.6 t -139.76 63.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.28 -0.887 . . . . 0.0 109.024 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.5 m -49.54 -25.94 3.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.729 -0.607 . . . . 0.0 111.069 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 25' ' ' VAL . 33.2 m-85 -105.87 126.06 51.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -29.77 7.46 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.485 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.6 pt -81.27 162.89 57.37 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.34 155.26 51.21 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.096 1.577 . . . . 0.0 111.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 t -56.94 -41.66 78.64 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.012 -0.43 . . . . 0.0 111.132 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -62.25 -45.75 91.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.9 m -66.37 -40.57 89.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.21 96.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.731 -0.605 . . . . 0.0 110.15 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -42.85 99.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.765 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.1 -38.9 89.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.526 -0.734 . . . . 0.0 109.703 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -62.83 -29.15 70.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.629 . . . . 0.0 110.396 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -85.98 -37.02 19.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.378 -0.826 . . . . 0.0 109.622 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -70.79 -36.66 73.11 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.701 -0.624 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -57.58 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.9 m-85 -81.76 -37.19 27.6 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.093 -1.004 . . . . 0.0 111.175 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.61 12.24 38.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.69 159.59 15.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.121 -1.223 . . . . 0.0 109.778 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 m 61.66 40.04 13.72 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.385 0.612 . . . . 0.0 109.77 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -90.88 -60.37 1.93 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.502 -0.748 . . . . 0.0 109.882 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -92.43 84.8 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.645 -0.66 . . . . 0.0 109.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.31 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 121.145 0.498 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t -88.54 116.23 26.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.505 -0.747 . . . . 0.0 110.031 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -83.77 99.12 10.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.348 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.37 -140.27 6.73 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -71.6 131.58 43.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.391 -1.064 . . . . 0.0 109.917 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -144.63 128.11 16.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 54.95 81.44 0.26 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.71 151.33 63.56 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.924 1.486 . . . . 0.0 110.867 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -141.85 133.43 26.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 110.097 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.599 ' N ' HD13 ' A' ' 9' ' ' LEU . 10.2 ttt180 -70.99 91.94 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.745 . . . . 0.0 109.934 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -144.94 109.86 4.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 176.83 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.813 1.428 . . . . 0.0 110.77 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.07 31.75 5.21 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.09 0.472 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.48 148.44 0.39 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.443 -0.785 . . . . 0.0 110.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.88 158.6 46.2 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.808 1.425 . . . . 0.0 110.858 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 66.9 mt -60.43 149.97 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.72 -0.612 . . . . 0.0 109.846 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 81.6 t80 61.47 163.94 0.08 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.444 0.64 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.5 pt -70.86 -172.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.144 -0.973 . . . . 0.0 110.57 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.86 153.92 61.84 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.274 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.46 171.85 12.3 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.962 1.506 . . . . 0.0 111.842 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -74.33 167.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.644 0.735 . . . . 0.0 110.945 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.2 -61.33 0.47 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.7 m -66.42 -30.54 70.92 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.831 -0.805 . . . . 0.0 110.594 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.0 12.27 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.785 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 t -139.57 63.04 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.322 -0.861 . . . . 0.0 108.862 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.6 m -49.83 -25.09 2.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.839 -0.538 . . . . 0.0 111.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -105.34 126.78 52.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.139 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.89 -28.29 8.98 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.9 pt -84.61 162.08 51.67 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.155 -1.203 . . . . 0.0 110.611 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -74.16 155.11 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.139 1.599 . . . . 0.0 111.011 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -58.36 -40.78 83.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.822 -0.549 . . . . 0.0 111.022 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -60.48 -45.98 91.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.45 -0.781 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.0 m -66.16 -41.83 89.79 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.24 92.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.758 -0.589 . . . . 0.0 109.904 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.8 -44.2 97.17 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.463 -0.773 . . . . 0.0 109.908 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.593 -0.692 . . . . 0.0 109.824 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.64 -35.15 78.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.635 . . . . 0.0 110.555 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -78.98 -38.62 36.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.83 -38.73 83.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.608 -0.683 . . . . 0.0 111.175 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -57.94 2.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.428 -0.795 . . . . 0.0 111.731 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.446 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 83.3 m-85 -84.02 -34.59 24.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.154 -0.966 . . . . 0.0 111.421 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.97 12.17 47.28 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -104.78 157.13 17.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.898 -1.354 . . . . 0.0 109.971 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.6 m 62.47 37.73 13.2 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.126 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.0 m -80.86 -58.97 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.985 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -91.75 67.72 5.4 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.561 -0.712 . . . . 0.0 110.019 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.446 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 120.993 0.425 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -152.34 76.37 1.16 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.542 -0.723 . . . . 0.0 110.201 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -139.35 147.22 41.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.41 66.56 0.28 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.9 t80 52.78 85.05 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.85 -0.794 . . . . 0.0 111.271 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 29.6 m -133.09 83.55 2.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 6' ' ' THR . 0.4 OUTLIER 67.29 131.18 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 122.069 -0.394 . . . . 0.0 110.899 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 7' ' ' ARG . 44.3 Cg_endo -71.34 146.42 50.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -94.27 133.57 37.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.914 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -147.41 109.41 4.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HG2' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -80.89 144.55 55.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD2' ' HG2' ' A' ' 11' ' ' LYS . 48.7 Cg_endo -75.68 -160.11 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 124.183 1.623 . . . . 0.0 110.424 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 m -54.18 146.93 14.0 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.0 110.61 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.77 124.85 84.87 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.501 -0.75 . . . . 0.0 110.274 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.38 173.69 13.89 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.024 1.539 . . . . 0.0 110.596 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 pt -61.1 161.0 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.692 -0.63 . . . . 0.0 110.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -141.66 164.44 30.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.706 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.5 pt -69.92 174.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.44 128.16 65.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 110.305 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.33 161.3 44.78 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.2 1.631 . . . . 0.0 110.915 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -78.28 166.71 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.681 0.753 . . . . 0.0 111.047 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 107.57 -62.34 0.3 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -67.24 -29.41 69.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.726 -0.867 . . . . 0.0 110.212 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.76 16.19 4.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.537 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 27' ' ' TYR . 16.3 t -141.71 63.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.224 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.7 m -48.14 -25.87 1.65 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.761 -0.587 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.464 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.4 m-85 -106.5 126.29 52.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.39 -31.76 6.26 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.459 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.8 pt -80.76 162.8 58.91 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.307 -1.113 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.7 Cg_endo -73.33 153.4 50.63 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.08 1.568 . . . . 0.0 111.134 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -37.67 73.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.878 -0.514 . . . . 0.0 111.309 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -65.13 -44.67 87.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.39 -0.819 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 54.2 m -64.81 -41.33 95.87 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 109.21 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.44 78.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.634 . . . . 0.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.06 -41.19 91.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 109.09 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -40.47 95.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.78 -40.46 95.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.633 . . . . 0.0 109.769 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.52 -38.52 68.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 109.983 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -67.5 -38.14 83.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.7 -0.625 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -58.74 1.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 111.811 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -77.7 -39.67 43.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.261 -0.899 . . . . 0.0 111.169 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.03 14.0 32.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.02 159.11 18.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.061 -1.258 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.3 m 62.44 39.73 11.62 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.364 0.602 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.4 m -82.84 -59.42 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.831 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.67 84.35 7.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.731 . . . . 0.0 109.622 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.8 t60 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t 62.65 174.6 0.14 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.491 0.662 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -141.66 131.86 24.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.471 -0.768 . . . . 0.0 110.264 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.5 146.87 36.38 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 t80 67.86 142.34 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.925 -0.75 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 m -74.39 114.24 12.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.345 -0.847 . . . . 0.0 109.798 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.95 67.35 3.28 Favored Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.832 -0.542 . . . . 0.0 110.258 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.38 148.24 38.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 124.062 1.559 . . . . 0.0 110.701 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.47 154.51 41.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.15 106.95 16.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 130.88 2.1 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.585 -0.697 . . . . 0.0 110.36 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.54 -160.95 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.97 1.511 . . . . 0.0 110.148 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -59.86 128.17 35.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -109.84 127.06 27.77 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.417 -0.802 . . . . 0.0 110.638 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.6 -178.03 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.915 1.481 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 pt -62.91 174.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 121.342 0.591 . . . . 0.0 110.728 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -52.05 153.67 2.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.639 -0.663 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 mt -60.5 139.06 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.629 -0.669 . . . . 0.0 110.677 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 136.27 19.64 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.681 -0.637 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.18 174.94 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.015 1.534 . . . . 0.0 111.321 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.2 mt -78.25 167.77 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.475 0.655 . . . . 0.0 110.26 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 106.99 -61.23 0.32 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -67.78 -31.14 70.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.796 -0.826 . . . . 0.0 109.83 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -72.22 -0.49 12.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.66 -0.65 . . . . 0.0 111.48 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 27' ' ' TYR . 19.1 t -143.03 74.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.14 -0.975 . . . . 0.0 108.989 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.1 m -50.43 -23.1 2.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.765 -0.585 . . . . 0.0 111.339 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.549 ' O ' HG12 ' A' ' 25' ' ' VAL . 22.3 m-85 -104.96 128.13 53.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.227 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -25.11 15.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.4 pt -79.55 162.09 64.57 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.153 -1.204 . . . . 0.0 110.908 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.53 156.65 49.6 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.206 1.635 . . . . 0.0 111.333 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -56.89 -40.97 77.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.958 -0.464 . . . . 0.0 111.31 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -63.35 -43.61 97.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.449 -0.782 . . . . 0.0 110.243 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 30.8 m -64.51 -41.15 96.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.42 -0.8 . . . . 0.0 109.111 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.75 79.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.712 -0.617 . . . . 0.0 110.294 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -64.71 -42.08 95.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.04 -37.22 78.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.635 -0.665 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -67.64 -31.53 71.6 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.557 -0.714 . . . . 0.0 110.269 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.9 t -86.85 -35.15 19.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -70.21 -40.58 74.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.602 -0.686 . . . . 0.0 111.363 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -53.42 3.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 111.844 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 94.5 m-85 -82.85 -36.03 25.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.89 . . . . 0.0 111.304 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 12.17 48.58 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -104.98 158.86 16.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 m 61.99 39.1 13.71 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.76 -0.588 . . . . 0.0 109.936 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.5 m -88.86 -59.91 2.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.429 -0.794 . . . . 0.0 109.949 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -99.07 66.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.586 -0.696 . . . . 0.0 109.88 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 27' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.981 0.42 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -104.61 107.22 18.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.412 -0.805 . . . . 0.0 109.986 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -127.94 74.65 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.459 -0.776 . . . . 0.0 110.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.11 169.22 39.09 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -132.24 135.41 46.27 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.44 -1.035 . . . . 0.0 109.987 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 6' ' ' THR . 11.4 t -106.49 54.23 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.42 -0.8 . . . . 0.0 110.647 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' THR . 4.7 ttp180 62.97 121.52 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.992 -0.442 . . . . 0.0 111.147 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 47.8 Cg_endo -76.84 163.49 31.22 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.457 1.241 . . . . 0.0 110.803 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.45 109.01 7.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.593 -0.692 . . . . 0.0 109.922 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 4.5 tpt180 60.19 92.33 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.366 0.603 . . . . 0.0 110.333 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 8' ' ' PRO . 15.6 mtpp -64.47 111.6 5.98 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.667 -0.645 . . . . 0.0 110.957 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 53.7 Cg_endo -79.06 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 124.024 1.539 . . . . 0.0 110.224 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -68.73 175.24 3.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.289 -0.882 . . . . 0.0 110.034 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -48.16 108.69 0.96 Allowed Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.549 -0.719 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.7 157.23 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.683 1.359 . . . . 0.0 110.866 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 pt -69.8 158.57 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.627 -0.671 . . . . 0.0 109.677 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -126.57 140.15 52.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.9 . . . . 0.0 110.996 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 HH11 ' A' ' 19' ' ' ARG . 44.5 pt -97.01 -177.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.868 -0.52 . . . . 0.0 109.743 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.544 HH11 HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -53.32 139.55 46.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 110.048 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.8 172.71 12.17 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.995 1.523 . . . . 0.0 111.256 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.2 mt -77.16 167.84 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.435 0.636 . . . . 0.0 110.123 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 107.38 -62.11 0.3 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 m -66.55 -28.98 68.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.788 -0.83 . . . . 0.0 109.813 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.24 3.09 9.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.6 -0.688 . . . . 0.0 111.346 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 27' ' ' TYR . 7.8 t -142.63 71.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.014 . . . . 0.0 109.216 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.8 m -51.34 -22.68 3.03 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.706 -0.621 . . . . 0.0 111.472 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.4 m-85 -105.97 128.71 53.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 0.0 110.313 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.41 -27.46 9.98 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.0 pt -84.41 161.93 52.68 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.142 -1.211 . . . . 0.0 110.769 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.0 156.36 47.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.103 1.58 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.0 t -58.82 -40.54 84.44 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.804 -0.56 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -60.14 -46.01 91.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.806 . . . . 0.0 109.871 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 98.4 m -68.96 -40.36 78.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.89 92.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.777 -0.577 . . . . 0.0 110.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -64.47 -42.03 96.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.405 -0.809 . . . . 0.0 109.374 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.93 -39.5 93.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.682 -0.637 . . . . 0.0 109.619 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -63.44 -29.94 71.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.785 -0.572 . . . . 0.0 110.263 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.0 t -86.18 -37.7 18.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 0.0 109.562 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -67.17 -38.69 85.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.816 -0.553 . . . . 0.0 111.191 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -100.2 -55.07 2.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -0.851 . . . . 0.0 112.036 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 91.2 m-85 -82.64 -36.18 26.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.102 -0.998 . . . . 0.0 111.13 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.96 11.18 43.91 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -105.21 158.31 16.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.012 -1.287 . . . . 0.0 109.959 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 m 61.95 39.18 13.75 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.4 m -84.58 -59.49 2.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.44 -0.787 . . . . 0.0 109.927 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -94.58 87.4 5.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.677 -0.64 . . . . 0.0 109.885 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.25 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 120.81 0.338 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 m 57.42 76.9 0.3 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.385 0.612 . . . . 0.0 110.479 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 p -66.58 142.53 57.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 0.0 110.268 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.3 -67.18 1.01 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 66.89 114.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.005 -0.703 . . . . 0.0 111.049 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.3 m -90.42 132.39 35.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 144.21 68.13 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.538 -0.726 . . . . 0.0 110.076 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.19 145.13 30.45 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.909 1.478 . . . . 0.0 110.688 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mp -75.71 170.49 16.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.606 -0.683 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 114.87 2.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 110.501 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.24 120.97 63.24 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.583 -0.698 . . . . 0.0 110.566 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.73 -162.21 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 124.04 1.548 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -97.58 61.5 1.63 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.379 -0.826 . . . . 0.0 110.281 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' HG3' ' HD2' ' A' ' 15' ' ' PRO . 9.4 tpt180 67.44 136.33 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.925 -0.485 . . . . 0.0 111.321 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 14' ' ' ARG . 49.1 Cg_endo -74.54 171.35 18.32 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.64 1.337 . . . . 0.0 110.886 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.94 159.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.784 -0.572 . . . . 0.0 110.352 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -61.78 179.07 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.626 -0.671 . . . . 0.0 111.056 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 mt -46.82 137.09 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.381 0.61 . . . . 0.0 111.059 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 120.38 78.2 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.764 -0.585 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.94 161.76 43.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.202 1.632 . . . . 0.0 110.704 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.5 mt -75.0 163.16 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -61.94 0.3 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 7.7 m -65.84 -30.58 71.22 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.702 -0.881 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.47 13.55 4.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.687 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 27' ' ' TYR . 14.0 t -141.67 63.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 108.879 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' HB3' HD13 ' A' ' 47' ' ' LEU . 57.5 m -49.99 -25.14 3.06 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.795 -0.566 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' VAL . 64.0 m-85 -105.78 129.35 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.73 -30.42 7.49 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.3 pt -84.97 162.38 49.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.22 -1.165 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.92 154.3 48.01 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.109 1.584 . . . . 0.0 110.887 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 t -58.3 -39.29 78.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.827 -0.545 . . . . 0.0 111.084 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.39 -46.62 89.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.84 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 86.0 m -66.85 -40.59 87.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 108.974 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.99 96.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.788 -0.57 . . . . 0.0 110.073 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -62.42 -42.73 99.66 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.13 -39.79 95.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -34.73 76.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.801 -0.562 . . . . 0.0 110.265 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.8 t -76.24 -38.35 56.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 13.8 t80 -67.11 -38.18 85.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 111.361 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 6.1 mmm180 -98.95 -57.06 2.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.228 -0.92 . . . . 0.0 111.75 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CD1' ' SG ' ' A' ' 23' ' ' CYS . 83.0 m-85 -81.5 -36.86 28.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.933 . . . . 0.0 111.208 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.01 12.11 47.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.11 155.78 18.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -1.207 . . . . 0.0 109.892 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.4 m 62.17 42.0 10.08 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.345 0.593 . . . . 0.0 109.773 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.4 m -84.86 -56.51 3.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 110.431 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -96.43 54.81 1.41 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.717 -0.614 . . . . 0.0 110.791 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' A' ' 26' ' ' CYS . 3.5 tp . . . . . 0 N--CA 1.499 1.975 0 O-C-N 121.262 -0.899 . . . . 0.0 110.534 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.075 0.464 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.74 112.48 25.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.427 -0.795 . . . . 0.0 110.265 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -133.33 111.87 11.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.94 -47.85 81.82 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.25 138.02 31.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.43 -1.041 . . . . 0.0 110.115 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -98.36 161.16 13.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.716 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.87 76.0 54.05 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.437 -0.789 . . . . 0.0 110.546 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.65 137.95 25.82 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.793 1.417 . . . . 0.0 110.37 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp 56.01 64.94 1.57 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.565 0.698 . . . . 0.0 110.136 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.4 118.75 9.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.643 -0.66 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 tptm 57.89 80.19 0.29 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.849 -0.532 . . . . 0.0 110.65 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.9 -161.99 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.837 1.44 . . . . 0.0 110.623 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -97.77 36.22 1.56 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.173 -0.954 . . . . 0.0 111.036 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.4 ttm180 64.13 142.81 0.07 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 121.909 -0.495 . . . . 0.0 111.661 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 14' ' ' ARG . 46.8 Cg_endo -74.11 175.68 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.716 1.377 . . . . 0.0 110.22 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 pt -52.35 135.55 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 121.347 0.594 . . . . 0.0 110.458 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -156.11 165.13 37.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.768 . . . . 0.0 110.556 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.43 -171.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.647 -0.658 . . . . 0.0 110.239 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 122.8 7.41 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.741 -0.6 . . . . 0.0 110.596 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.86 169.88 19.24 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.296 1.682 . . . . 0.0 111.289 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.9 mm -78.53 166.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.676 0.751 . . . . 0.0 111.095 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.44 -63.61 0.29 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 1.6 m -71.21 -28.93 64.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.765 -0.844 . . . . 0.0 110.465 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 14.28 4.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.303 -0.873 . . . . 0.0 110.55 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 27' ' ' TYR . 23.3 t -139.33 65.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 108.702 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' HB3' HD13 ' A' ' 47' ' ' LEU . 90.2 m -47.95 -24.17 0.98 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.903 -0.498 . . . . 0.0 111.551 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 25' ' ' VAL . 25.6 m-85 -102.82 127.08 50.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.91 -26.1 13.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.46 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.9 pt -87.63 162.68 41.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.193 -1.181 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.8 Cg_endo -74.55 154.66 44.97 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.152 1.606 . . . . 0.0 111.182 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 t -59.28 -39.37 82.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.813 -0.555 . . . . 0.0 110.914 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -59.3 -46.5 88.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.744 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 90.6 m -68.38 -41.15 80.99 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.45 88.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.732 -0.605 . . . . 0.0 110.176 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -65.75 -43.87 87.61 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.341 -0.849 . . . . 0.0 109.392 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -36.45 80.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.554 -0.716 . . . . 0.0 109.373 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -60.84 -31.08 70.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.82 -0.55 . . . . 0.0 110.465 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.5 t -84.35 -37.33 21.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.14 -0.975 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -68.91 -38.97 79.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 0.0 111.234 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -56.91 2.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.309 -0.869 . . . . 0.0 111.836 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 63.5 m-85 -80.19 -37.8 32.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.219 -0.926 . . . . 0.0 111.234 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.36 12.29 42.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.2 157.44 17.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -1.21 . . . . 0.0 109.585 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 m 62.05 40.21 12.33 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.713 -0.617 . . . . 0.0 109.676 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 m -90.29 -59.34 2.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.538 -0.726 . . . . 0.0 110.426 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -86.19 51.73 2.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.578 -0.701 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 26' ' ' CYS . 3.0 tt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.306 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.039 0.447 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.45 164.53 32.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.485 -0.759 . . . . 0.0 110.473 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t 56.44 77.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.275 0.56 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.08 51.69 4.58 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -171.61 153.54 3.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.652 -0.91 . . . . 0.0 110.028 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.24 164.32 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.517 0.675 . . . . 0.0 110.986 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.452 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -82.8 137.42 43.95 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.452 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 48.1 Cg_endo -74.61 152.02 42.34 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 124.021 1.537 . . . . 0.0 110.755 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mp -76.99 175.4 9.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.647 -0.658 . . . . 0.0 110.571 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -68.31 92.53 0.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.627 -0.671 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.99 86.46 3.43 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.567 -0.708 . . . . 0.0 109.969 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.17 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.893 1.47 . . . . 0.0 110.74 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -77.53 166.37 23.15 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.521 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.83 60.34 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.493 -0.754 . . . . 0.0 110.456 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.4 153.55 65.88 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.084 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pt -90.98 172.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.763 -0.585 . . . . 0.0 110.507 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -124.53 140.16 53.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.55 -0.719 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -133.58 -179.47 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.502 -0.749 . . . . 0.0 110.53 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.64 ' HD3' ' HD2' ' A' ' 20' ' ' PRO . 1.1 tpp85 -61.08 126.39 85.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.632 -0.668 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.64 ' HD2' ' HD3' ' A' ' 19' ' ' ARG . 40.7 Cg_endo -70.92 166.22 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 124.161 1.611 . . . . 0.0 111.026 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 4.5 mm -80.53 167.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.71 0.767 . . . . 0.0 111.2 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.06 -61.53 0.34 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.7 m -66.51 -29.17 69.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.689 -0.889 . . . . 0.0 110.684 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.38 15.16 4.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.225 -0.922 . . . . 0.0 110.497 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -138.46 62.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.726 ' HB3' HD21 ' A' ' 47' ' ' LEU . 70.1 m -48.71 -24.72 1.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.851 -0.531 . . . . 0.0 111.357 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 47' ' ' LEU . 46.8 m-85 -105.65 126.93 52.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.822 . . . . 0.0 109.955 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.84 8.89 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.0 pt -83.31 161.63 56.5 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.198 -1.177 . . . . 0.0 110.532 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.442 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.8 Cg_endo -74.02 153.66 47.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.186 1.624 . . . . 0.0 111.315 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 t -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.952 -0.467 . . . . 0.0 111.112 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.96 -45.7 92.49 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.523 -0.736 . . . . 0.0 110.246 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.7 m -67.52 -41.38 84.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 0.0 108.731 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.6 91.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.732 -0.605 . . . . 0.0 110.037 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.461 -0.774 . . . . 0.0 109.473 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -37.54 87.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.763 -0.585 . . . . 0.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -64.01 -32.55 74.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.771 -0.58 . . . . 0.0 110.558 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.5 t -81.9 -37.83 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.77 -37.77 85.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.695 -0.628 . . . . 0.0 111.325 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -101.78 -58.41 1.89 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -0.916 . . . . 0.0 111.638 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.4 m-85 -77.01 -38.45 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.157 -0.964 . . . . 0.0 111.16 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.51 42.95 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.15 157.15 18.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.009 -1.289 . . . . 0.0 109.934 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.548 ' HA ' HD23 ' A' ' 47' ' ' LEU . 10.7 m 62.1 42.81 9.38 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.443 0.639 . . . . 0.0 109.705 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.6 m -86.45 -58.5 2.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.544 -0.722 . . . . 0.0 110.128 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -95.73 64.27 2.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.627 -0.671 . . . . 0.0 110.292 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.178 0.514 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -65.95 153.91 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.65 135.17 51.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 110.485 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.11 94.0 0.89 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.18 152.08 46.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.534 -0.98 . . . . 0.0 110.762 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -79.66 128.32 33.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.675 -0.641 . . . . 0.0 110.135 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.48 115.47 10.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.71 -0.618 . . . . 0.0 110.638 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.0 149.27 41.46 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.724 1.381 . . . . 0.0 110.711 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.36 168.39 19.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.558 -0.714 . . . . 0.0 110.405 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 65.8 160.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.502 0.668 . . . . 0.0 110.807 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.58 148.32 56.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.64 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.37 -160.23 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.993 1.522 . . . . 0.0 110.642 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -67.2 166.42 14.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.354 -0.841 . . . . 0.0 110.835 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 153.86 52.07 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.603 -0.686 . . . . 0.0 110.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.15 152.28 61.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.81 1.426 . . . . 0.0 111.023 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.3 pt -137.47 178.64 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.637 . . . . 0.0 110.427 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -65.07 173.54 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.29 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.8 pt -67.04 169.88 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.553 -0.717 . . . . 0.0 110.635 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.57 151.95 69.14 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 0.0 110.245 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.19 167.83 22.56 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.056 1.556 . . . . 0.0 111.372 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.3 mt -81.63 166.24 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.526 0.679 . . . . 0.0 110.93 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 105.63 -61.07 0.37 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 m -66.02 -29.2 69.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.752 -0.852 . . . . 0.0 110.8 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 11.6 6.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.02 63.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 108.745 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.596 ' HB3' HD11 ' A' ' 47' ' ' LEU . 57.7 m -49.8 -23.06 1.66 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.0 111.796 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -105.81 126.48 52.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.306 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.95 -24.75 14.06 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.853 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.2 pt -86.17 160.07 52.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.031 -1.276 . . . . 0.0 110.924 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.3 Cg_endo -74.34 157.82 45.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.214 1.639 . . . . 0.0 111.24 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -59.43 -40.28 86.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.734 -0.604 . . . . 0.0 110.94 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -59.65 -44.86 93.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.399 -0.813 . . . . 0.0 109.697 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.433 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 82.1 m -68.43 -41.04 80.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.34 90.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.713 -0.617 . . . . 0.0 109.793 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.54 -45.5 93.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.503 -0.748 . . . . 0.0 109.305 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -36.25 82.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 109.833 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -68.06 -37.39 81.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.6 t -80.33 -33.85 37.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 0.0 110.049 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 35' ' ' ARG . 28.1 t80 -70.85 -41.43 71.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 111.528 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.355 -0.841 . . . . 0.0 111.821 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 90.6 m-85 -82.37 -37.1 26.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.175 -0.953 . . . . 0.0 111.14 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.04 42.82 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -106.87 156.24 18.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.246 . . . . 0.0 109.845 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 m 63.09 41.5 8.1 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.426 0.632 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -89.5 -61.91 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.521 -0.737 . . . . 0.0 109.74 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -92.62 76.27 5.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.705 -0.622 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.9 p80 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.106 0.479 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -78.73 139.73 38.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.465 -0.772 . . . . 0.0 109.919 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 124.77 49.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.46 -0.775 . . . . 0.0 110.278 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.3 -100.61 0.15 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.6 t80 63.93 101.88 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.909 -0.759 . . . . 0.0 111.029 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -68.56 103.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 110.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -79.68 140.71 55.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 110.42 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.44 143.88 35.44 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.881 1.464 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.28 123.37 22.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.331 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -131.89 139.92 48.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.743 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -73.27 142.53 82.02 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.508 -0.745 . . . . 0.0 110.655 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.45 -163.47 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 124.016 1.535 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.05 46.1 2.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -76.72 159.55 78.84 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.449 -0.782 . . . . 0.0 110.539 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.33 168.87 23.79 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 124.09 1.574 . . . . 0.0 110.939 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mt -57.79 146.09 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.792 -0.568 . . . . 0.0 110.461 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.33 162.05 30.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.508 -0.745 . . . . 0.0 110.513 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 pt -77.15 -173.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.699 -0.626 . . . . 0.0 110.535 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 117.15 9.33 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.746 -0.597 . . . . 0.0 110.196 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.79 169.41 22.09 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 124.314 1.692 . . . . 0.0 111.412 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -78.41 166.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.516 0.674 . . . . 0.0 110.81 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 108.27 -59.4 0.37 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.87 -16.37 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.747 -0.855 . . . . 0.0 110.293 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.94 -4.28 43.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.669 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.7 t -143.71 74.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.312 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.52 ' HB3' HD11 ' A' ' 47' ' ' LEU . 16.5 m -48.47 -26.91 2.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.921 -0.487 . . . . 0.0 111.281 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.613 ' O ' HG12 ' A' ' 25' ' ' VAL . 98.2 m-85 -107.57 129.26 55.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.925 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.81 -28.97 8.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 45.0 pt -80.06 163.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.214 -1.168 . . . . 0.0 110.498 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.45 155.64 50.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.118 1.589 . . . . 0.0 111.144 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 t -58.54 -39.29 79.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 111.033 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 t -61.18 -46.42 90.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.6 m -67.19 -41.39 85.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.69 87.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.706 -0.621 . . . . 0.0 110.129 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -64.23 -44.07 92.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.542 -0.723 . . . . 0.0 109.579 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -67.12 -37.25 83.54 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 0.0 109.888 179.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -65.9 -30.22 70.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.48 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -87.98 -36.44 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 109.982 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.81 -38.01 70.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 111.329 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -100.21 -55.36 2.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.279 -0.888 . . . . 0.0 111.601 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.3 m-85 -79.16 -37.76 37.66 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.183 -0.948 . . . . 0.0 110.932 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.52 12.11 42.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -109.07 160.0 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.064 -1.257 . . . . 0.0 110.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.6 m 62.96 40.88 8.96 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.722 -0.611 . . . . 0.0 109.761 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.66 -60.81 1.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.906 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -90.3 71.26 7.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.499 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.029 0.442 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.51 148.09 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.503 -0.748 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.33 92.73 3.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 109.957 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.49 -156.59 27.04 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.38 151.5 21.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.438 -1.036 . . . . 0.0 110.593 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.3 m -119.73 135.95 54.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.173 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 148.29 66.15 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.536 -0.727 . . . . 0.0 110.24 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.42 160.12 49.51 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.917 1.483 . . . . 0.0 110.797 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 148.23 52.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.684 -0.635 . . . . 0.0 110.291 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.4 107.6 1.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.424 -0.797 . . . . 0.0 110.272 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.85 139.71 36.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 110.303 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.81 -161.85 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.978 1.515 . . . . 0.0 110.337 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t 51.77 52.82 13.77 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.53 -0.731 . . . . 0.0 110.445 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -89.12 164.65 29.94 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.576 -0.702 . . . . 0.0 110.762 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.65 -179.12 4.22 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 124.08 1.568 . . . . 0.0 111.09 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 pt -62.25 176.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.401 0.62 . . . . 0.0 110.901 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -57.37 152.69 13.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.595 -0.691 . . . . 0.0 110.809 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.465 HD12 ' HD3' ' A' ' 19' ' ' ARG . 11.4 pt -90.61 -172.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.662 -0.649 . . . . 0.0 110.61 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HD3' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.74 145.4 16.34 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 -179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.33 173.1 11.07 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 124.086 1.572 . . . . 0.0 112.194 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -77.54 169.26 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.627 0.727 . . . . 0.0 111.045 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 102.3 -62.1 0.5 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -68.11 -30.12 69.21 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.834 -0.803 . . . . 0.0 110.244 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.57 13.3 4.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.36 -0.838 . . . . 0.0 110.573 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.0 t -139.81 64.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 109.174 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.7 m -49.34 -24.24 1.8 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.769 -0.582 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.2 m-85 -105.36 126.78 52.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.18 8.44 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 38.3 pt -83.52 162.56 53.0 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -73.57 154.59 49.96 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.123 1.591 . . . . 0.0 111.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -57.95 -38.73 76.52 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.924 -0.485 . . . . 0.0 111.264 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 t -63.9 -44.99 91.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.389 -0.82 . . . . 0.0 110.011 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 70.0 m -65.89 -41.63 91.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.31 -0.869 . . . . 0.0 109.056 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.83 84.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -46.19 86.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.45 -0.781 . . . . 0.0 109.584 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.56 -31.5 72.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.672 -0.643 . . . . 0.0 110.409 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -83.36 -36.63 24.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -69.38 -37.59 77.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.653 . . . . 0.0 111.144 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -99.77 -59.75 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.355 -0.84 . . . . 0.0 111.605 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 63.8 m-85 -76.74 -39.21 52.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.901 . . . . 0.0 111.112 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.2 35.95 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 9.1 m-20 -108.24 159.03 16.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.064 -1.256 . . . . 0.0 110.128 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m 62.55 42.03 9.01 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.471 0.653 . . . . 0.0 109.543 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -89.42 -61.21 1.75 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.056 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -90.14 76.38 6.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.645 -0.659 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.343 -179.909 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.028 0.442 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -115.46 133.85 55.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.478 -0.764 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.65 75.17 0.37 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 74.67 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.23 149.61 38.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.464 -1.021 . . . . 0.0 110.437 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 6' ' ' THR . 6.7 t -92.53 89.12 6.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.563 -0.711 . . . . 0.0 110.366 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -158.18 130.36 4.18 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 110.406 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.53 135.14 17.76 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.893 1.47 . . . . 0.0 110.565 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.8 mt -86.47 153.63 21.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.414 -0.804 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -59.35 139.8 56.69 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 110.647 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 50.53 69.2 2.75 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.767 -0.583 . . . . 0.0 110.696 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.78 -168.53 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.741 1.39 . . . . 0.0 110.667 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 m -118.68 57.39 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 110.199 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -89.79 119.69 69.44 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 110.123 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.13 173.72 13.65 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 124.007 1.53 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.9 pt -50.38 133.87 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-O 121.364 0.602 . . . . 0.0 110.529 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -148.1 176.42 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 110.634 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.3 pt -69.27 174.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.664 -0.648 . . . . 0.0 110.301 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.63 114.13 5.31 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.722 -0.611 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.21 171.29 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 124.308 1.688 . . . . 0.0 111.171 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.4 mm -81.19 167.78 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.49 0.662 . . . . 0.0 110.797 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.62 -56.45 0.5 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.3 m -79.2 -13.44 59.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.815 -0.814 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.26 -0.82 38.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.438 -0.789 . . . . 0.0 111.515 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.2 t -143.69 72.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.104 -0.998 . . . . 0.0 109.463 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.649 ' HB3' HD11 ' A' ' 47' ' ' LEU . 20.9 m -50.04 -24.91 2.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.869 -0.52 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 25' ' ' VAL . 10.4 m-85 -107.53 126.7 52.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 110.033 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.76 -27.77 9.5 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 42.2 pt -80.27 162.7 60.46 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.197 -1.178 . . . . 0.0 110.445 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.61 155.19 49.91 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.053 1.554 . . . . 0.0 111.201 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -57.94 -39.99 79.41 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.787 -0.571 . . . . 0.0 110.863 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -47.41 86.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 109.876 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.7 m -67.86 -40.43 83.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.042 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 110.095 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.16 -42.95 93.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.4 -0.813 . . . . 0.0 109.412 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.1 -39.29 86.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.651 . . . . 0.0 109.817 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -64.19 -28.83 70.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 110.069 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.9 t -88.18 -37.07 16.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.77 -39.26 70.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.663 . . . . 0.0 111.276 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -52.27 3.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 111.749 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.1 m-85 -82.96 -38.22 23.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 11.7 39.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.97 160.74 15.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.024 -1.28 . . . . 0.0 110.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m 62.41 39.74 11.73 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.387 0.613 . . . . 0.0 109.704 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.41 -62.12 1.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.799 . . . . 0.0 110.141 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -92.78 65.49 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.712 . . . . 0.0 109.944 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD11 ' HB3' ' A' ' 26' ' ' CYS . 1.1 tp . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.616 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 2' ' ' SER . 77.1 m-70 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.841 0.353 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 1' ' ' HIS . 44.6 m 61.42 172.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 121.511 0.672 . . . . 0.0 111.136 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 p -154.9 153.27 30.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.345 -0.847 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.54 -136.18 3.76 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 t80 54.61 78.35 0.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.759 -0.847 . . . . 0.0 110.706 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 m -85.43 77.89 9.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 71.4 7.83 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.811 . . . . 0.0 110.297 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.83 131.68 14.78 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.984 1.518 . . . . 0.0 110.633 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 94.87 4.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 110.475 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.8 111.4 7.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.381 -0.824 . . . . 0.0 110.137 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.22 125.99 8.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 110.398 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.4 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.893 1.47 . . . . 0.0 110.276 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t 52.06 52.18 14.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.513 0.673 . . . . 0.0 110.246 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -73.39 154.58 89.99 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.541 -0.725 . . . . 0.0 110.746 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.63 -176.2 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 124.036 1.546 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -56.13 167.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.312 0.577 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -56.38 156.06 6.34 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.536 -0.727 . . . . 0.0 111.218 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 18' ' ' ILE . 23.3 pt -88.19 62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.791 0.805 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.62 151.81 38.77 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 110.587 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.26 165.13 31.46 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 124.02 1.537 . . . . 0.0 111.382 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 2.5 mm -78.96 168.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.661 0.743 . . . . 0.0 111.193 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.29 -60.66 0.48 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.3 -29.94 70.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.774 -0.839 . . . . 0.0 111.049 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.32 13.24 6.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.311 -0.868 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.26 61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.195 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.7 m -48.8 -25.5 1.89 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.764 -0.585 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -105.03 124.94 50.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.883 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.1 -29.44 7.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.456 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.1 pt -84.26 161.96 52.97 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.205 -1.174 . . . . 0.0 110.514 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.82 154.78 48.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.157 1.609 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -58.78 -38.51 78.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.901 -0.499 . . . . 0.0 111.169 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -62.78 -45.62 91.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.863 . . . . 0.0 109.846 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.5 m -67.55 -41.23 84.6 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.2 -40.85 97.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.574 . . . . 0.0 109.905 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -61.78 -43.42 98.89 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.475 -0.765 . . . . 0.0 109.683 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.32 -39.39 93.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.676 -0.64 . . . . 0.0 109.78 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.99 -31.12 72.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.741 -0.599 . . . . 0.0 110.597 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.2 t -82.52 -38.6 23.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 9.8 t80 -68.67 -35.83 77.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.673 -0.642 . . . . 0.0 111.219 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -100.92 -58.01 1.98 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.177 -0.952 . . . . 0.0 111.597 -178.587 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.2 m-85 -79.46 -38.36 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.217 -0.927 . . . . 0.0 111.074 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.43 39.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.65 158.14 17.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.112 -1.229 . . . . 0.0 110.074 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.21 42.93 8.98 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.464 0.649 . . . . 0.0 109.596 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.0 m -87.22 -58.34 2.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.747 . . . . 0.0 110.159 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -123.46 109.06 13.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.646 -0.658 . . . . 0.0 110.198 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.331 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.958 0.409 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.94 177.4 0.15 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.425 0.631 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.28 130.12 8.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.497 -0.752 . . . . 0.0 110.241 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.71 178.21 15.22 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -140.93 129.25 22.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.462 -1.022 . . . . 0.0 110.279 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.6 m -145.77 149.13 33.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -143.26 152.56 57.92 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.314 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.52 148.32 42.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.875 1.461 . . . . 0.0 110.656 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.72 91.78 6.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.588 -0.695 . . . . 0.0 110.093 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.86 165.66 31.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.399 -0.813 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.89 115.0 9.65 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.72 -0.612 . . . . 0.0 110.271 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.1 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 124.021 1.537 . . . . 0.0 110.749 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -65.09 173.52 2.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.827 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -56.11 163.95 2.06 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.531 -0.731 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.88 158.41 56.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.962 1.506 . . . . 0.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.3 -170.3 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.448 0.642 . . . . 0.0 110.992 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -65.33 -175.41 0.24 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.465 0.65 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 18' ' ' ILE . 4.3 mm -54.4 165.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.587 0.708 . . . . 0.0 111.286 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 1.6 tmm_? -46.38 124.5 7.32 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 122.0 -0.437 . . . . 0.0 111.299 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.51 166.16 30.63 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.244 1.655 . . . . 0.0 110.565 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 22' ' ' GLY . 2.8 mp -83.24 165.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.535 0.683 . . . . 0.0 111.231 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 106.3 -62.08 0.33 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.6 m -67.72 -30.23 69.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.659 -0.906 . . . . 0.0 111.114 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' HD3' ' A' ' 19' ' ' ARG . 2.1 t70 -85.43 14.05 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.521 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.9 t -138.9 63.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.853 . . . . 0.0 109.02 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.07 -24.16 1.49 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.76 -0.588 . . . . 0.0 111.3 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 25' ' ' VAL . 38.6 m-85 -104.38 128.86 52.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.22 -28.54 9.6 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 34.6 pt -87.18 162.09 44.42 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.197 -1.178 . . . . 0.0 110.511 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.2 Cg_endo -74.35 154.64 46.0 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -58.71 -39.74 81.65 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.775 -0.578 . . . . 0.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -60.61 -44.76 95.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.349 -0.844 . . . . 0.0 109.778 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 79.6 m -67.89 -41.52 82.62 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.73 87.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.826 -0.546 . . . . 0.0 110.168 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -44.94 92.0 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.377 -0.827 . . . . 0.0 109.399 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.43 -38.27 90.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.59 -0.694 . . . . 0.0 109.732 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.612 . . . . 0.0 110.428 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.7 t -80.79 -37.91 29.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -68.27 -37.8 81.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 111.167 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -60.17 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -0.877 . . . . 0.0 111.673 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 70.8 m-85 -77.3 -39.72 46.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.134 -0.979 . . . . 0.0 111.075 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.74 11.94 36.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.52 158.34 17.29 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.043 -1.269 . . . . 0.0 110.074 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.4 m 62.32 40.42 11.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.386 0.612 . . . . 0.0 109.645 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -85.28 -59.19 2.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.472 -0.767 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -83.55 88.7 7.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.023 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.545 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.016 0.436 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p -82.45 68.93 9.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.448 -0.782 . . . . 0.0 109.856 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -75.75 130.15 38.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.556 -0.715 . . . . 0.0 110.21 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.4 -48.83 0.96 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -157.08 135.04 10.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.983 . . . . 0.0 110.402 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 m -96.8 106.73 19.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.525 -0.735 . . . . 0.0 109.752 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 116.2 21.02 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 110.286 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.45 169.83 21.13 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.752 1.396 . . . . 0.0 111.174 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER 66.67 113.72 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.331 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 105.88 1.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 109.526 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.0 85.7 0.15 Allowed Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.867 -0.521 . . . . 0.0 109.805 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.01 -164.65 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.85 1.447 . . . . 0.0 110.603 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -51.55 135.26 28.42 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.459 -0.776 . . . . 0.0 111.326 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.5 mtt85 -101.54 164.11 16.57 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.737 -0.602 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 14' ' ' ARG . 46.8 Cg_endo -74.63 173.79 13.75 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 124.0 1.526 . . . . 0.0 110.556 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.65 150.75 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.639 -0.663 . . . . 0.0 110.492 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -162.71 158.55 23.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.436 -0.79 . . . . 0.0 110.803 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 18' ' ' ILE . 15.8 pt -78.83 68.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.695 0.759 . . . . 0.0 110.141 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.53 150.79 0.85 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.589 -0.694 . . . . 0.0 111.552 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.64 170.57 17.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.09 1.574 . . . . 0.0 111.578 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -78.25 168.13 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.588 0.708 . . . . 0.0 110.664 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 105.31 -60.57 0.39 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.653 -0.91 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.43 12.69 6.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 110.782 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 27' ' ' TYR . 11.3 t -139.69 63.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.0 m -48.2 -26.21 1.83 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.714 -0.616 . . . . 0.0 111.134 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 25' ' ' VAL . 94.4 m-85 -100.72 128.62 46.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.68 -26.17 15.15 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.6 pt -88.14 161.34 43.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.173 -1.192 . . . . 0.0 110.677 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.33 154.25 45.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.203 1.633 . . . . 0.0 111.258 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -56.82 -41.42 77.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.955 -0.466 . . . . 0.0 111.104 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 t -61.56 -46.17 91.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.764 . . . . 0.0 110.378 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 83.7 m -67.32 -41.25 85.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 108.934 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.37 -38.14 89.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.722 -0.611 . . . . 0.0 110.03 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.94 -45.47 93.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.537 -0.727 . . . . 0.0 109.535 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.2 -38.15 90.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.743 -0.598 . . . . 0.0 109.783 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -60.99 -34.61 75.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 0.0 110.349 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -80.38 -36.62 33.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -0.915 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.58 -39.68 88.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.775 -0.578 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.17 -54.29 2.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.265 -0.897 . . . . 0.0 111.829 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 89.6 m-85 -81.9 -36.57 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.209 -0.932 . . . . 0.0 111.114 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 10.6 47.42 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.978 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.64 156.4 19.09 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.988 -1.301 . . . . 0.0 110.248 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 m 62.35 42.69 8.87 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.425 0.631 . . . . 0.0 109.743 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 m -81.53 -54.13 5.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.49 -0.756 . . . . 0.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -77.56 -158.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.631 -0.668 . . . . 0.0 109.669 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tt . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.652 -0.655 . . . . 0.0 110.603 -179.834 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.856 0.36 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m 48.64 68.2 0.74 Allowed 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.359 0.6 . . . . 0.0 110.839 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 p -85.45 81.42 8.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 110.081 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.42 -88.76 1.56 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 t80 67.27 153.96 0.09 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.98 -0.718 . . . . 0.0 111.009 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.4 m -80.14 131.46 35.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -73.39 150.11 89.23 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.627 -0.67 . . . . 0.0 110.148 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.66 135.25 25.68 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.927 1.488 . . . . 0.0 110.872 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 tp 66.67 141.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.485 0.659 . . . . 0.0 111.221 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -60.8 134.92 57.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.379 -0.826 . . . . 0.0 109.591 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttt 61.89 95.11 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.975 -0.453 . . . . 0.0 110.299 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.38 -159.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.876 1.461 . . . . 0.0 110.691 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t 65.54 -173.75 0.18 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.663 -0.648 . . . . 0.0 110.921 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -77.45 135.37 65.28 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.16 166.03 29.86 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.974 1.513 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.1 pt -72.63 172.33 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 121.329 0.585 . . . . 0.0 110.868 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.98 152.52 45.41 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.624 -0.672 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 pt -107.68 -177.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.572 -0.705 . . . . 0.0 110.698 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER 65.15 150.07 0.12 Allowed Pre-proline 0 N--CA 1.501 2.11 0 CA-C-O 121.035 0.445 . . . . 0.0 111.404 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.55 176.67 7.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.799 1.421 . . . . 0.0 111.909 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.7 mm -76.0 167.29 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.682 0.753 . . . . 0.0 110.823 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 105.73 -62.79 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 5.3 m -69.6 -28.02 65.59 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.746 -0.855 . . . . 0.0 110.668 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.36 9.28 6.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.428 -0.795 . . . . 0.0 110.918 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.46 64.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.871 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.7 m -49.44 -24.6 2.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -104.38 126.27 51.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.361 -0.837 . . . . 0.0 110.119 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -27.12 10.87 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.464 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.4 pt -82.79 161.82 57.24 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.159 -1.2 . . . . 0.0 110.658 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.0 Cg_endo -73.79 155.63 48.83 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.167 1.614 . . . . 0.0 111.227 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t -58.76 -38.34 78.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.816 -0.552 . . . . 0.0 111.084 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -62.65 -45.08 94.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 0.0 109.876 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 99.0 m -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.09 95.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.814 -0.554 . . . . 0.0 110.199 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -64.47 -43.16 95.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.2 -37.42 83.6 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 109.629 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.8 -29.93 71.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.204 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.1 t -88.36 -36.82 16.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -68.5 -39.01 81.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.729 -0.607 . . . . 0.0 110.947 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -99.15 -61.75 1.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -73.42 -42.2 62.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.291 -0.881 . . . . 0.0 111.178 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.62 10.39 31.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 2.1 m-20 -102.6 160.78 14.27 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.049 -1.265 . . . . 0.0 109.911 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 m 60.85 40.31 15.94 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.335 0.588 . . . . 0.0 109.704 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.7 m -91.69 -59.65 2.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 110.213 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -87.94 87.07 7.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.879 -1.058 . . . . 0.0 110.41 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -70.37 -25.99 63.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.691 -0.887 . . . . 0.0 110.36 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -76.89 3.75 11.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 111.2 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' TYR . 6.5 t -142.76 69.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 m -50.65 -25.82 4.7 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.635 -0.666 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 25' ' ' VAL . 9.9 m-85 -107.61 124.87 50.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.855 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.05 -29.28 7.81 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 41.2 pt -77.4 163.2 65.73 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.245 -1.15 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.46 154.38 50.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.023 1.539 . . . . 0.0 111.165 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -57.44 -41.35 80.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.89 -0.506 . . . . 0.0 110.969 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -60.58 -45.55 93.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 80.1 m -67.8 -40.4 83.89 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.54 91.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 110.012 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -43.48 98.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.355 -0.841 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.7 -40.45 95.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.763 -0.586 . . . . 0.0 109.811 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -64.27 -30.12 71.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.456 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.6 t -85.93 -36.95 19.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.843 . . . . 0.0 109.741 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -70.07 -38.8 75.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.68 -0.638 . . . . 0.0 111.034 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -58.74 1.95 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 111.757 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 87.0 m-85 -79.88 -36.91 35.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 111.257 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.44 13.51 38.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -106.73 160.07 15.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.074 -1.251 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 121.379 0.609 . . . . 0.0 109.694 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -66.66 -30.29 70.52 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.676 -0.896 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -83.53 10.92 7.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 0.0 110.78 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.29 61.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 108.719 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.2 m -47.37 -27.55 1.69 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.935 -0.478 . . . . 0.0 111.37 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.73 125.77 51.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 0.0 109.819 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.97 -29.28 7.84 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.2 pt -79.37 164.0 56.42 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.234 -1.157 . . . . 0.0 110.463 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.25 155.76 51.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.046 1.55 . . . . 0.0 111.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 t -57.74 -41.04 81.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.898 -0.501 . . . . 0.0 111.219 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -62.46 -43.48 98.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.854 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 47.6 m -64.86 -41.36 95.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.396 -0.815 . . . . 0.0 109.299 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.11 -41.76 88.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.723 -0.611 . . . . 0.0 110.48 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -63.62 -43.11 97.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.478 -0.764 . . . . 0.0 109.826 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -37.09 80.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -66.9 -30.14 70.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.61 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 t -86.28 -36.28 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.913 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 17.1 t80 -70.41 -38.77 74.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.635 -0.665 . . . . 0.0 111.047 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -98.18 -60.21 1.6 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 111.696 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 77.7 m-85 -75.58 -39.22 58.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.232 -0.918 . . . . 0.0 111.068 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.99 38.78 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.668 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.59 160.52 15.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.917 -179.406 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.22 -29.35 68.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.669 -0.901 . . . . 0.0 110.674 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 16.76 4.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -0.816 . . . . 0.0 110.556 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 27' ' ' TYR . 12.2 t -141.58 61.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.031 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.2 m -48.64 -26.24 2.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.811 -0.556 . . . . 0.0 111.241 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 25' ' ' VAL . 70.1 m-85 -105.34 128.32 53.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.84 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.82 -30.84 7.46 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.433 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.8 pt -84.0 162.18 52.93 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.336 -1.097 . . . . 0.0 110.426 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.1 Cg_endo -74.21 153.09 45.77 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.166 1.614 . . . . 0.0 111.001 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -58.73 -36.67 74.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.861 -0.524 . . . . 0.0 111.288 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -64.14 -45.04 90.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.8 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 81.7 m -68.41 -41.86 79.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.94 89.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.815 -0.553 . . . . 0.0 110.213 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -64.01 -42.78 97.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -0.768 . . . . 0.0 109.428 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.18 -38.8 91.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.606 -0.684 . . . . 0.0 109.618 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -61.04 -33.82 73.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.783 -0.573 . . . . 0.0 110.329 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.4 t -78.67 -37.74 41.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 109.907 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -66.81 -38.97 87.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.38 -56.23 2.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 111.856 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.1 m-85 -80.18 -37.33 33.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.202 -0.936 . . . . 0.0 111.072 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 11.41 45.91 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.42 157.86 18.04 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.999 -1.295 . . . . 0.0 110.273 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.502 2.144 0 CA-C-O 121.38 0.61 . . . . 0.0 109.987 -179.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.82 -28.57 61.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.631 -0.923 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.84 8.8 6.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.302 -0.874 . . . . 0.0 111.02 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.41 65.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.021 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.4 m -50.51 -24.17 2.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.664 -0.647 . . . . 0.0 111.288 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -106.78 126.03 51.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.39 -27.2 10.23 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.5 pt -81.84 162.17 58.46 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.123 -1.222 . . . . 0.0 110.754 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.77 155.53 48.95 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.16 1.611 . . . . 0.0 111.099 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -58.58 -39.15 79.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.79 -0.569 . . . . 0.0 111.111 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 t -61.8 -45.52 93.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.372 -0.83 . . . . 0.0 109.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.6 m -69.43 -40.13 77.42 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.08 93.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.701 -0.624 . . . . 0.0 110.282 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -65.7 -42.32 91.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.428 -0.795 . . . . 0.0 109.517 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.88 -38.25 85.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.709 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -61.93 -30.89 71.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.62 -0.675 . . . . 0.0 110.202 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -83.93 -37.68 22.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.358 -0.838 . . . . 0.0 109.548 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -71.2 -35.46 71.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 111.015 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -55.72 2.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -86.31 -36.22 19.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.308 -0.87 . . . . 0.0 111.129 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.32 37.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.64 159.97 15.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.089 -1.242 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.502 2.155 0 O-C-N 121.794 -0.566 . . . . 0.0 109.913 -179.693 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.32 -28.15 66.91 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.669 -0.901 . . . . 0.0 110.979 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.9 11.86 5.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.8 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 27' ' ' TYR . 8.6 t -139.76 63.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.28 -0.887 . . . . 0.0 109.024 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.5 m -49.54 -25.94 3.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.729 -0.607 . . . . 0.0 111.069 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 25' ' ' VAL . 33.2 m-85 -105.87 126.06 51.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -29.77 7.46 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.485 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.6 pt -81.27 162.89 57.37 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.34 155.26 51.21 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.096 1.577 . . . . 0.0 111.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 t -56.94 -41.66 78.64 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.012 -0.43 . . . . 0.0 111.132 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -62.25 -45.75 91.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.9 m -66.37 -40.57 89.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.21 96.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.731 -0.605 . . . . 0.0 110.15 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -42.85 99.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.765 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.1 -38.9 89.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.526 -0.734 . . . . 0.0 109.703 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -62.83 -29.15 70.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.629 . . . . 0.0 110.396 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -85.98 -37.02 19.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.378 -0.826 . . . . 0.0 109.622 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -70.79 -36.66 73.11 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.701 -0.624 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -57.58 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.9 m-85 -81.76 -37.19 27.6 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.093 -1.004 . . . . 0.0 111.175 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.61 12.24 38.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.69 159.59 15.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.121 -1.223 . . . . 0.0 109.778 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 121.385 0.612 . . . . 0.0 109.77 -179.436 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.7 m -66.42 -30.54 70.92 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.831 -0.805 . . . . 0.0 110.594 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.0 12.27 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.785 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 t -139.57 63.04 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.322 -0.861 . . . . 0.0 108.862 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.6 m -49.83 -25.09 2.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.839 -0.538 . . . . 0.0 111.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -105.34 126.78 52.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.139 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.89 -28.29 8.98 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.9 pt -84.61 162.08 51.67 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.155 -1.203 . . . . 0.0 110.611 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -74.16 155.11 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.139 1.599 . . . . 0.0 111.011 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -58.36 -40.78 83.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.822 -0.549 . . . . 0.0 111.022 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -60.48 -45.98 91.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.45 -0.781 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.0 m -66.16 -41.83 89.79 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.24 92.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.758 -0.589 . . . . 0.0 109.904 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.8 -44.2 97.17 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.463 -0.773 . . . . 0.0 109.908 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.593 -0.692 . . . . 0.0 109.824 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.64 -35.15 78.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.635 . . . . 0.0 110.555 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -78.98 -38.62 36.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.83 -38.73 83.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.608 -0.683 . . . . 0.0 111.175 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -57.94 2.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.428 -0.795 . . . . 0.0 111.731 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.446 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 83.3 m-85 -84.02 -34.59 24.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.154 -0.966 . . . . 0.0 111.421 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.97 12.17 47.28 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -104.78 157.13 17.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.898 -1.354 . . . . 0.0 109.971 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.502 2.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.126 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -67.24 -29.41 69.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.726 -0.867 . . . . 0.0 110.212 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.76 16.19 4.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.537 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 27' ' ' TYR . 16.3 t -141.71 63.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.224 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.7 m -48.14 -25.87 1.65 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.761 -0.587 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.464 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.4 m-85 -106.5 126.29 52.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.39 -31.76 6.26 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.459 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.8 pt -80.76 162.8 58.91 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.307 -1.113 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.7 Cg_endo -73.33 153.4 50.63 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.08 1.568 . . . . 0.0 111.134 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -37.67 73.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.878 -0.514 . . . . 0.0 111.309 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -65.13 -44.67 87.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.39 -0.819 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 54.2 m -64.81 -41.33 95.87 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 109.21 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.44 78.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.634 . . . . 0.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.06 -41.19 91.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 109.09 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -40.47 95.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.78 -40.46 95.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.633 . . . . 0.0 109.769 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.52 -38.52 68.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 109.983 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -67.5 -38.14 83.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.7 -0.625 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -58.74 1.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 111.811 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -77.7 -39.67 43.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.261 -0.899 . . . . 0.0 111.169 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.03 14.0 32.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.02 159.11 18.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.061 -1.258 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.364 0.602 . . . . 0.0 109.944 -179.599 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -67.78 -31.14 70.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.796 -0.826 . . . . 0.0 109.83 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -72.22 -0.49 12.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.66 -0.65 . . . . 0.0 111.48 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 27' ' ' TYR . 19.1 t -143.03 74.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.14 -0.975 . . . . 0.0 108.989 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.1 m -50.43 -23.1 2.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.765 -0.585 . . . . 0.0 111.339 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.549 ' O ' HG12 ' A' ' 25' ' ' VAL . 22.3 m-85 -104.96 128.13 53.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.227 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -25.11 15.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.468 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.4 pt -79.55 162.09 64.57 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.153 -1.204 . . . . 0.0 110.908 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.53 156.65 49.6 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.206 1.635 . . . . 0.0 111.333 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -56.89 -40.97 77.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.958 -0.464 . . . . 0.0 111.31 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -63.35 -43.61 97.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.449 -0.782 . . . . 0.0 110.243 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 30.8 m -64.51 -41.15 96.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.42 -0.8 . . . . 0.0 109.111 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.75 79.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.712 -0.617 . . . . 0.0 110.294 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -64.71 -42.08 95.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.04 -37.22 78.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.635 -0.665 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -67.64 -31.53 71.6 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.557 -0.714 . . . . 0.0 110.269 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.9 t -86.85 -35.15 19.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -70.21 -40.58 74.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.602 -0.686 . . . . 0.0 111.363 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -53.42 3.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 111.844 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 94.5 m-85 -82.85 -36.03 25.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.89 . . . . 0.0 111.304 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 12.17 48.58 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -104.98 158.86 16.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.76 -0.588 . . . . 0.0 109.936 -179.719 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.407 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 m -66.55 -28.98 68.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.788 -0.83 . . . . 0.0 109.813 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.24 3.09 9.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.6 -0.688 . . . . 0.0 111.346 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 27' ' ' TYR . 7.8 t -142.63 71.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.014 . . . . 0.0 109.216 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.8 m -51.34 -22.68 3.03 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.706 -0.621 . . . . 0.0 111.472 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.4 m-85 -105.97 128.71 53.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 0.0 110.313 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.41 -27.46 9.98 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.0 pt -84.41 161.93 52.68 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.142 -1.211 . . . . 0.0 110.769 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.0 156.36 47.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.103 1.58 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.0 t -58.82 -40.54 84.44 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.804 -0.56 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -60.14 -46.01 91.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.806 . . . . 0.0 109.871 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 98.4 m -68.96 -40.36 78.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.89 92.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.777 -0.577 . . . . 0.0 110.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -64.47 -42.03 96.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.405 -0.809 . . . . 0.0 109.374 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.93 -39.5 93.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.682 -0.637 . . . . 0.0 109.619 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -63.44 -29.94 71.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.785 -0.572 . . . . 0.0 110.263 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.0 t -86.18 -37.7 18.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 0.0 109.562 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -67.17 -38.69 85.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.816 -0.553 . . . . 0.0 111.191 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -100.2 -55.07 2.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -0.851 . . . . 0.0 112.036 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 91.2 m-85 -82.64 -36.18 26.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.102 -0.998 . . . . 0.0 111.13 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.96 11.18 43.91 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -105.21 158.31 16.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.012 -1.287 . . . . 0.0 109.959 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 -179.686 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 7.7 m -65.84 -30.58 71.22 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.702 -0.881 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.47 13.55 4.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.687 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 27' ' ' TYR . 14.0 t -141.67 63.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 108.879 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.5 m -49.99 -25.14 3.06 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.795 -0.566 . . . . 0.0 111.269 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' VAL . 64.0 m-85 -105.78 129.35 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.73 -30.42 7.49 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.3 pt -84.97 162.38 49.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.22 -1.165 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.92 154.3 48.01 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.109 1.584 . . . . 0.0 110.887 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 t -58.3 -39.29 78.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.827 -0.545 . . . . 0.0 111.084 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.39 -46.62 89.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.84 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 86.0 m -66.85 -40.59 87.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 108.974 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.99 96.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.788 -0.57 . . . . 0.0 110.073 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -62.42 -42.73 99.66 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.13 -39.79 95.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -34.73 76.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.801 -0.562 . . . . 0.0 110.265 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.8 t -76.24 -38.35 56.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 13.8 t80 -67.11 -38.18 85.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 111.361 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 6.1 mmm180 -98.95 -57.06 2.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.228 -0.92 . . . . 0.0 111.75 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CD1' ' SG ' ' A' ' 23' ' ' CYS . 83.0 m-85 -81.5 -36.86 28.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.933 . . . . 0.0 111.208 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.01 12.11 47.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.11 155.78 18.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -1.207 . . . . 0.0 109.892 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 121.345 0.593 . . . . 0.0 109.773 -179.715 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 1.6 m -71.21 -28.93 64.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.765 -0.844 . . . . 0.0 110.465 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 14.28 4.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.303 -0.873 . . . . 0.0 110.55 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 27' ' ' TYR . 23.3 t -139.33 65.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 108.702 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 90.2 m -47.95 -24.17 0.98 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.903 -0.498 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 25' ' ' VAL . 25.6 m-85 -102.82 127.08 50.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.91 -26.1 13.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.46 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.9 pt -87.63 162.68 41.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.193 -1.181 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.8 Cg_endo -74.55 154.66 44.97 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.152 1.606 . . . . 0.0 111.182 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 t -59.28 -39.37 82.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.813 -0.555 . . . . 0.0 110.914 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -59.3 -46.5 88.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.744 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 90.6 m -68.38 -41.15 80.99 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.45 88.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.732 -0.605 . . . . 0.0 110.176 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -65.75 -43.87 87.61 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.341 -0.849 . . . . 0.0 109.392 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -36.45 80.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.554 -0.716 . . . . 0.0 109.373 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -60.84 -31.08 70.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.82 -0.55 . . . . 0.0 110.465 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.5 t -84.35 -37.33 21.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.14 -0.975 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -68.91 -38.97 79.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 0.0 111.234 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -56.91 2.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.309 -0.869 . . . . 0.0 111.836 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 63.5 m-85 -80.19 -37.8 32.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.219 -0.926 . . . . 0.0 111.234 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.36 12.29 42.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.2 157.44 17.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -1.21 . . . . 0.0 109.585 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.504 2.236 0 O-C-N 121.713 -0.617 . . . . 0.0 109.676 -179.202 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.7 m -66.51 -29.17 69.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.689 -0.889 . . . . 0.0 110.684 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.38 15.16 4.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.225 -0.922 . . . . 0.0 110.497 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -138.46 62.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.1 m -48.71 -24.72 1.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.851 -0.531 . . . . 0.0 111.357 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -105.65 126.93 52.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.822 . . . . 0.0 109.955 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.84 8.89 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.0 pt -83.31 161.63 56.5 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.198 -1.177 . . . . 0.0 110.532 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.442 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.8 Cg_endo -74.02 153.66 47.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.186 1.624 . . . . 0.0 111.315 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 t -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.952 -0.467 . . . . 0.0 111.112 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.96 -45.7 92.49 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.523 -0.736 . . . . 0.0 110.246 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.7 m -67.52 -41.38 84.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 0.0 108.731 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.6 91.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.732 -0.605 . . . . 0.0 110.037 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.461 -0.774 . . . . 0.0 109.473 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -37.54 87.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.763 -0.585 . . . . 0.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -64.01 -32.55 74.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.771 -0.58 . . . . 0.0 110.558 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.5 t -81.9 -37.83 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.77 -37.77 85.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.695 -0.628 . . . . 0.0 111.325 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -101.78 -58.41 1.89 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -0.916 . . . . 0.0 111.638 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.4 m-85 -77.01 -38.45 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.157 -0.964 . . . . 0.0 111.16 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.51 42.95 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.15 157.15 18.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.009 -1.289 . . . . 0.0 109.934 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.443 0.639 . . . . 0.0 109.705 -179.402 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 m -66.02 -29.2 69.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.752 -0.852 . . . . 0.0 110.8 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 11.6 6.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.02 63.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 108.745 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.7 m -49.8 -23.06 1.66 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.0 111.796 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -105.81 126.48 52.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.306 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.95 -24.75 14.06 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.853 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.2 pt -86.17 160.07 52.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.031 -1.276 . . . . 0.0 110.924 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.3 Cg_endo -74.34 157.82 45.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.214 1.639 . . . . 0.0 111.24 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -59.43 -40.28 86.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.734 -0.604 . . . . 0.0 110.94 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -59.65 -44.86 93.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.399 -0.813 . . . . 0.0 109.697 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.433 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 82.1 m -68.43 -41.04 80.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.34 90.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.713 -0.617 . . . . 0.0 109.793 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.54 -45.5 93.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.503 -0.748 . . . . 0.0 109.305 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -36.25 82.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 109.833 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -68.06 -37.39 81.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.6 t -80.33 -33.85 37.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 0.0 110.049 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 35' ' ' ARG . 28.1 t80 -70.85 -41.43 71.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 111.528 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.355 -0.841 . . . . 0.0 111.821 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 90.6 m-85 -82.37 -37.1 26.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.175 -0.953 . . . . 0.0 111.14 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.04 42.82 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -106.87 156.24 18.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.246 . . . . 0.0 109.845 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 121.426 0.632 . . . . 0.0 109.821 -179.71 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.87 -16.37 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.747 -0.855 . . . . 0.0 110.293 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.94 -4.28 43.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.669 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.7 t -143.71 74.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.312 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.5 m -48.47 -26.91 2.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.921 -0.487 . . . . 0.0 111.281 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.613 ' O ' HG12 ' A' ' 25' ' ' VAL . 98.2 m-85 -107.57 129.26 55.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.925 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.81 -28.97 8.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 45.0 pt -80.06 163.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.214 -1.168 . . . . 0.0 110.498 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.45 155.64 50.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.118 1.589 . . . . 0.0 111.144 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 t -58.54 -39.29 79.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 111.033 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 t -61.18 -46.42 90.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.6 m -67.19 -41.39 85.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.69 87.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.706 -0.621 . . . . 0.0 110.129 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -64.23 -44.07 92.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.542 -0.723 . . . . 0.0 109.579 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -67.12 -37.25 83.54 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 0.0 109.888 179.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -65.9 -30.22 70.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.48 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -87.98 -36.44 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 109.982 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.81 -38.01 70.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 111.329 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -100.21 -55.36 2.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.279 -0.888 . . . . 0.0 111.601 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.3 m-85 -79.16 -37.76 37.66 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.183 -0.948 . . . . 0.0 110.932 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.52 12.11 42.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -109.07 160.0 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.064 -1.257 . . . . 0.0 110.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.503 2.189 0 O-C-N 121.722 -0.611 . . . . 0.0 109.761 -179.29 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -68.11 -30.12 69.21 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.834 -0.803 . . . . 0.0 110.244 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.57 13.3 4.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.36 -0.838 . . . . 0.0 110.573 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.0 t -139.81 64.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 109.174 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.7 m -49.34 -24.24 1.8 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.769 -0.582 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.2 m-85 -105.36 126.78 52.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.18 8.44 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 38.3 pt -83.52 162.56 53.0 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -73.57 154.59 49.96 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.123 1.591 . . . . 0.0 111.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -57.95 -38.73 76.52 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.924 -0.485 . . . . 0.0 111.264 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 t -63.9 -44.99 91.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.389 -0.82 . . . . 0.0 110.011 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 70.0 m -65.89 -41.63 91.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.31 -0.869 . . . . 0.0 109.056 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.83 84.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -46.19 86.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.45 -0.781 . . . . 0.0 109.584 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.56 -31.5 72.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.672 -0.643 . . . . 0.0 110.409 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -83.36 -36.63 24.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -69.38 -37.59 77.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.653 . . . . 0.0 111.144 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -99.77 -59.75 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.355 -0.84 . . . . 0.0 111.605 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 63.8 m-85 -76.74 -39.21 52.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.901 . . . . 0.0 111.112 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.2 35.95 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 9.1 m-20 -108.24 159.03 16.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.064 -1.256 . . . . 0.0 110.128 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 121.471 0.653 . . . . 0.0 109.543 -179.131 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.563 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.3 m -79.2 -13.44 59.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.815 -0.814 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.26 -0.82 38.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.438 -0.789 . . . . 0.0 111.515 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.2 t -143.69 72.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.104 -0.998 . . . . 0.0 109.463 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.9 m -50.04 -24.91 2.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.869 -0.52 . . . . 0.0 111.112 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 25' ' ' VAL . 10.4 m-85 -107.53 126.7 52.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 110.033 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.76 -27.77 9.5 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 42.2 pt -80.27 162.7 60.46 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.197 -1.178 . . . . 0.0 110.445 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.61 155.19 49.91 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.053 1.554 . . . . 0.0 111.201 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -57.94 -39.99 79.41 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.787 -0.571 . . . . 0.0 110.863 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -47.41 86.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 109.876 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.7 m -67.86 -40.43 83.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.042 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 110.095 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.16 -42.95 93.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.4 -0.813 . . . . 0.0 109.412 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.1 -39.29 86.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.651 . . . . 0.0 109.817 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -64.19 -28.83 70.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 110.069 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.9 t -88.18 -37.07 16.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.77 -39.26 70.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.663 . . . . 0.0 111.276 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -52.27 3.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 111.749 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.1 m-85 -82.96 -38.22 23.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 11.7 39.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.97 160.74 15.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.024 -1.28 . . . . 0.0 110.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.503 2.195 0 CA-C-O 121.387 0.613 . . . . 0.0 109.704 -179.219 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.3 -29.94 70.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.774 -0.839 . . . . 0.0 111.049 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.32 13.24 6.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.311 -0.868 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.26 61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.195 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.7 m -48.8 -25.5 1.89 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.764 -0.585 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -105.03 124.94 50.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.883 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.1 -29.44 7.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.456 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.1 pt -84.26 161.96 52.97 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.205 -1.174 . . . . 0.0 110.514 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.82 154.78 48.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.157 1.609 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -58.78 -38.51 78.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.901 -0.499 . . . . 0.0 111.169 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -62.78 -45.62 91.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.863 . . . . 0.0 109.846 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.5 m -67.55 -41.23 84.6 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.2 -40.85 97.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.574 . . . . 0.0 109.905 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -61.78 -43.42 98.89 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.475 -0.765 . . . . 0.0 109.683 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.32 -39.39 93.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.676 -0.64 . . . . 0.0 109.78 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.99 -31.12 72.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.741 -0.599 . . . . 0.0 110.597 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.2 t -82.52 -38.6 23.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 9.8 t80 -68.67 -35.83 77.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.673 -0.642 . . . . 0.0 111.219 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -100.92 -58.01 1.98 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.177 -0.952 . . . . 0.0 111.597 -178.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.2 m-85 -79.46 -38.36 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.217 -0.927 . . . . 0.0 111.074 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.43 39.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.65 158.14 17.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.112 -1.229 . . . . 0.0 110.074 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.464 0.649 . . . . 0.0 109.596 -179.169 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.42 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.6 m -67.72 -30.23 69.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.659 -0.906 . . . . 0.0 111.114 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.43 14.05 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.521 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.9 t -138.9 63.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.853 . . . . 0.0 109.02 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.07 -24.16 1.49 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.76 -0.588 . . . . 0.0 111.3 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 25' ' ' VAL . 38.6 m-85 -104.38 128.86 52.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.22 -28.54 9.6 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 34.6 pt -87.18 162.09 44.42 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.197 -1.178 . . . . 0.0 110.511 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.2 Cg_endo -74.35 154.64 46.0 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -58.71 -39.74 81.65 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.775 -0.578 . . . . 0.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -60.61 -44.76 95.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.349 -0.844 . . . . 0.0 109.778 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 79.6 m -67.89 -41.52 82.62 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.73 87.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.826 -0.546 . . . . 0.0 110.168 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -44.94 92.0 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.377 -0.827 . . . . 0.0 109.399 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.43 -38.27 90.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.59 -0.694 . . . . 0.0 109.732 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.612 . . . . 0.0 110.428 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.7 t -80.79 -37.91 29.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -68.27 -37.8 81.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 111.167 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -60.17 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -0.877 . . . . 0.0 111.673 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 70.8 m-85 -77.3 -39.72 46.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.134 -0.979 . . . . 0.0 111.075 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.74 11.94 36.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.52 158.34 17.29 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.043 -1.269 . . . . 0.0 110.074 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.386 0.612 . . . . 0.0 109.645 -179.281 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.653 -0.91 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.43 12.69 6.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 110.782 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 27' ' ' TYR . 11.3 t -139.69 63.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.0 m -48.2 -26.21 1.83 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.714 -0.616 . . . . 0.0 111.134 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 25' ' ' VAL . 94.4 m-85 -100.72 128.62 46.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.68 -26.17 15.15 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.6 pt -88.14 161.34 43.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.173 -1.192 . . . . 0.0 110.677 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.33 154.25 45.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.203 1.633 . . . . 0.0 111.258 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -56.82 -41.42 77.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.955 -0.466 . . . . 0.0 111.104 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 t -61.56 -46.17 91.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.764 . . . . 0.0 110.378 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 83.7 m -67.32 -41.25 85.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 108.934 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.37 -38.14 89.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.722 -0.611 . . . . 0.0 110.03 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.94 -45.47 93.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.537 -0.727 . . . . 0.0 109.535 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.2 -38.15 90.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.743 -0.598 . . . . 0.0 109.783 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -60.99 -34.61 75.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 0.0 110.349 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -80.38 -36.62 33.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -0.915 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.58 -39.68 88.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.775 -0.578 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.17 -54.29 2.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.265 -0.897 . . . . 0.0 111.829 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 89.6 m-85 -81.9 -36.57 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.209 -0.932 . . . . 0.0 111.114 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 10.6 47.42 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.978 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.64 156.4 19.09 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.988 -1.301 . . . . 0.0 110.248 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 121.425 0.631 . . . . 0.0 109.743 -179.219 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 5.3 m -69.6 -28.02 65.59 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.746 -0.855 . . . . 0.0 110.668 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.36 9.28 6.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.428 -0.795 . . . . 0.0 110.918 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.46 64.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.871 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.7 m -49.44 -24.6 2.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -104.38 126.27 51.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.361 -0.837 . . . . 0.0 110.119 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -27.12 10.87 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.464 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.4 pt -82.79 161.82 57.24 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.159 -1.2 . . . . 0.0 110.658 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.0 Cg_endo -73.79 155.63 48.83 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.167 1.614 . . . . 0.0 111.227 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t -58.76 -38.34 78.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.816 -0.552 . . . . 0.0 111.084 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -62.65 -45.08 94.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 0.0 109.876 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 99.0 m -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.09 95.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.814 -0.554 . . . . 0.0 110.199 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -64.47 -43.16 95.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.2 -37.42 83.6 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 109.629 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.8 -29.93 71.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.204 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.1 t -88.36 -36.82 16.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -68.5 -39.01 81.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.729 -0.607 . . . . 0.0 110.947 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -99.15 -61.75 1.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -73.42 -42.2 62.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.291 -0.881 . . . . 0.0 111.178 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.62 10.39 31.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 2.1 m-20 -102.6 160.78 14.27 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.049 -1.265 . . . . 0.0 109.911 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.503 2.219 0 CA-C-O 121.335 0.588 . . . . 0.0 109.704 -179.478 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 23.9 t60 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 120.89 0.376 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t 52.37 65.77 1.41 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.531 0.681 . . . . 0.0 110.56 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.7 m -84.69 163.15 19.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.44 -0.787 . . . . 0.0 110.382 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.35 -91.97 0.75 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -160.65 134.4 6.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.508 -0.995 . . . . 0.0 110.548 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.617 HG22 ' HD3' ' A' ' 8' ' ' PRO . 17.0 m -147.67 133.98 19.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.548 -0.72 . . . . 0.0 110.06 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.6 72.66 7.42 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.825 . . . . 0.0 110.548 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.617 ' HD3' HG22 ' A' ' 6' ' ' THR . 47.9 Cg_endo -75.8 162.08 35.54 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 124.04 1.548 . . . . 0.0 110.632 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.2 mt -60.75 145.2 50.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.683 -0.636 . . . . 0.0 110.277 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -138.94 138.04 36.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.351 -0.843 . . . . 0.0 110.875 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.24 163.36 68.34 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.552 -0.718 . . . . 0.0 110.311 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.22 -166.78 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 124.024 1.539 . . . . 0.0 110.742 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.8 m -58.91 129.01 40.06 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.503 -0.748 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 153.83 73.6 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.533 -0.73 . . . . 0.0 110.348 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.85 159.22 48.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 124.075 1.566 . . . . 0.0 110.533 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.89 165.68 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.645 -0.659 . . . . 0.0 110.608 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -164.79 164.22 21.15 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.727 . . . . 0.0 110.196 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.3 pt -68.6 168.5 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.389 -0.82 . . . . 0.0 110.005 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -88.91 164.22 32.06 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 110.309 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 19' ' ' ARG . 39.8 Cg_endo -70.9 169.35 20.59 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 124.15 1.605 . . . . 0.0 111.17 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.2 mm -72.2 165.4 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.683 0.754 . . . . 0.0 110.684 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 108.36 -62.26 0.3 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -70.37 -25.99 63.52 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.691 -0.887 . . . . 0.0 110.36 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -76.89 3.75 11.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.509 -0.744 . . . . 0.0 111.2 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 27' ' ' TYR . 6.5 t -142.76 69.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.041 -1.037 . . . . 0.0 109.316 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.2 m -50.65 -25.82 4.7 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.635 -0.666 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 25' ' ' VAL . 9.9 m-85 -107.61 124.87 50.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 109.855 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.05 -29.28 7.81 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.49 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 41.2 pt -77.4 163.2 65.73 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.245 -1.15 . . . . 0.0 110.432 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.46 154.38 50.41 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.023 1.539 . . . . 0.0 111.165 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -57.44 -41.35 80.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.89 -0.506 . . . . 0.0 110.969 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -60.58 -45.55 93.53 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.333 -0.854 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 80.1 m -67.8 -40.4 83.89 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.54 91.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 110.012 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.05 -43.48 98.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.355 -0.841 . . . . 0.0 109.453 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -64.7 -40.45 95.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.763 -0.586 . . . . 0.0 109.811 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -64.27 -30.12 71.18 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.719 -0.613 . . . . 0.0 110.456 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.6 t -85.93 -36.95 19.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.352 -0.843 . . . . 0.0 109.741 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -70.07 -38.8 75.85 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.68 -0.638 . . . . 0.0 111.034 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -58.74 1.95 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.356 -0.84 . . . . 0.0 111.757 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 87.0 m-85 -79.88 -36.91 35.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.304 -0.873 . . . . 0.0 111.257 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.44 13.51 38.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -106.73 160.07 15.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.074 -1.251 . . . . 0.0 109.79 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 m 61.14 41.18 13.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.379 0.609 . . . . 0.0 109.694 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.7 m -90.31 -60.47 1.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 0.0 110.199 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -101.13 83.43 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.579 -0.7 . . . . 0.0 110.129 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.396 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 34.8 p80 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.043 0.449 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 56.86 79.0 0.2 Allowed 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.384 0.612 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.71 162.83 40.48 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.408 -0.808 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.44 -116.44 4.51 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 68.13 156.28 0.12 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.955 -0.732 . . . . 0.0 111.04 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.0 m -116.6 135.04 54.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.487 -0.758 . . . . 0.0 110.379 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 152.79 92.47 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.632 -0.668 . . . . 0.0 110.253 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.31 149.29 56.85 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.896 1.472 . . . . 0.0 110.902 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.07 175.71 9.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.658 -0.651 . . . . 0.0 110.65 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.26 148.55 51.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.53 -0.731 . . . . 0.0 110.504 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.79 107.33 10.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.509 -0.745 . . . . 0.0 110.241 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -80.29 -170.32 0.98 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.875 1.46 . . . . 0.0 110.654 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -105.54 63.4 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.545 -0.722 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.44 136.99 19.27 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.805 . . . . 0.0 110.241 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.74 171.67 17.36 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 124.053 1.554 . . . . 0.0 110.835 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.5 pt -59.38 168.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.705 -0.622 . . . . 0.0 110.588 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -154.47 165.02 37.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 110.651 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.0 pt -73.09 174.39 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.636 -0.665 . . . . 0.0 110.517 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.81 154.14 91.16 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.588 -0.695 . . . . 0.0 110.31 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -70.38 165.14 32.65 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.983 1.517 . . . . 0.0 111.372 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.3 mt -79.74 165.54 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.497 0.665 . . . . 0.0 110.933 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 106.42 -60.44 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -66.66 -30.29 70.52 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.676 -0.896 . . . . 0.0 110.988 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -83.53 10.92 7.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.271 -0.893 . . . . 0.0 110.78 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -136.29 61.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.289 -0.882 . . . . 0.0 108.719 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 47' ' ' LEU . 68.2 m -47.37 -27.55 1.69 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.935 -0.478 . . . . 0.0 111.37 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.73 125.77 51.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 0.0 109.819 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.97 -29.28 7.84 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.513 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.2 pt -79.37 164.0 56.42 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.234 -1.157 . . . . 0.0 110.463 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.25 155.76 51.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.046 1.55 . . . . 0.0 111.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 t -57.74 -41.04 81.06 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.898 -0.501 . . . . 0.0 111.219 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t -62.46 -43.48 98.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.333 -0.854 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 47.6 m -64.86 -41.36 95.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.396 -0.815 . . . . 0.0 109.299 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.11 -41.76 88.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.723 -0.611 . . . . 0.0 110.48 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -63.62 -43.11 97.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.478 -0.764 . . . . 0.0 109.826 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -37.09 80.67 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.445 -0.784 . . . . 0.0 109.79 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -66.9 -30.14 70.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.489 -0.757 . . . . 0.0 110.61 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 t -86.28 -36.28 19.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.913 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 17.1 t80 -70.41 -38.77 74.67 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.635 -0.665 . . . . 0.0 111.047 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.451 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -98.18 -60.21 1.6 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.322 -0.861 . . . . 0.0 111.696 -178.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 77.7 m-85 -75.58 -39.22 58.39 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.232 -0.918 . . . . 0.0 111.068 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 11.99 38.78 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.668 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -107.59 160.52 15.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.011 -1.288 . . . . 0.0 109.909 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' HA ' HD13 ' A' ' 47' ' ' LEU . 20.3 m 63.59 36.44 11.0 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.917 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.5 m -88.01 -61.42 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.52 -0.737 . . . . 0.0 109.54 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -89.66 88.36 7.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.686 -0.634 . . . . 0.0 109.55 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.501 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.036 0.446 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -146.07 150.98 36.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.0 110.351 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 t -94.32 118.77 32.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.437 -0.789 . . . . 0.0 110.32 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.19 125.1 7.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 134.1 41.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.409 -1.054 . . . . 0.0 110.622 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.0 m -96.6 103.59 15.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.539 -0.726 . . . . 0.0 109.59 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tpp180 -158.65 135.65 6.8 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.796 . . . . 0.0 110.7 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 7' ' ' ARG . 46.9 Cg_endo -73.67 152.17 47.58 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.977 1.514 . . . . 0.0 110.504 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.48 155.84 11.45 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.587 -0.695 . . . . 0.0 110.969 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.64 128.74 38.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.221 -0.925 . . . . 0.0 110.296 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -77.68 146.95 73.86 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 110.553 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.27 -156.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.221 1.643 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.5 m -58.09 171.93 0.49 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 110.85 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -44.8 127.98 5.2 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.636 -0.665 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.53 -179.08 3.78 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 O-C-N 124.08 1.569 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 69.6 mt -55.38 162.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-O 121.295 0.569 . . . . 0.0 110.739 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -62.43 -179.2 0.23 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.532 -0.73 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.64 -177.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 121.584 0.707 . . . . 0.0 111.287 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.27 123.2 41.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.75 -0.594 . . . . 0.0 110.262 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.79 175.84 8.39 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 124.119 1.589 . . . . 0.0 111.385 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.3 mt -83.49 166.18 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.61 -0.681 . . . . 0.0 110.675 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 107.1 -61.69 0.31 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -67.22 -29.35 68.98 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.669 -0.901 . . . . 0.0 110.674 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 16.76 4.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -0.816 . . . . 0.0 110.556 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 27' ' ' TYR . 12.2 t -141.58 61.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.031 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.2 m -48.64 -26.24 2.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.811 -0.556 . . . . 0.0 111.241 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 25' ' ' VAL . 70.1 m-85 -105.34 128.32 53.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.84 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.82 -30.84 7.46 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.433 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.8 pt -84.0 162.18 52.93 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.336 -1.097 . . . . 0.0 110.426 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.1 Cg_endo -74.21 153.09 45.77 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.166 1.614 . . . . 0.0 111.001 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 t -58.73 -36.67 74.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.861 -0.524 . . . . 0.0 111.288 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -64.14 -45.04 90.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.8 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 81.7 m -68.41 -41.86 79.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.39 -37.94 89.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.815 -0.553 . . . . 0.0 110.213 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -64.01 -42.78 97.04 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -0.768 . . . . 0.0 109.428 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -65.18 -38.8 91.67 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.606 -0.684 . . . . 0.0 109.618 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -61.04 -33.82 73.89 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.783 -0.573 . . . . 0.0 110.329 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.4 t -78.67 -37.74 41.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.295 -0.878 . . . . 0.0 109.907 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -66.81 -38.97 87.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.649 -0.657 . . . . 0.0 111.312 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.38 -56.23 2.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 111.856 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.1 m-85 -80.18 -37.33 33.52 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.202 -0.936 . . . . 0.0 111.072 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.1 11.41 45.91 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -108.42 157.86 18.04 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.999 -1.295 . . . . 0.0 110.273 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 m 63.09 39.99 9.46 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.38 0.61 . . . . 0.0 109.987 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.3 m -82.38 -58.51 2.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.416 -0.802 . . . . 0.0 109.68 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -92.49 88.34 6.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 0.0 109.845 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 117.9 -1.047 . . . . 0.0 110.484 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.0 t60 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.097 0.475 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.8 p -77.69 145.0 36.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.731 . . . . 0.0 110.167 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 2' ' ' SER . 44.5 m 64.42 116.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 121.379 0.609 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.86 85.8 1.08 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -113.8 142.01 46.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.548 -0.972 . . . . 0.0 110.442 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 6' ' ' THR . 8.4 t -79.42 92.7 5.25 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.554 -0.716 . . . . 0.0 110.168 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.04 147.14 17.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.291 -0.88 . . . . 0.0 110.252 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.6 128.95 13.12 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.877 1.462 . . . . 0.0 110.831 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.9 mt -83.89 131.68 34.85 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.54 -0.725 . . . . 0.0 110.443 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -74.75 91.48 2.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.448 -0.782 . . . . 0.0 110.454 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -151.45 107.78 2.94 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.52 -0.737 . . . . 0.0 110.186 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.98 -165.88 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.866 1.456 . . . . 0.0 110.348 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 89.8 p -87.67 161.22 17.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.336 -0.852 . . . . 0.0 110.33 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.589 ' HG2' ' HD2' ' A' ' 15' ' ' PRO . 6.1 ttt180 66.78 134.72 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 122.019 -0.426 . . . . 0.0 111.143 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' HG2' ' A' ' 14' ' ' ARG . 45.0 Cg_endo -70.56 161.38 46.24 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 O-C-N 123.609 1.32 . . . . 0.0 110.636 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 pt -74.03 176.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.594 -0.691 . . . . 0.0 110.924 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.53 170.11 3.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.632 -0.667 . . . . 0.0 110.737 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 pt -71.14 178.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.57 -0.706 . . . . 0.0 110.622 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 138.05 88.62 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.723 . . . . 0.0 110.706 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.62 175.86 7.43 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 124.187 1.625 . . . . 0.0 111.855 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -74.52 165.43 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.692 0.758 . . . . 0.0 110.806 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.51 -59.12 0.41 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.82 -28.57 61.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.631 -0.923 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.84 8.8 6.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.302 -0.874 . . . . 0.0 111.02 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.41 65.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 0.0 109.021 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.495 ' HB3' HD11 ' A' ' 47' ' ' LEU . 42.4 m -50.51 -24.17 2.99 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.664 -0.647 . . . . 0.0 111.288 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -106.78 126.03 51.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.345 -0.847 . . . . 0.0 110.123 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.39 -27.2 10.23 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.5 pt -81.84 162.17 58.46 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.123 -1.222 . . . . 0.0 110.754 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.77 155.53 48.95 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.16 1.611 . . . . 0.0 111.099 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -58.58 -39.15 79.53 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.79 -0.569 . . . . 0.0 111.111 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.4 t -61.8 -45.52 93.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.372 -0.83 . . . . 0.0 109.928 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.6 m -69.43 -40.13 77.42 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.89 -39.08 93.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.701 -0.624 . . . . 0.0 110.282 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -65.7 -42.32 91.32 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.428 -0.795 . . . . 0.0 109.517 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.88 -38.25 85.95 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.534 -0.729 . . . . 0.0 109.709 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -61.93 -30.89 71.21 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.62 -0.675 . . . . 0.0 110.202 179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 t -83.93 -37.68 22.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.358 -0.838 . . . . 0.0 109.548 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -71.2 -35.46 71.57 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 111.015 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.91 -55.72 2.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.243 -0.911 . . . . 0.0 111.69 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -86.31 -36.22 19.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.308 -0.87 . . . . 0.0 111.129 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.77 12.32 37.9 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.64 159.97 15.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.089 -1.242 . . . . 0.0 109.989 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m 60.63 38.26 18.75 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.794 -0.566 . . . . 0.0 109.913 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.8 m -83.7 -59.22 2.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.451 -0.781 . . . . 0.0 109.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -93.44 86.6 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.684 -0.635 . . . . 0.0 109.78 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.869 -1.062 . . . . 0.0 110.226 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.7 t60 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.036 0.446 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.34 114.62 2.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.481 -0.762 . . . . 0.0 110.123 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.9 m -73.08 144.33 47.08 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.455 -0.778 . . . . 0.0 110.58 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.16 113.49 4.23 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -131.89 140.7 49.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.4 -1.059 . . . . 0.0 110.546 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.5 m -144.76 121.48 11.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.542 -0.724 . . . . 0.0 109.915 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.54 127.19 36.66 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.341 -0.849 . . . . 0.0 110.349 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.06 155.9 38.2 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.937 1.493 . . . . 0.0 110.792 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tp -82.85 60.9 5.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.496 -0.752 . . . . 0.0 110.016 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.53 135.15 0.89 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.758 -0.588 . . . . 0.0 109.674 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -133.32 88.59 34.91 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 110.385 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -78.21 -164.35 0.27 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.964 1.507 . . . . 0.0 110.661 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -87.39 -160.75 0.63 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.41 -0.806 . . . . 0.0 110.303 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 -55.23 124.71 55.23 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.588 -0.695 . . . . 0.0 110.329 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.46 164.36 35.97 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.974 1.513 . . . . 0.0 111.109 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 17' ' ' PHE . 4.3 mt -75.37 166.48 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.798 -0.564 . . . . 0.0 110.238 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.432 ' N ' HG22 ' A' ' 16' ' ' ILE . 64.0 m-85 -56.89 152.56 12.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.536 -0.727 . . . . 0.0 110.778 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.1 pt -68.85 169.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.554 -0.716 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.54 153.32 37.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.637 -0.664 . . . . 0.0 110.212 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.89 177.38 5.73 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 124.044 1.549 . . . . 0.0 111.808 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.4 mm -86.91 167.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.501 0.667 . . . . 0.0 110.876 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.94 -60.76 0.45 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -68.32 -28.15 66.91 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.669 -0.901 . . . . 0.0 110.979 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.9 11.86 5.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.8 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 27' ' ' TYR . 8.6 t -139.76 63.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.28 -0.887 . . . . 0.0 109.024 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.5 m -49.54 -25.94 3.1 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.729 -0.607 . . . . 0.0 111.069 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 25' ' ' VAL . 33.2 m-85 -105.87 126.06 51.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.431 -0.793 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -29.77 7.46 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.485 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.6 pt -81.27 162.89 57.37 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.7 Cg_endo -73.34 155.26 51.21 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 124.096 1.577 . . . . 0.0 111.357 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 t -56.94 -41.66 78.64 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.012 -0.43 . . . . 0.0 111.132 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -62.25 -45.75 91.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.5 -0.75 . . . . 0.0 110.369 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 93.9 m -66.37 -40.57 89.83 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.21 96.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.731 -0.605 . . . . 0.0 110.15 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -42.85 99.94 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.765 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.1 -38.9 89.38 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.526 -0.734 . . . . 0.0 109.703 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -62.83 -29.15 70.51 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.629 . . . . 0.0 110.396 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -85.98 -37.02 19.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.378 -0.826 . . . . 0.0 109.622 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -70.79 -36.66 73.11 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.701 -0.624 . . . . 0.0 111.012 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -57.58 2.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.264 -0.897 . . . . 0.0 111.689 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.9 m-85 -81.76 -37.19 27.6 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.093 -1.004 . . . . 0.0 111.175 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.61 12.24 38.63 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.69 159.59 15.65 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.121 -1.223 . . . . 0.0 109.778 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.0 m 61.66 40.04 13.72 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.385 0.612 . . . . 0.0 109.77 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.3 m -90.88 -60.37 1.93 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.502 -0.748 . . . . 0.0 109.882 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -92.43 84.8 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.645 -0.66 . . . . 0.0 109.888 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.31 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 121.145 0.498 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 t -88.54 116.23 26.63 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.505 -0.747 . . . . 0.0 110.031 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.0 m -83.77 99.12 10.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.758 . . . . 0.0 110.348 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.37 -140.27 6.73 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -71.6 131.58 43.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.391 -1.064 . . . . 0.0 109.917 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -144.63 128.11 16.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 0.0 110.065 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 54.95 81.44 0.26 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.797 -0.564 . . . . 0.0 110.292 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.71 151.33 63.56 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.924 1.486 . . . . 0.0 110.867 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.599 HD13 ' N ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -141.85 133.43 26.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 110.097 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.599 ' N ' HD13 ' A' ' 9' ' ' LEU . 10.2 ttt180 -70.99 91.94 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.509 -0.745 . . . . 0.0 109.934 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -144.94 109.86 4.72 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.562 -0.711 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 176.83 9.01 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.813 1.428 . . . . 0.0 110.77 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.07 31.75 5.21 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.09 0.472 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.48 148.44 0.39 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.443 -0.785 . . . . 0.0 110.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.88 158.6 46.2 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.808 1.425 . . . . 0.0 110.858 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 66.9 mt -60.43 149.97 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.72 -0.612 . . . . 0.0 109.846 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 16' ' ' ILE . 81.6 t80 61.47 163.94 0.08 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.444 0.64 . . . . 0.0 110.661 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.5 pt -70.86 -172.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.144 -0.973 . . . . 0.0 110.57 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -60.86 153.92 61.84 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.465 -0.772 . . . . 0.0 110.274 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.46 171.85 12.3 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.962 1.506 . . . . 0.0 111.842 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -74.33 167.53 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.644 0.735 . . . . 0.0 110.945 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.2 -61.33 0.47 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.7 m -66.42 -30.54 70.92 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.831 -0.805 . . . . 0.0 110.594 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.0 12.27 5.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.445 -0.785 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.9 t -139.57 63.04 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.322 -0.861 . . . . 0.0 108.862 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.6 m -49.83 -25.09 2.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.839 -0.538 . . . . 0.0 111.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -105.34 126.78 52.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 110.139 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.89 -28.29 8.98 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.9 pt -84.61 162.08 51.67 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.155 -1.203 . . . . 0.0 110.611 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -74.16 155.11 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.139 1.599 . . . . 0.0 111.011 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -58.36 -40.78 83.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.822 -0.549 . . . . 0.0 111.022 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -60.48 -45.98 91.77 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.45 -0.781 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.0 m -66.16 -41.83 89.79 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.24 92.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.758 -0.589 . . . . 0.0 109.904 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -60.8 -44.2 97.17 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.463 -0.773 . . . . 0.0 109.908 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.593 -0.692 . . . . 0.0 109.824 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 m -62.64 -35.15 78.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.685 -0.635 . . . . 0.0 110.555 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.6 t -78.98 -38.62 36.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.83 -38.73 83.58 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.608 -0.683 . . . . 0.0 111.175 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.59 -57.94 2.18 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.428 -0.795 . . . . 0.0 111.731 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.446 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 83.3 m-85 -84.02 -34.59 24.25 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.154 -0.966 . . . . 0.0 111.421 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.97 12.17 47.28 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.224 -0.989 . . . . 0.0 110.785 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -104.78 157.13 17.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.898 -1.354 . . . . 0.0 109.971 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.6 m 62.47 37.73 13.2 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-O 121.251 0.548 . . . . 0.0 110.126 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.0 m -80.86 -58.97 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.985 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -91.75 67.72 5.4 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.561 -0.712 . . . . 0.0 110.019 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.7 tp . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.446 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 120.993 0.425 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -152.34 76.37 1.16 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.542 -0.723 . . . . 0.0 110.201 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 m -139.35 147.22 41.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.465 -0.772 . . . . 0.0 110.304 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.41 66.56 0.28 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.9 t80 52.78 85.05 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.85 -0.794 . . . . 0.0 111.271 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 29.6 m -133.09 83.55 2.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.04 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 6' ' ' THR . 0.4 OUTLIER 67.29 131.18 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 122.069 -0.394 . . . . 0.0 110.899 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 7' ' ' ARG . 44.3 Cg_endo -71.34 146.42 50.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.604 1.318 . . . . 0.0 110.49 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -94.27 133.57 37.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.746 . . . . 0.0 110.914 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -147.41 109.41 4.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.449 -0.782 . . . . 0.0 109.844 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HG2' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -80.89 144.55 55.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.561 -0.712 . . . . 0.0 110.356 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.418 ' HD2' ' HG2' ' A' ' 11' ' ' LYS . 48.7 Cg_endo -75.68 -160.11 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 124.183 1.623 . . . . 0.0 110.424 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 m -54.18 146.93 14.0 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.427 -0.796 . . . . 0.0 110.61 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.77 124.85 84.87 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.501 -0.75 . . . . 0.0 110.274 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -77.38 173.69 13.89 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.024 1.539 . . . . 0.0 110.596 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.5 pt -61.1 161.0 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.692 -0.63 . . . . 0.0 110.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -141.66 164.44 30.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.278 -0.889 . . . . 0.0 110.706 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.5 pt -69.92 174.54 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.44 128.16 65.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.688 -0.633 . . . . 0.0 110.305 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.33 161.3 44.78 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 124.2 1.631 . . . . 0.0 110.915 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -78.28 166.71 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.681 0.753 . . . . 0.0 111.047 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 107.57 -62.34 0.3 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.5 m -67.24 -29.41 69.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.726 -0.867 . . . . 0.0 110.212 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.76 16.19 4.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.807 . . . . 0.0 110.537 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 27' ' ' TYR . 16.3 t -141.71 63.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.224 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.7 m -48.14 -25.87 1.65 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.761 -0.587 . . . . 0.0 111.1 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.464 ' O ' HG12 ' A' ' 25' ' ' VAL . 11.4 m-85 -106.5 126.29 52.08 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.39 -31.76 6.26 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.459 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.8 pt -80.76 162.8 58.91 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.307 -1.113 . . . . 0.0 110.21 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.7 Cg_endo -73.33 153.4 50.63 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.08 1.568 . . . . 0.0 111.134 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.69 -37.67 73.86 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.878 -0.514 . . . . 0.0 111.309 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -65.13 -44.67 87.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.39 -0.819 . . . . 0.0 110.163 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 54.2 m -64.81 -41.33 95.87 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.44 -0.788 . . . . 0.0 109.21 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.44 78.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.686 -0.634 . . . . 0.0 109.816 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.06 -41.19 91.1 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.452 -0.78 . . . . 0.0 109.09 178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -40.47 95.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -64.78 -40.46 95.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.688 -0.633 . . . . 0.0 109.769 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 30.9 t -72.52 -38.52 68.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.45 -0.781 . . . . 0.0 109.983 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -67.5 -38.14 83.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.7 -0.625 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -58.74 1.86 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.262 -0.899 . . . . 0.0 111.811 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -77.7 -39.67 43.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.261 -0.899 . . . . 0.0 111.169 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.03 14.0 32.34 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.02 159.11 18.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.061 -1.258 . . . . 0.0 110.205 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.3 m 62.44 39.73 11.62 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.364 0.602 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.4 m -82.84 -59.42 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -0.771 . . . . 0.0 109.831 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.67 84.35 7.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.531 -0.731 . . . . 0.0 109.622 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.614 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 36.8 t60 . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.9 0.381 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t 62.65 174.6 0.14 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.491 0.662 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -141.66 131.86 24.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.471 -0.768 . . . . 0.0 110.264 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.5 146.87 36.38 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 t80 67.86 142.34 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.925 -0.75 . . . . 0.0 111.002 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 m -74.39 114.24 12.54 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.345 -0.847 . . . . 0.0 109.798 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.95 67.35 3.28 Favored Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.832 -0.542 . . . . 0.0 110.258 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.38 148.24 38.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 124.062 1.559 . . . . 0.0 110.701 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.47 154.51 41.71 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.15 106.95 16.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.427 -0.796 . . . . 0.0 110.099 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 130.88 2.1 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.585 -0.697 . . . . 0.0 110.36 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.54 -160.95 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 123.97 1.511 . . . . 0.0 110.148 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.7 m -59.86 128.17 35.58 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -109.84 127.06 27.77 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.417 -0.802 . . . . 0.0 110.638 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.6 -178.03 3.47 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.915 1.481 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 pt -62.91 174.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 121.342 0.591 . . . . 0.0 110.728 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -52.05 153.67 2.58 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.639 -0.663 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 mt -60.5 139.06 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.629 -0.669 . . . . 0.0 110.677 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 136.27 19.64 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.681 -0.637 . . . . 0.0 110.729 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.18 174.94 9.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.015 1.534 . . . . 0.0 111.321 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.2 mt -78.25 167.77 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 121.475 0.655 . . . . 0.0 110.26 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 106.99 -61.23 0.32 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.4 m -67.78 -31.14 70.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.796 -0.826 . . . . 0.0 109.83 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -72.22 -0.49 12.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.66 -0.65 . . . . 0.0 111.48 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 27' ' ' TYR . 19.1 t -143.03 74.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.14 -0.975 . . . . 0.0 108.989 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.1 m -50.43 -23.1 2.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.765 -0.585 . . . . 0.0 111.339 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.549 ' O ' HG12 ' A' ' 25' ' ' VAL . 22.3 m-85 -104.96 128.13 53.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.839 . . . . 0.0 110.227 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -25.11 15.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.4 pt -79.55 162.09 64.57 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.153 -1.204 . . . . 0.0 110.908 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.53 156.65 49.6 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.206 1.635 . . . . 0.0 111.333 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -56.89 -40.97 77.21 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.958 -0.464 . . . . 0.0 111.31 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.2 t -63.35 -43.61 97.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.449 -0.782 . . . . 0.0 110.243 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 30.8 m -64.51 -41.15 96.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.42 -0.8 . . . . 0.0 109.111 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.75 79.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.712 -0.617 . . . . 0.0 110.294 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -64.71 -42.08 95.53 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.514 -0.741 . . . . 0.0 109.676 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.04 -37.22 78.47 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.635 -0.665 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -67.64 -31.53 71.6 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.557 -0.714 . . . . 0.0 110.269 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.9 t -86.85 -35.15 19.2 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -70.21 -40.58 74.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.602 -0.686 . . . . 0.0 111.363 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -53.42 3.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 111.844 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 94.5 m-85 -82.85 -36.03 25.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.277 -0.89 . . . . 0.0 111.304 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 12.17 48.58 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -104.98 158.86 16.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.051 -1.264 . . . . 0.0 109.764 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 m 61.99 39.1 13.71 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.76 -0.588 . . . . 0.0 109.936 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.5 m -88.86 -59.91 2.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.429 -0.794 . . . . 0.0 109.949 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -99.07 66.59 1.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.586 -0.696 . . . . 0.0 109.88 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 27' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.429 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.981 0.42 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -104.61 107.22 18.05 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.412 -0.805 . . . . 0.0 109.986 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -127.94 74.65 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.459 -0.776 . . . . 0.0 110.187 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.11 169.22 39.09 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -132.24 135.41 46.27 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.44 -1.035 . . . . 0.0 109.987 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 6' ' ' THR . 11.4 t -106.49 54.23 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.42 -0.8 . . . . 0.0 110.647 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' THR . 4.7 ttp180 62.97 121.52 0.02 OUTLIER Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.992 -0.442 . . . . 0.0 111.147 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 47.8 Cg_endo -76.84 163.49 31.22 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.457 1.241 . . . . 0.0 110.803 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.45 109.01 7.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.593 -0.692 . . . . 0.0 109.922 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 4.5 tpt180 60.19 92.33 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.366 0.603 . . . . 0.0 110.333 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 8' ' ' PRO . 15.6 mtpp -64.47 111.6 5.98 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.667 -0.645 . . . . 0.0 110.957 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 10' ' ' ARG . 53.7 Cg_endo -79.06 -159.31 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 124.024 1.539 . . . . 0.0 110.224 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.5 p -68.73 175.24 3.67 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.289 -0.882 . . . . 0.0 110.034 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -48.16 108.69 0.96 Allowed Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.549 -0.719 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -84.7 157.23 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.683 1.359 . . . . 0.0 110.866 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 pt -69.8 158.57 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.627 -0.671 . . . . 0.0 109.677 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -126.57 140.15 52.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.259 -0.9 . . . . 0.0 110.996 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.544 HD12 HH11 ' A' ' 19' ' ' ARG . 44.5 pt -97.01 -177.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.868 -0.52 . . . . 0.0 109.743 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.544 HH11 HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -53.32 139.55 46.7 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.418 -0.801 . . . . 0.0 110.048 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.8 172.71 12.17 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.995 1.523 . . . . 0.0 111.256 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.2 mt -77.16 167.84 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.435 0.636 . . . . 0.0 110.123 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 107.38 -62.11 0.3 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 m -66.55 -28.98 68.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.788 -0.83 . . . . 0.0 109.813 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.24 3.09 9.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.6 -0.688 . . . . 0.0 111.346 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 27' ' ' TYR . 7.8 t -142.63 71.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.077 -1.014 . . . . 0.0 109.216 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.8 m -51.34 -22.68 3.03 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.706 -0.621 . . . . 0.0 111.472 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.445 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.4 m-85 -105.97 128.71 53.99 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.233 -0.917 . . . . 0.0 110.313 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.41 -27.46 9.98 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.0 pt -84.41 161.93 52.68 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.142 -1.211 . . . . 0.0 110.769 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.0 156.36 47.6 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.103 1.58 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.0 t -58.82 -40.54 84.44 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.804 -0.56 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -60.14 -46.01 91.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.41 -0.806 . . . . 0.0 109.871 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 98.4 m -68.96 -40.36 78.92 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.31 -38.89 92.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.777 -0.577 . . . . 0.0 110.204 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -64.47 -42.03 96.14 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.405 -0.809 . . . . 0.0 109.374 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.93 -39.5 93.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.682 -0.637 . . . . 0.0 109.619 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -63.44 -29.94 71.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.785 -0.572 . . . . 0.0 110.263 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.0 t -86.18 -37.7 18.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 0.0 109.562 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -67.17 -38.69 85.87 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.816 -0.553 . . . . 0.0 111.191 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -100.2 -55.07 2.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -0.851 . . . . 0.0 112.036 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 91.2 m-85 -82.64 -36.18 26.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.102 -0.998 . . . . 0.0 111.13 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.96 11.18 43.91 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -105.21 158.31 16.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.012 -1.287 . . . . 0.0 109.959 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.0 m 61.95 39.18 13.75 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.4 m -84.58 -59.49 2.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.44 -0.787 . . . . 0.0 109.927 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -94.58 87.4 5.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.677 -0.64 . . . . 0.0 109.885 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.25 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 120.81 0.338 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 m 57.42 76.9 0.3 Allowed 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.385 0.612 . . . . 0.0 110.479 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 p -66.58 142.53 57.46 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 0.0 110.268 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.3 -67.18 1.01 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 66.89 114.51 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 122.005 -0.703 . . . . 0.0 111.049 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 90.3 m -90.42 132.39 35.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.278 -0.889 . . . . 0.0 110.18 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 144.21 68.13 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.538 -0.726 . . . . 0.0 110.076 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.19 145.13 30.45 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.909 1.478 . . . . 0.0 110.688 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mp -75.71 170.49 16.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.606 -0.683 . . . . 0.0 110.435 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.21 114.87 2.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 0.0 110.501 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.24 120.97 63.24 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.583 -0.698 . . . . 0.0 110.566 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.73 -162.21 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.212 0 O-C-N 124.04 1.548 . . . . 0.0 110.801 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -97.58 61.5 1.63 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.379 -0.826 . . . . 0.0 110.281 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' HG3' ' HD2' ' A' ' 15' ' ' PRO . 9.4 tpt180 67.44 136.33 0.05 OUTLIER Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.925 -0.485 . . . . 0.0 111.321 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 14' ' ' ARG . 49.1 Cg_endo -74.54 171.35 18.32 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 O-C-N 123.64 1.337 . . . . 0.0 110.886 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.94 159.54 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.784 -0.572 . . . . 0.0 110.352 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -61.78 179.07 0.28 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.626 -0.671 . . . . 0.0 111.056 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 mt -46.82 137.09 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.381 0.61 . . . . 0.0 111.059 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 120.38 78.2 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.764 -0.585 . . . . 0.0 110.221 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.94 161.76 43.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.202 1.632 . . . . 0.0 110.704 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.5 mt -75.0 163.16 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.13 -61.94 0.3 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 7.7 m -65.84 -30.58 71.22 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.702 -0.881 . . . . 0.0 110.712 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.47 13.55 4.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.435 -0.79 . . . . 0.0 110.687 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 27' ' ' TYR . 14.0 t -141.67 63.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 108.879 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' HB3' HD13 ' A' ' 47' ' ' LEU . 57.5 m -49.99 -25.14 3.06 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.795 -0.566 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' VAL . 64.0 m-85 -105.78 129.35 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.73 -30.42 7.49 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 37.3 pt -84.97 162.38 49.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.22 -1.165 . . . . 0.0 110.451 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.92 154.3 48.01 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.109 1.584 . . . . 0.0 110.887 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.7 t -58.3 -39.29 78.94 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.827 -0.545 . . . . 0.0 111.084 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.39 -46.62 89.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.395 -0.816 . . . . 0.0 109.84 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 86.0 m -66.85 -40.59 87.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.443 -0.786 . . . . 0.0 108.974 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.99 96.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.788 -0.57 . . . . 0.0 110.073 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 45.5 mtt-85 -62.42 -42.73 99.66 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 0.0 109.746 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.13 -39.79 95.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.522 -0.736 . . . . 0.0 109.442 178.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -34.73 76.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.801 -0.562 . . . . 0.0 110.265 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.8 t -76.24 -38.35 56.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.423 -0.798 . . . . 0.0 110.163 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.502 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 13.8 t80 -67.11 -38.18 85.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 111.361 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 6.1 mmm180 -98.95 -57.06 2.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.228 -0.92 . . . . 0.0 111.75 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CD1' ' SG ' ' A' ' 23' ' ' CYS . 83.0 m-85 -81.5 -36.86 28.74 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.933 . . . . 0.0 111.208 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.01 12.11 47.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.11 155.78 18.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -1.207 . . . . 0.0 109.892 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.4 m 62.17 42.0 10.08 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.345 0.593 . . . . 0.0 109.773 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.4 m -84.86 -56.51 3.54 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 110.431 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -96.43 54.81 1.41 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.717 -0.614 . . . . 0.0 110.791 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' A' ' 26' ' ' CYS . 3.5 tp . . . . . 0 N--CA 1.499 1.975 0 O-C-N 121.262 -0.899 . . . . 0.0 110.534 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.075 0.464 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.74 112.48 25.49 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.427 -0.795 . . . . 0.0 110.265 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -133.33 111.87 11.16 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.289 -0.882 . . . . 0.0 110.219 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.94 -47.85 81.82 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.25 138.02 31.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.43 -1.041 . . . . 0.0 110.115 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 m -98.36 161.16 13.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.716 . . . . 0.0 110.096 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.87 76.0 54.05 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.437 -0.789 . . . . 0.0 110.546 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.65 137.95 25.82 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.793 1.417 . . . . 0.0 110.37 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp 56.01 64.94 1.57 Allowed 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.565 0.698 . . . . 0.0 110.136 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.4 118.75 9.17 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.643 -0.66 . . . . 0.0 110.337 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 tptm 57.89 80.19 0.29 Allowed Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.849 -0.532 . . . . 0.0 110.65 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.9 -161.99 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.837 1.44 . . . . 0.0 110.623 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -97.77 36.22 1.56 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.173 -0.954 . . . . 0.0 111.036 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.4 ttm180 64.13 142.81 0.07 OUTLIER Pre-proline 0 N--CA 1.505 2.319 0 O-C-N 121.909 -0.495 . . . . 0.0 111.661 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 14' ' ' ARG . 46.8 Cg_endo -74.11 175.68 10.57 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.716 1.377 . . . . 0.0 110.22 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 pt -52.35 135.55 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 121.347 0.594 . . . . 0.0 110.458 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -156.11 165.13 37.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.472 -0.768 . . . . 0.0 110.556 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.43 -171.53 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.647 -0.658 . . . . 0.0 110.239 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.81 122.8 7.41 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.741 -0.6 . . . . 0.0 110.596 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.86 169.88 19.24 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 124.296 1.682 . . . . 0.0 111.289 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.9 mm -78.53 166.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.676 0.751 . . . . 0.0 111.095 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.44 -63.61 0.29 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 1.6 m -71.21 -28.93 64.56 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.765 -0.844 . . . . 0.0 110.465 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.45 14.28 4.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.303 -0.873 . . . . 0.0 110.55 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 27' ' ' TYR . 23.3 t -139.33 65.09 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 108.702 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.402 ' HB3' HD13 ' A' ' 47' ' ' LEU . 90.2 m -47.95 -24.17 0.98 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.903 -0.498 . . . . 0.0 111.551 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 25' ' ' VAL . 25.6 m-85 -102.82 127.08 50.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.139 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.91 -26.1 13.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.46 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 35.9 pt -87.63 162.68 41.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.193 -1.181 . . . . 0.0 110.62 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.8 Cg_endo -74.55 154.66 44.97 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.152 1.606 . . . . 0.0 111.182 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 t -59.28 -39.37 82.71 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.813 -0.555 . . . . 0.0 110.914 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 t -59.3 -46.5 88.38 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.395 -0.816 . . . . 0.0 109.744 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 90.6 m -68.38 -41.15 80.99 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.45 88.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.732 -0.605 . . . . 0.0 110.176 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -65.75 -43.87 87.61 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.341 -0.849 . . . . 0.0 109.392 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -36.45 80.71 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.554 -0.716 . . . . 0.0 109.373 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -60.84 -31.08 70.52 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.82 -0.55 . . . . 0.0 110.465 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.5 t -84.35 -37.33 21.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.14 -0.975 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -68.91 -38.97 79.92 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 0.0 111.234 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 -56.91 2.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.309 -0.869 . . . . 0.0 111.836 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' CD2' ' SG ' ' A' ' 23' ' ' CYS . 63.5 m-85 -80.19 -37.8 32.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.219 -0.926 . . . . 0.0 111.234 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.36 12.29 42.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -104.2 157.44 17.12 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.143 -1.21 . . . . 0.0 109.585 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 11.2 m 62.05 40.21 12.33 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.713 -0.617 . . . . 0.0 109.676 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.6 m -90.29 -59.34 2.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.538 -0.726 . . . . 0.0 110.426 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -86.19 51.73 2.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.578 -0.701 . . . . 0.0 110.583 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.402 HD13 ' HB3' ' A' ' 26' ' ' CYS . 3.0 tt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.306 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.039 0.447 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.45 164.53 32.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.485 -0.759 . . . . 0.0 110.473 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t 56.44 77.86 0.23 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.275 0.56 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.08 51.69 4.58 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -171.61 153.54 3.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.652 -0.91 . . . . 0.0 110.028 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.24 164.32 0.11 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.517 0.675 . . . . 0.0 110.986 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.452 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -82.8 137.42 43.95 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.31 -0.869 . . . . 0.0 110.12 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.452 ' HD2' ' HD3' ' A' ' 7' ' ' ARG . 48.1 Cg_endo -74.61 152.02 42.34 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 124.021 1.537 . . . . 0.0 110.755 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mp -76.99 175.4 9.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.647 -0.658 . . . . 0.0 110.571 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.8 ttm-85 -68.31 92.53 0.42 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.627 -0.671 . . . . 0.0 110.365 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.99 86.46 3.43 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.567 -0.708 . . . . 0.0 109.969 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.17 -163.39 0.21 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.893 1.47 . . . . 0.0 110.74 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.4 m -77.53 166.37 23.15 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.385 -0.822 . . . . 0.0 110.521 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 148.83 60.34 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.493 -0.754 . . . . 0.0 110.456 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.4 153.55 65.88 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.861 1.453 . . . . 0.0 111.084 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pt -90.98 172.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.763 -0.585 . . . . 0.0 110.507 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -124.53 140.16 53.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.55 -0.719 . . . . 0.0 110.259 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -133.58 -179.47 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.502 -0.749 . . . . 0.0 110.53 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.64 ' HD3' ' HD2' ' A' ' 20' ' ' PRO . 1.1 tpp85 -61.08 126.39 85.86 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.632 -0.668 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.64 ' HD2' ' HD3' ' A' ' 19' ' ' ARG . 40.7 Cg_endo -70.92 166.22 29.75 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 124.161 1.611 . . . . 0.0 111.026 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 4.5 mm -80.53 167.26 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 121.71 0.767 . . . . 0.0 111.2 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.06 -61.53 0.34 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.7 m -66.51 -29.17 69.21 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.689 -0.889 . . . . 0.0 110.684 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.38 15.16 4.61 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.225 -0.922 . . . . 0.0 110.497 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.9 t -138.46 62.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.918 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.726 ' HB3' HD21 ' A' ' 47' ' ' LEU . 70.1 m -48.71 -24.72 1.48 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.851 -0.531 . . . . 0.0 111.357 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 47' ' ' LEU . 46.8 m-85 -105.65 126.93 52.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.384 -0.822 . . . . 0.0 109.955 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.08 -28.84 8.89 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 40.0 pt -83.31 161.63 56.5 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.198 -1.177 . . . . 0.0 110.532 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.442 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.8 Cg_endo -74.02 153.66 47.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.186 1.624 . . . . 0.0 111.315 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 t -56.06 -40.96 74.34 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.952 -0.467 . . . . 0.0 111.112 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -61.96 -45.7 92.49 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.523 -0.736 . . . . 0.0 110.246 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 85.7 m -67.52 -41.38 84.5 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.327 -0.858 . . . . 0.0 108.731 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.6 91.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.732 -0.605 . . . . 0.0 110.037 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -62.63 -44.75 95.5 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.461 -0.774 . . . . 0.0 109.473 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -37.54 87.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.763 -0.585 . . . . 0.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -64.01 -32.55 74.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.771 -0.58 . . . . 0.0 110.558 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.5 t -81.9 -37.83 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.195 -0.941 . . . . 0.0 109.947 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.77 -37.77 85.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.695 -0.628 . . . . 0.0 111.325 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -101.78 -58.41 1.89 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.234 -0.916 . . . . 0.0 111.638 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 76.4 m-85 -77.01 -38.45 53.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.157 -0.964 . . . . 0.0 111.16 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 11.51 42.95 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.614 -0.995 . . . . 0.0 110.614 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -107.15 157.15 18.09 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.009 -1.289 . . . . 0.0 109.934 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.548 ' HA ' HD23 ' A' ' 47' ' ' LEU . 10.7 m 62.1 42.81 9.38 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-O 121.443 0.639 . . . . 0.0 109.705 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.6 m -86.45 -58.5 2.59 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.544 -0.722 . . . . 0.0 110.128 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -95.73 64.27 2.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.627 -0.671 . . . . 0.0 110.292 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' A' ' 26' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.437 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.178 0.514 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 t -65.95 153.91 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.489 -0.757 . . . . 0.0 110.046 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.65 135.17 51.03 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.421 -0.799 . . . . 0.0 110.485 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.11 94.0 0.89 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -68.18 152.08 46.01 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.534 -0.98 . . . . 0.0 110.762 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m -79.66 128.32 33.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.675 -0.641 . . . . 0.0 110.135 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.48 115.47 10.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.71 -0.618 . . . . 0.0 110.638 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.0 149.27 41.46 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.724 1.381 . . . . 0.0 110.711 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.36 168.39 19.06 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.558 -0.714 . . . . 0.0 110.405 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 65.8 160.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.502 0.668 . . . . 0.0 110.807 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.58 148.32 56.57 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.351 -0.843 . . . . 0.0 110.64 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.37 -160.23 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.993 1.522 . . . . 0.0 110.642 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.6 m -67.2 166.42 14.13 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.354 -0.841 . . . . 0.0 110.835 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.92 153.86 52.07 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.603 -0.686 . . . . 0.0 110.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.15 152.28 61.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.81 1.426 . . . . 0.0 111.023 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.3 pt -137.47 178.64 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.637 . . . . 0.0 110.427 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -65.07 173.54 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.29 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.8 pt -67.04 169.88 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.553 -0.717 . . . . 0.0 110.635 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.57 151.95 69.14 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 0.0 110.245 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.19 167.83 22.56 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.056 1.556 . . . . 0.0 111.372 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 22' ' ' GLY . 3.3 mt -81.63 166.24 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.526 0.679 . . . . 0.0 110.93 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 105.63 -61.07 0.37 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.5 m -66.02 -29.2 69.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.752 -0.852 . . . . 0.0 110.8 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.58 11.6 6.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.319 -0.863 . . . . 0.0 110.739 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.02 63.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.85 . . . . 0.0 108.745 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.596 ' HB3' HD11 ' A' ' 47' ' ' LEU . 57.7 m -49.8 -23.06 1.66 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.891 -0.506 . . . . 0.0 111.796 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -105.81 126.48 52.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.306 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.95 -24.75 14.06 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.373 -0.917 . . . . 0.0 110.853 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 33.2 pt -86.17 160.07 52.54 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.031 -1.276 . . . . 0.0 110.924 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.3 Cg_endo -74.34 157.82 45.18 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.214 1.639 . . . . 0.0 111.24 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.5 t -59.43 -40.28 86.21 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.734 -0.604 . . . . 0.0 110.94 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -59.65 -44.86 93.38 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.399 -0.813 . . . . 0.0 109.697 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.433 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 82.1 m -68.43 -41.04 80.9 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.34 90.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.713 -0.617 . . . . 0.0 109.793 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.54 -45.5 93.92 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.503 -0.748 . . . . 0.0 109.305 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -36.25 82.23 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 109.833 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -68.06 -37.39 81.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 109.988 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 32.6 t -80.33 -33.85 37.12 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 0.0 110.049 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 35' ' ' ARG . 28.1 t80 -70.85 -41.43 71.46 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.665 -0.647 . . . . 0.0 111.528 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -52.93 3.49 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.355 -0.841 . . . . 0.0 111.821 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 90.6 m-85 -82.37 -37.1 26.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.175 -0.953 . . . . 0.0 111.14 -178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.39 14.04 42.82 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -106.87 156.24 18.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.246 . . . . 0.0 109.845 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 m 63.09 41.5 8.1 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.426 0.632 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -89.5 -61.91 1.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.521 -0.737 . . . . 0.0 109.74 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -92.62 76.27 5.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.705 -0.622 . . . . 0.0 109.91 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.523 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 29.9 p80 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.106 0.479 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -78.73 139.73 38.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.465 -0.772 . . . . 0.0 109.919 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 124.77 49.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.46 -0.775 . . . . 0.0 110.278 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.3 -100.61 0.15 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.6 t80 63.93 101.88 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.909 -0.759 . . . . 0.0 111.029 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -68.56 103.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.433 -0.792 . . . . 0.0 110.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -79.68 140.71 55.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.512 -0.743 . . . . 0.0 110.42 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.44 143.88 35.44 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.881 1.464 . . . . 0.0 110.805 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.28 123.37 22.11 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.331 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.5 ttp85 -131.89 139.92 48.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.743 . . . . 0.0 110.315 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -73.27 142.53 82.02 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.508 -0.745 . . . . 0.0 110.655 -179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.45 -163.47 0.21 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 124.016 1.535 . . . . 0.0 110.567 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.05 46.1 2.11 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.415 -0.803 . . . . 0.0 110.078 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -76.72 159.55 78.84 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.449 -0.782 . . . . 0.0 110.539 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.33 168.87 23.79 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 O-C-N 124.09 1.574 . . . . 0.0 110.939 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mt -57.79 146.09 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.792 -0.568 . . . . 0.0 110.461 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.33 162.05 30.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.508 -0.745 . . . . 0.0 110.513 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.8 pt -77.15 -173.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.699 -0.626 . . . . 0.0 110.535 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 117.15 9.33 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.746 -0.597 . . . . 0.0 110.196 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.79 169.41 22.09 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 124.314 1.692 . . . . 0.0 111.412 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -78.41 166.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 121.516 0.674 . . . . 0.0 110.81 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 108.27 -59.4 0.37 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 34.1 m -75.87 -16.37 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.747 -0.855 . . . . 0.0 110.293 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.94 -4.28 43.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.455 -0.778 . . . . 0.0 111.669 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.7 t -143.71 74.6 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.312 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.52 ' HB3' HD11 ' A' ' 47' ' ' LEU . 16.5 m -48.47 -26.91 2.35 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.921 -0.487 . . . . 0.0 111.281 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.613 ' O ' HG12 ' A' ' 25' ' ' VAL . 98.2 m-85 -107.57 129.26 55.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.925 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.81 -28.97 8.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.472 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 45.0 pt -80.06 163.03 59.77 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.214 -1.168 . . . . 0.0 110.498 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.45 155.64 50.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.118 1.589 . . . . 0.0 111.144 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 t -58.54 -39.29 79.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 111.033 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 t -61.18 -46.42 90.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.426 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.6 m -67.19 -41.39 85.95 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.69 87.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.706 -0.621 . . . . 0.0 110.129 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -64.23 -44.07 92.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.542 -0.723 . . . . 0.0 109.579 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -67.12 -37.25 83.54 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 0.0 109.888 179.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.2 m -65.9 -30.22 70.77 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.511 -0.743 . . . . 0.0 110.48 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.1 t -87.98 -36.44 17.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.134 -0.979 . . . . 0.0 109.982 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.81 -38.01 70.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 111.329 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -100.21 -55.36 2.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.279 -0.888 . . . . 0.0 111.601 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.3 m-85 -79.16 -37.76 37.66 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.183 -0.948 . . . . 0.0 110.932 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.52 12.11 42.4 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -109.07 160.0 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.064 -1.257 . . . . 0.0 110.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.6 m 62.96 40.88 8.96 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.722 -0.611 . . . . 0.0 109.761 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.66 -60.81 1.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.516 -0.74 . . . . 0.0 109.906 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -90.3 71.26 7.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.603 -0.686 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 26' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.499 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.029 0.442 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.51 148.09 42.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.503 -0.748 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.33 92.73 3.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.507 -0.746 . . . . 0.0 109.957 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.49 -156.59 27.04 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.38 151.5 21.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.438 -1.036 . . . . 0.0 110.593 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.3 m -119.73 135.95 54.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.173 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.41 148.29 66.15 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.536 -0.727 . . . . 0.0 110.24 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.42 160.12 49.51 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.917 1.483 . . . . 0.0 110.797 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.29 148.23 52.06 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.684 -0.635 . . . . 0.0 110.291 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.4 107.6 1.14 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.424 -0.797 . . . . 0.0 110.272 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.85 139.71 36.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 110.303 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.81 -161.85 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.978 1.515 . . . . 0.0 110.337 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t 51.77 52.82 13.77 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.53 -0.731 . . . . 0.0 110.445 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -89.12 164.65 29.94 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.576 -0.702 . . . . 0.0 110.762 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.65 -179.12 4.22 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 124.08 1.568 . . . . 0.0 111.09 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 pt -62.25 176.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.401 0.62 . . . . 0.0 110.901 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -57.37 152.69 13.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.595 -0.691 . . . . 0.0 110.809 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.465 HD12 ' HD3' ' A' ' 19' ' ' ARG . 11.4 pt -90.61 -172.54 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.662 -0.649 . . . . 0.0 110.61 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HD3' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -51.74 145.4 16.34 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.788 -0.57 . . . . 0.0 110.871 -179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.33 173.1 11.07 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 124.086 1.572 . . . . 0.0 112.194 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.6 mm -77.54 169.26 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.627 0.727 . . . . 0.0 111.045 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 102.3 -62.1 0.5 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.1 m -68.11 -30.12 69.21 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.834 -0.803 . . . . 0.0 110.244 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.57 13.3 4.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.36 -0.838 . . . . 0.0 110.573 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.0 t -139.81 64.15 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.226 -0.921 . . . . 0.0 109.174 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.7 m -49.34 -24.24 1.8 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.769 -0.582 . . . . 0.0 111.217 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 25' ' ' VAL . 21.2 m-85 -105.36 126.78 52.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.342 -0.849 . . . . 0.0 110.033 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.18 8.44 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 38.3 pt -83.52 162.56 53.0 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.233 -1.157 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 37.9 Cg_endo -73.57 154.59 49.96 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.123 1.591 . . . . 0.0 111.308 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -57.95 -38.73 76.52 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.924 -0.485 . . . . 0.0 111.264 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 t -63.9 -44.99 91.3 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.389 -0.82 . . . . 0.0 110.011 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 70.0 m -65.89 -41.63 91.29 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.31 -0.869 . . . . 0.0 109.056 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.83 84.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.713 -0.617 . . . . 0.0 110.34 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.72 -46.19 86.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.45 -0.781 . . . . 0.0 109.584 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.48 -37.87 89.05 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.691 -0.631 . . . . 0.0 109.924 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.56 -31.5 72.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.672 -0.643 . . . . 0.0 110.409 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.6 t -83.36 -36.63 24.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.033 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -69.38 -37.59 77.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.656 -0.653 . . . . 0.0 111.144 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -99.77 -59.75 1.66 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.355 -0.84 . . . . 0.0 111.605 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 63.8 m-85 -76.74 -39.21 52.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.901 . . . . 0.0 111.112 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.62 12.2 35.95 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 9.1 m-20 -108.24 159.03 16.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.064 -1.256 . . . . 0.0 110.128 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.7 m 62.55 42.03 9.01 Favored 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 121.471 0.653 . . . . 0.0 109.543 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -89.42 -61.21 1.75 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.566 -0.709 . . . . 0.0 110.056 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -90.14 76.38 6.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.645 -0.659 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.343 -179.909 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.028 0.442 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -115.46 133.85 55.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.478 -0.764 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 56.65 75.17 0.37 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 74.67 2.35 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.23 149.61 38.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.464 -1.021 . . . . 0.0 110.437 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 6' ' ' THR . 6.7 t -92.53 89.12 6.6 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.563 -0.711 . . . . 0.0 110.366 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -158.18 130.36 4.18 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 110.406 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.53 135.14 17.76 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.893 1.47 . . . . 0.0 110.565 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.8 mt -86.47 153.63 21.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.414 -0.804 . . . . 0.0 110.304 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -59.35 139.8 56.69 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.501 -0.749 . . . . 0.0 110.647 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 tttt 50.53 69.2 2.75 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.767 -0.583 . . . . 0.0 110.696 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.78 -168.53 0.64 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.741 1.39 . . . . 0.0 110.667 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.8 m -118.68 57.39 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 110.199 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -89.79 119.69 69.44 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.482 -0.761 . . . . 0.0 110.123 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.13 173.72 13.65 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 O-C-N 124.007 1.53 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.9 pt -50.38 133.87 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-O 121.364 0.602 . . . . 0.0 110.529 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -148.1 176.42 10.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.512 -0.742 . . . . 0.0 110.634 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.3 pt -69.27 174.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.664 -0.648 . . . . 0.0 110.301 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.63 114.13 5.31 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.722 -0.611 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.21 171.29 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 124.308 1.688 . . . . 0.0 111.171 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.4 mm -81.19 167.78 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.49 0.662 . . . . 0.0 110.797 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 106.62 -56.45 0.5 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.3 m -79.2 -13.44 59.7 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.815 -0.814 . . . . 0.0 110.52 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.26 -0.82 38.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.438 -0.789 . . . . 0.0 111.515 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 27' ' ' TYR . 13.2 t -143.69 72.83 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.104 -0.998 . . . . 0.0 109.463 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.649 ' HB3' HD11 ' A' ' 47' ' ' LEU . 20.9 m -50.04 -24.91 2.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.869 -0.52 . . . . 0.0 111.112 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 25' ' ' VAL . 10.4 m-85 -107.53 126.7 52.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.403 -0.811 . . . . 0.0 110.033 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.76 -27.77 9.5 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 42.2 pt -80.27 162.7 60.46 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.197 -1.178 . . . . 0.0 110.445 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.8 Cg_endo -73.61 155.19 49.91 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 124.053 1.554 . . . . 0.0 111.201 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 t -57.94 -39.99 79.41 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.787 -0.571 . . . . 0.0 110.863 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -60.15 -47.41 86.03 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.46 -0.775 . . . . 0.0 109.876 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.7 m -67.86 -40.43 83.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 0.0 109.042 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.81 -38.04 89.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 110.095 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.16 -42.95 93.24 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.4 -0.813 . . . . 0.0 109.412 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.1 -39.29 86.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.651 . . . . 0.0 109.817 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -64.19 -28.83 70.02 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.58 -0.7 . . . . 0.0 110.069 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.9 t -88.18 -37.07 16.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.178 -0.951 . . . . 0.0 109.847 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.77 -39.26 70.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.663 . . . . 0.0 111.276 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -52.27 3.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 111.749 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 82.1 m-85 -82.96 -38.22 23.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.132 -0.98 . . . . 0.0 110.968 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 11.7 39.12 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.97 160.74 15.77 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.024 -1.28 . . . . 0.0 110.127 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.1 m 62.41 39.74 11.73 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.387 0.613 . . . . 0.0 109.704 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 63.4 m -90.41 -62.12 1.53 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.422 -0.799 . . . . 0.0 110.141 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -92.78 65.49 4.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.562 -0.712 . . . . 0.0 109.944 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.649 HD11 ' HB3' ' A' ' 26' ' ' CYS . 1.1 tp . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.616 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 2' ' ' SER . 77.1 m-70 . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.841 0.353 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 1' ' ' HIS . 44.6 m 61.42 172.97 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 121.511 0.672 . . . . 0.0 111.136 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 p -154.9 153.27 30.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.345 -0.847 . . . . 0.0 110.433 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.54 -136.18 3.76 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 t80 54.61 78.35 0.17 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.759 -0.847 . . . . 0.0 110.706 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 m -85.43 77.89 9.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.45 -0.781 . . . . 0.0 110.073 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.07 71.4 7.83 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.402 -0.811 . . . . 0.0 110.297 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.83 131.68 14.78 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.984 1.518 . . . . 0.0 110.633 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.96 94.87 4.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 110.475 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.8 111.4 7.9 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.381 -0.824 . . . . 0.0 110.137 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.22 125.99 8.89 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 110.398 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.4 -171.82 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.893 1.47 . . . . 0.0 110.276 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t 52.06 52.18 14.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.513 0.673 . . . . 0.0 110.246 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -73.39 154.58 89.99 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.541 -0.725 . . . . 0.0 110.746 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.63 -176.2 2.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 124.036 1.546 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 pt -56.13 167.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.312 0.577 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -56.38 156.06 6.34 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.536 -0.727 . . . . 0.0 111.218 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 18' ' ' ILE . 23.3 pt -88.19 62.72 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.791 0.805 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.62 151.81 38.77 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.531 -0.73 . . . . 0.0 110.587 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.26 165.13 31.46 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 124.02 1.537 . . . . 0.0 111.382 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 2.5 mm -78.96 168.37 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.661 0.743 . . . . 0.0 111.193 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 103.29 -60.66 0.48 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -66.3 -29.94 70.26 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.774 -0.839 . . . . 0.0 111.049 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.32 13.24 6.77 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.311 -0.868 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.26 61.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 109.195 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 89.7 m -48.8 -25.5 1.89 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.764 -0.585 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -105.03 124.94 50.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.883 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.1 -29.44 7.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.456 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.1 pt -84.26 161.96 52.97 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.205 -1.174 . . . . 0.0 110.514 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -73.82 154.78 48.8 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.157 1.609 . . . . 0.0 111.122 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 t -58.78 -38.51 78.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.901 -0.499 . . . . 0.0 111.169 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -62.78 -45.62 91.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.32 -0.863 . . . . 0.0 109.846 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 84.5 m -67.55 -41.23 84.6 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.2 -40.85 97.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.574 . . . . 0.0 109.905 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -61.78 -43.42 98.89 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.475 -0.765 . . . . 0.0 109.683 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.7 tt -64.32 -39.39 93.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.676 -0.64 . . . . 0.0 109.78 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.99 -31.12 72.18 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.741 -0.599 . . . . 0.0 110.597 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 20.2 t -82.52 -38.6 23.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 109.914 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 40' ' ' ARG . 9.8 t80 -68.67 -35.83 77.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.673 -0.642 . . . . 0.0 111.219 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -100.92 -58.01 1.98 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.177 -0.952 . . . . 0.0 111.597 -178.587 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.2 m-85 -79.46 -38.36 34.75 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.217 -0.927 . . . . 0.0 111.074 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.19 11.43 39.31 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -108.65 158.14 17.87 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.112 -1.229 . . . . 0.0 110.074 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.8 m 62.21 42.93 8.98 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.464 0.649 . . . . 0.0 109.596 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.0 m -87.22 -58.34 2.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.504 -0.747 . . . . 0.0 110.159 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -123.46 109.06 13.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.646 -0.658 . . . . 0.0 110.198 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.331 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 120.958 0.409 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.94 177.4 0.15 Allowed 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.425 0.631 . . . . 0.0 110.818 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.28 130.12 8.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.497 -0.752 . . . . 0.0 110.241 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.71 178.21 15.22 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -140.93 129.25 22.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.462 -1.022 . . . . 0.0 110.279 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.6 m -145.77 149.13 33.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.437 -0.79 . . . . 0.0 110.188 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.9 mtm180 -143.26 152.56 57.92 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.775 . . . . 0.0 110.314 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.52 148.32 42.35 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.875 1.461 . . . . 0.0 110.656 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.72 91.78 6.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.588 -0.695 . . . . 0.0 110.093 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.86 165.66 31.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.399 -0.813 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -57.89 115.0 9.65 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.72 -0.612 . . . . 0.0 110.271 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.1 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 124.021 1.537 . . . . 0.0 110.749 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -65.09 173.52 2.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.476 -0.765 . . . . 0.0 110.827 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.4 mtt-85 -56.11 163.95 2.06 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.531 -0.731 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.88 158.41 56.89 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.962 1.506 . . . . 0.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.3 -170.3 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.448 0.642 . . . . 0.0 110.992 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -65.33 -175.41 0.24 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.465 0.65 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 18' ' ' ILE . 4.3 mm -54.4 165.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-O 121.587 0.708 . . . . 0.0 111.286 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 1.6 tmm_? -46.38 124.5 7.32 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 122.0 -0.437 . . . . 0.0 111.299 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.51 166.16 30.63 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 124.244 1.655 . . . . 0.0 110.565 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 22' ' ' GLY . 2.8 mp -83.24 165.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.535 0.683 . . . . 0.0 111.231 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 21' ' ' ILE . . . 106.3 -62.08 0.33 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.427 ' SG ' ' CD1' ' A' ' 41' ' ' TYR . 2.6 m -67.72 -30.23 69.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.659 -0.906 . . . . 0.0 111.114 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' HD3' ' A' ' 19' ' ' ARG . 2.1 t70 -85.43 14.05 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.312 -0.868 . . . . 0.0 110.521 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 27' ' ' TYR . 17.9 t -138.9 63.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.853 . . . . 0.0 109.02 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 92.3 m -49.07 -24.16 1.49 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.76 -0.588 . . . . 0.0 111.3 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' HG12 ' A' ' 25' ' ' VAL . 38.6 m-85 -104.38 128.86 52.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.117 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.22 -28.54 9.6 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 34.6 pt -87.18 162.09 44.42 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.197 -1.178 . . . . 0.0 110.511 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HG2' ' OG1' ' A' ' 33' ' ' THR . 38.2 Cg_endo -74.35 154.64 46.0 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.187 1.625 . . . . 0.0 111.09 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 t -58.71 -39.74 81.65 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.775 -0.578 . . . . 0.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 t -60.61 -44.76 95.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.349 -0.844 . . . . 0.0 109.778 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 79.6 m -67.89 -41.52 82.62 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.74 -37.73 87.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.826 -0.546 . . . . 0.0 110.168 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -44.94 92.0 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.377 -0.827 . . . . 0.0 109.399 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.43 -38.27 90.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.59 -0.694 . . . . 0.0 109.732 179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.1 m -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.612 . . . . 0.0 110.428 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.7 t -80.79 -37.91 29.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -68.27 -37.8 81.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.685 -0.634 . . . . 0.0 111.167 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -60.17 1.59 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -0.877 . . . . 0.0 111.673 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 70.8 m-85 -77.3 -39.72 46.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.134 -0.979 . . . . 0.0 111.075 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.74 11.94 36.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.52 158.34 17.29 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.043 -1.269 . . . . 0.0 110.074 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.4 m 62.32 40.42 11.31 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.386 0.612 . . . . 0.0 109.645 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.4 m -85.28 -59.19 2.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.472 -0.767 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -83.55 88.7 7.02 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.634 -0.666 . . . . 0.0 110.023 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.545 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.016 0.436 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p -82.45 68.93 9.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.448 -0.782 . . . . 0.0 109.856 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -75.75 130.15 38.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.556 -0.715 . . . . 0.0 110.21 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.4 -48.83 0.96 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -157.08 135.04 10.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.529 -0.983 . . . . 0.0 110.402 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.1 m -96.8 106.73 19.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.525 -0.735 . . . . 0.0 109.752 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 116.2 21.02 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.525 -0.735 . . . . 0.0 110.286 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.45 169.83 21.13 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.752 1.396 . . . . 0.0 111.174 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.461 ' HA ' HD22 ' A' ' 9' ' ' LEU . 0.7 OUTLIER 66.67 113.72 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.337 0.589 . . . . 0.0 111.331 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.55 105.88 1.05 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.426 -0.796 . . . . 0.0 109.526 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.0 85.7 0.15 Allowed Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.867 -0.521 . . . . 0.0 109.805 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.01 -164.65 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.85 1.447 . . . . 0.0 110.603 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -51.55 135.26 28.42 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.459 -0.776 . . . . 0.0 111.326 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 1.5 mtt85 -101.54 164.11 16.57 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.737 -0.602 . . . . 0.0 110.277 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 14' ' ' ARG . 46.8 Cg_endo -74.63 173.79 13.75 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 124.0 1.526 . . . . 0.0 110.556 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.65 150.75 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 121.639 -0.663 . . . . 0.0 110.492 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -162.71 158.55 23.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.436 -0.79 . . . . 0.0 110.803 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 18' ' ' ILE . 15.8 pt -78.83 68.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.695 0.759 . . . . 0.0 110.141 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.53 150.79 0.85 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.589 -0.694 . . . . 0.0 111.552 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.64 170.57 17.31 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.09 1.574 . . . . 0.0 111.578 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.8 mm -78.25 168.13 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 121.588 0.708 . . . . 0.0 110.664 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 105.31 -60.57 0.39 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.7 -31.21 72.08 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.653 -0.91 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.43 12.69 6.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 110.782 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 27' ' ' TYR . 11.3 t -139.69 63.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.272 -0.893 . . . . 0.0 109.381 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 96.0 m -48.2 -26.21 1.83 Allowed 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.714 -0.616 . . . . 0.0 111.134 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 25' ' ' VAL . 94.4 m-85 -100.72 128.62 46.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.818 . . . . 0.0 110.164 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.68 -26.17 15.15 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.425 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 36.6 pt -88.14 161.34 43.81 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.173 -1.192 . . . . 0.0 110.677 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 37.9 Cg_endo -74.33 154.25 45.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.203 1.633 . . . . 0.0 111.258 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 t -56.82 -41.42 77.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.955 -0.466 . . . . 0.0 111.104 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 t -61.56 -46.17 91.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.478 -0.764 . . . . 0.0 110.378 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 83.7 m -67.32 -41.25 85.58 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 0.0 108.934 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.37 -38.14 89.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.722 -0.611 . . . . 0.0 110.03 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.94 -45.47 93.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.537 -0.727 . . . . 0.0 109.535 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.2 -38.15 90.01 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.743 -0.598 . . . . 0.0 109.783 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -60.99 -34.61 75.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 0.0 110.349 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.6 t -80.38 -36.62 33.67 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.236 -0.915 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.58 -39.68 88.55 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.775 -0.578 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.17 -54.29 2.82 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.265 -0.897 . . . . 0.0 111.829 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 89.6 m-85 -81.9 -36.57 27.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.209 -0.932 . . . . 0.0 111.114 -178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.4 10.6 47.42 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.978 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -107.64 156.4 19.09 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.988 -1.301 . . . . 0.0 110.248 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 m 62.35 42.69 8.87 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.425 0.631 . . . . 0.0 109.743 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 m -81.53 -54.13 5.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.49 -0.756 . . . . 0.0 110.148 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.503 ' CD2' ' HB2' ' A' ' 47' ' ' LEU . 30.7 p-80 -77.56 -158.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.631 -0.668 . . . . 0.0 109.669 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.503 ' HB2' ' CD2' ' A' ' 46' ' ' HIS . 1.6 tt . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.652 -0.655 . . . . 0.0 110.603 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.856 0.36 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m 48.64 68.2 0.74 Allowed 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.359 0.6 . . . . 0.0 110.839 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 p -85.45 81.42 8.73 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.452 -0.78 . . . . 0.0 110.081 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.42 -88.76 1.56 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.2 t80 67.27 153.96 0.09 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.98 -0.718 . . . . 0.0 111.009 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.4 m -80.14 131.46 35.74 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mmt-85 -73.39 150.11 89.23 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.627 -0.67 . . . . 0.0 110.148 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.66 135.25 25.68 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.927 1.488 . . . . 0.0 110.872 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 tp 66.67 141.27 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.485 0.659 . . . . 0.0 111.221 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -60.8 134.92 57.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.379 -0.826 . . . . 0.0 109.591 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttt 61.89 95.11 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 121.975 -0.453 . . . . 0.0 110.299 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.38 -159.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.876 1.461 . . . . 0.0 110.691 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.6 t 65.54 -173.75 0.18 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.663 -0.648 . . . . 0.0 110.921 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -77.45 135.37 65.28 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.16 166.03 29.86 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.974 1.513 . . . . 0.0 111.099 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.1 pt -72.63 172.33 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 121.329 0.585 . . . . 0.0 110.868 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.98 152.52 45.41 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.624 -0.672 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 pt -107.68 -177.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.572 -0.705 . . . . 0.0 110.698 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER 65.15 150.07 0.12 Allowed Pre-proline 0 N--CA 1.501 2.11 0 CA-C-O 121.035 0.445 . . . . 0.0 111.404 179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.55 176.67 7.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.799 1.421 . . . . 0.0 111.909 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 22' ' ' GLY . 1.7 mm -76.0 167.29 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.682 0.753 . . . . 0.0 110.823 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 105.73 -62.79 0.32 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' ' CD2' ' A' ' 41' ' ' TYR . 5.3 m -69.6 -28.02 65.59 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.746 -0.855 . . . . 0.0 110.668 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.36 9.28 6.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.428 -0.795 . . . . 0.0 110.918 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.46 64.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.203 -0.936 . . . . 0.0 108.871 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.7 m -49.44 -24.6 2.08 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.761 -0.587 . . . . 0.0 111.275 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -104.38 126.27 51.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.361 -0.837 . . . . 0.0 110.119 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -27.12 10.87 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.464 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 39.4 pt -82.79 161.82 57.24 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.159 -1.2 . . . . 0.0 110.658 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 38.0 Cg_endo -73.79 155.63 48.83 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.167 1.614 . . . . 0.0 111.227 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 t -58.76 -38.34 78.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.816 -0.552 . . . . 0.0 111.084 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -62.65 -45.08 94.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.365 -0.834 . . . . 0.0 109.876 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 30' ' ' PRO . 99.0 m -69.52 -40.73 76.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.48 -40.09 95.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.814 -0.554 . . . . 0.0 110.199 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -64.47 -43.16 95.06 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.497 -0.752 . . . . 0.0 109.559 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.2 -37.42 83.6 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.619 -0.676 . . . . 0.0 109.629 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.0 OUTLIER -62.8 -29.93 71.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.204 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.1 t -88.36 -36.82 16.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.346 -0.846 . . . . 0.0 109.696 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -68.5 -39.01 81.44 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.729 -0.607 . . . . 0.0 110.947 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -99.15 -61.75 1.33 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.37 -0.831 . . . . 0.0 111.515 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 79.6 m-85 -73.42 -42.2 62.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.291 -0.881 . . . . 0.0 111.178 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.62 10.39 31.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 41' ' ' TYR . 2.1 m-20 -102.6 160.78 14.27 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.049 -1.265 . . . . 0.0 109.911 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.7 m 60.85 40.31 15.94 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.335 0.588 . . . . 0.0 109.704 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 56.7 m -91.69 -59.65 2.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 0.0 110.213 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -87.94 87.07 7.24 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.661 -0.649 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.879 -1.058 . . . . 0.0 110.41 -179.888 . . . . . . . . 0 0 . 1 stop_ save_